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ABSTRACT
SYNTHESIS AND CHARACTERIZATION OF BIOMIMETIC MODELS OF
MONONUCLEAR NONHEME IRON DIOXYGENASES
AND THEIR REACTIVE INTERMEDIATES
Anne Fischer, B.S.
Marquette University, 2018
Mononuclear non-heme iron dioxygenases (MNIDs) are a class of enzymes that
catalyze a variety of reactions, from amino acid catabolism to bioremediation using
molecular oxygen. This work focuses on three types of MNIDs: thiol dioxygenaes
(TDOs), aminophenol dioxygenases (APDOs), and sulfoxide synthases (SOSs). TDOs,
found in mammals, regulate the levels of cysteine along with other thiol-containing
molecules, using molecular oxygen to convert them into their corresponding sulfinic
acids.
APDOs catalyze the oxidative ring cleavage in the biodegradation of
nitroaromatics. SOSs are involved in the biosynthesis of large biologically relevant
molecules in humans. Although this class of enzymes has gained more attention in recent
years, their catalytic mechanism is still not well understood. In order to gain more insight
into these procedures, synthetic models have been prepared and studied. This is a
common strategy used to learn more about the structural and electronic properties of
enzymes as well as their reactivities because small-molecule metal complexes are
generally easier to prepare, handle, and characterize. Also, it is possible to trap reactive
species and catalytic intermediates in synthetic systems due to greater flexibility in
structure and reaction conditions. There have been previously published synthetic
models of TDOs and APDOs, but they lack the correct coordination, charge, or reactivity
to mimic the active sites of the enzymes. There have been no reports of synthetic models
of SOSs in literature to date.
Series of iron-containing biomimetic complexes were made to mimic the active
site structures of these enzymes. A variety of spectroscopic techniques were used to
characterize these complexes – these techniques include 1H NMR, UV-Vis, infrared,
electron paramagnetic resonance, and resonance Raman spectroscopies. Computational
studies, elemental analyses, and electrochemical studies were also performed. The
reactions of these complexes with O2 were studied extensively, using the techniques
mentioned above. Other small molecules that mimic the binding of O2 were also used to
probe the metal center – including nitric oxide, cyanide, and azide. Additionally, cobalt
was substituted for the iron center because it is more spectroscopically accessible, giving
even more insight into the active site structre.
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CHAPTER 1
Introduction to Non-heme Iron Dioxygenases and Synthetic Models

(Ye,S.; Wu, X.; Tang, D.; Sun, P.; Bartlam, M.; Rao, Z. J. Biol Chem.,
2007, 282, 3391-3402)

Abstract
Non-heme iron dioxygenases are a class of enzymes that catalyze a variety of reactions,
from amino acid catabolism to bioremediation. This work focuses on two types of
mononuclear nonheme iron dioxygenases: cysteine dioxgyenase (CDO) and aminophenol
dioxygenase (APDO). CDO regulates the level of cysteine in mammals, whereas APDO
catalyzes the oxidative ring cleavage in biodegradation pathways. APDO contains the
commonly observed 2-histidine-1-carboxylate facial triad. CDO contains a unique 3histidine facial triad found only in a few other enzymes. The catalytic mechanisms of
these enzymes are still poorly understood. Biomimetic models have been synthesized
and characterized in order to gain more understanding about these enzymes. This chapter
gives the background of these enzymes along with previously published biomimetic
models.
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1.A. Introduction of mononuclear non-heme iron dioxygenases
Metalloenzymes and their reaction with O2 is a very important part of
biochemistry and have been studied for decades. These metalloenzymes feature one of
two metals found abundantly in nature – iron and copper.1 Iron enzymes containing
heme ligation around the metal center are fairly well understood.

Non-heme iron

enzymes, both mononuclear and dinuclear, are involved in a variety of reactions similar
to those seen for heme-containing enzymes, but are much less understood. In recent
years, more focus has been turned to understanding these non-heme iron enzymes.2 This
progress is due in large part by the various crystal structures obtained and the
development of refined spectroscopic and computational techniques to probe the active
sites. Most recently, the discovery of functional biomimetic systems have helped shed
light on how these iron centers activate dioxygen to perform such a wide range of
oxidative transformations.3
Most non-heme iron enzymes employ dioxygen as one of the substrates in the
catalytic reaction. These reactions without a catalyst are thermodynamically favorable,
but are extremely slow because they are spin forbidden and also because of the low
reduction potential of O2.2
Mononuclear non-heme iron enzymes (MNIDs) use either a high-spin ferrous site
to activate dioxygen (such as aminophenol dioxygenases) or a low-spin ferric site to
active the substrate ligand (such as introadiol-cleaving catechol dioxygenases).2 It was
found that most MNIDs that activate dioxygen have a very similar structural motif.
These active sites exhibited the iron(II) center ligated by three specific amino acid
residues – two histidines and one aspartic acid or glutamine, which was bound through
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the carboxylate moiety. This motif is now referred to as the 2-histidine-1-carboxyalte
(2H1C) facial triad. This class of enzymes catalyze a large number of reactions, from the
biodegradation of aromatic molecules to dihydroxylation. Because the 2H1C triad is
monoanionic, it serves as a great platform to bind a divalent metal ion. The three
remaining coordination sites, which are usually occupied by solvent ligands in the resting
state of the enzyme, allow for the substrate ligand to bind, along with O2. A general
mechanism for activation of these enzymes has been proposed based on various
crystallographic and spectroscopic studies.

The 6-coordinate resting state active site is

generally stable and unreactive toward O2. The substrate binds in a bidentate manner to
the metal center, releasing the three solvent molecules, resulting in a less stable 5coordinate structure. This unsaturated active site allows for the binding of O2. Once O2
is bound, the catalytic mechanism can proceed. Therefore, the metal center only becomes
reactive toward O2 after the substrate is bound. This structure allows the metal center to
activate both the substrate and dioxygen, and bring them close enough to each other to
react.3
Recently, another motif of MNIDs has been uncovered, where the three histidine
residues are bound to the iron(II) active site, referred to as the 3His facial triad. This
motif is only found in a select few microbial MNIDs: β-diketone dioxygenase (Dke1),
gentisate dioxygense (GDO), salicylate dioxygenase (SDO), and cysteine dioxygenase
(CDO). It is still unknown why this difference in structural motifs is present in these
particular enzymes.4
This chapter will focus on three specific types of MNIDs – cysteine dioxygenase
(CDO), aminophenol dioxygenase (APDO), and sulfoxide synthase (SOS). CDO and
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SOS contain the unique 3His facial triad, whereas APDO employs the 2H1C triad.
Although their active sites differ slightly, it is thought that the catalytic mechanisms are
similar. Here, I will discuss the background and characterization of the enzymes and
previously published biomimetic models.

1.B. Cysteine dioxgyenase, its homologues, and synthetic models

1.B.i. Discovery and characterization of cysteine dioxygenase
Cysteine dioxgyenase (CDO) is responsible for the catabolism of cysteine,
coverting L-cysteine to L-cysteine sulfinic acid (Figure 1.1). Cysteine sulfinic acid is used
in the production of other biologically relevant molecules, such as taurine, hypotaurine,
and pyruvate.5 Imbalances in cysteine catabolism can be very harmful and have been
proven to have a cytotoxic effect. This can lead to neurological disorders, such as Down
syndrome, Alzheimer’s disease, and Parkinson’s disease, as well as autoimmune diseases
including rheumatoid arthritis and systemic lupus erythematosus.6,7

Figure 1.1 The conversion of L-cysteine to L-cysteine sulfinic acid catalyzed by cysteine
dioxygenase.5
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CDO was first reported by Ewetz and co-workers in 1966,8 but the crystal
structure was not solved until 2006.9,10 The crystal structure consists of a monomer with
two α-helices (α1 and α2), one mixed helix with half α-helix and half 310 helix (α3), one
single-turn 310 helix (α4), thirteen β strands that form two antiparallel β-sheets (β5, 6, 8
and β10, 11), and one mixed β-sheet (β1-4, 7, 9) (Figure 1.2). CDO is considered to be
part of the cupin protein family because of its β-barrel shape. The cupin family consists
mostly of iron containing enzymes, with certain conserved residues contained in a βstrand.11

Figure 1.2. The overall crystal structure of cysteine dioxygenase obtained by Etwetz.
Figure obtained from Reference 12.
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The typical active site of non-heme iron dioxygenases consists of a 2-histidine-1carboxylate (2H1C) facial triad bound to the ferrous center (Figure 1.3A). CDO is
unique in that it exhibits a neutral 3-histidine (3His) facial triad (Figure 1.3B), which has
only been seen in a select few enzymes.5 CDO has a high affinity for L-cysteine,
exhibiting low to no reactivity with D-cysteine, glutathione, or L-cystine.6 The L-cysteine
substrate binds in a bidentate manner, though the thiolate sulfur and amine nitrogen,
forming a 5-coordinate complex. This coordinatively unsaturated active site allows for
the activation and binding of molecular oxygen.5
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A)

B)

Figure 1.3. A) The typical 2-Histidine-1-carboxylate facial triad found in most nonheme iron dioxygenases. B) The unique 3-histidine facial triad found in the active site of
cysteine dioxygenase. Figure obtained from Reference 5.
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1.B.ii. Cys-Tyr cofactor
Another unique feature of CDO is a crosslink between Cys93 and Tyr157, 3.3 Å
away from the active site.5 The sulfur of cysteine is linked to the ortho position of
tyrosine (Figure 1.4). Although this post-translationally modified adduct is not bound
directly to the iron center, it is close enough to be involved in hydrogen bonding
interactions that could be crucial to the catalytic cycle. In 2007, Ye and co-workers were
the first to perform several studies involving mutations of certain conserved residues in
order to grasp the importance of this crosslink.

Tyr157 was replaced with a

phenylalanine, and the catalytic activity dropped to ~5% of the wild type enzyme. This
result indicates that the hydroxyl group of the tyrosine is crucial for efficient catalysis.
Similarly, Cys93 was replaced with a serine, and catalytic activity was reduced to
~50%.12

Figure 1.4. Structure of the Cys-Tyr crosslinked cofactor found near the active site of
cysteine dioxygenase. Figure obtained from Reference 5.
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Another metalloenzyme known to have this Cys-Tyr cofactor is galactose
oxidase, which as been studied extensively. The active site contains a copper center
which is directly coordinated to the tyrosyl oxygen of the Cys-Tyr cofactor. This leads to
a decrease in the bond dissociation energy of O-H, aiding the formation of a Cu(II)tyrosyl radical.

However, since this cofactor acts as a ligand, its function may be

different than that of the same adduct in CDO.12
Ye and co-workers proposed two different roles for this Cyr-Tyr crosslink. First,
it could act as a structural aid, stabilizing the active site of the resting enzyme through
hydrogen bonding to a labile water ligand. Stabilizing this geometry would prevent the
ferrous center from being oxidized, leading to the inactive ferric form. The second
proposed role is prevention of hydroxyl radicals, which can be very harmful to the
enzyme. During the catalytic cycle, the dioxygen bond is cleaved, creating unstable
oxygen-derived intermediates, which could be stabilized by interaction with the hydroxyl
hydrogen of Tyr.12
However, not all types of CDO possess this cofactor. CDO expressed by bacteria
have glycine residue instead of Cys93.

Bacterial CDO have an octahedral

[Fe(NHis)3(H2O)3] geometry in the resting state, as opposed to the less stable tetrahedral
geometry found in mammalian CDO. Even in the absence of the cofactor, these enzymes
have a high activity and the same substrate specificity as mammalian CDO.
Superposition of the two different active sites revealed that the corresponding Tyr164 is
still approximately in the same position as Tyr157 (Figure 1.5).13
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Figure 1.5. A) Active site of mammalian cysteine dioxygenase. B) Comparison of the
active site of mammalian CDO (black) and bacterial CDO (green). Figure obtained from
Reference 13.
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The biosynthesis of this Cys-Tyr cofactor was studied by Dominy and co-workers
in 2008. This sytnethesis proved to have two unique features that set it apart from those
found in other enzymes. First, the enzyme itself has to be functional. In other cofactorcontaining enzymes, the cofactor is produced before the enzyme becomes catalytically
active.

However, in CDO, the cofactor is produced after the enzyme becomes

catalytically active. The second unique feature is that the substrate cysteine is essential
for the assembly of the cofactor. In the absence of the substrate, the cofactor was not
produced upon addition of O2 and ferrous iron. Adding different substrates instead of Lcysteine, such as 2-aminoethanethiol and β-mercaptoethanol, did not prompt production
of the cofactor. One reason for this dependence on cysteine could be the substrate
binding order of CDO. The wild type enzyme in the absence of L-cysteine was totally
unreactive to nitric oxide (NO) and, theoretically, molecular oxygen. However, in the
presence of L-cysteine, NO was bound to the iron center, indicating the enzyme was now
active. This suggests that the substrate must bind before any other reactions can occur.
Because it is substrate-dependent, it was proposed that the function of this Cys-Tyr
cofactor is to control cysteine levels in vivo. When cysteine levels increase, the cofactor
is formed, causing the enzyme to have a higher turnover rate.13
The mechanism of cofactor formation proposed by Dominy can be seen in Figure
1.6. First, molecular oxygen reacts with the ferrous center to form a ferric superoxide
complex in the presence of excess cysteine (2). This intermediate then interacts with
Tyr157 to form a radical, and the ferrous center is restored (3). The thiol group of Cys93
adds to the ortho position of Tyr157 (4). A proton coupled electron transfer occurs from
the tyrosine to the iron superoxide moiety (5), generating a cation radical that rearranges
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to form the cross-linked species (6). Dissociation of hydrogen peroxide returns the iron
center to its resting state (7).13

Figure 1.6. The proposed biosynthesis of the Cys-Tyr cofactor of CDO. Figure obtained
from Reference 13.

Due to a lack of solid evidence regarding purpose and function, studies of this
Cys-Tyr crosslink are ongoing.

In 2013, Li et. al. investigated the second sphere

interactions with regard to the cofactor.7 In general among MNIDs, second sphere
residues surrounding the active site are used to control unstable intermediates during the
catalytic cycle (i.e. the reactive Fe-oxo intermediates). In CDO, there is a conserved
arginine (Arg60) residue 2.27 – 2.88 Å away from the carboxylate group of cysteine, a
favorable distance for a stabilizing hydrogen bond. Similarly, the hydroxyl group of
Tyr157 could also play a role in hydrogen bonding, being 2.75 Å away from the
carboxylate group of the substrate (Figure 1.7). When the substrate is changed to Dcysteine, both of these hydrogen bonds are disrupted, which could explain the specificity
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of this enzyme. This suggests that Tyr157 is an important enzyme-substrate interaction
point.7

Figure 1.7. Second sphere interactions with the substrate-bound active site. A) Structure
of the resting form of mammalian CDO showing some conserved residues. B) Hydrogen
bonds form between the cysteine substrate and the conserved R60 and Y157 residues.
Figure obtained from Reference 7.
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In 2015, Arjune and co-workers studied the effect that the Cys-Tyr crosslink had
on the iron binding at the active site. Studies were done with wild type (wt) CDO and the
enzyme with Cys93 replaced with alanine.

First, the iron was removed from both

enzymes by using EDTA to chelate the iron. The mutated enzyme was inactivated with a
much lower concentration of EDTA than wt CDO, suggesting the iron was more easily
removed. Next, iron was titrated back into the enzyme, and the activity was measured. A
much higher concentration of iron was needed to restore any activity for the mutated
enzyme, and maximum activity was never achieved. This suggests that the Cys-Tyr
cofactor plays a role in binding or the stabilization of iron in the active site of CDO.14
In summary, the exact function of this Cys-Tyr crosslink is still unknown.
Although it is not necessary for catalysis, it greatly increases the catalytic efficiency of
CDO. When excess cysteine is present, the cofactor is formed, and catalytic efficiency
increases. It has unique biosynthetic requirements in that the enzyme must already be
catalytically active, and the cysteine substrate must be previously bound to the active site.
Not all types of CDO contain this cofactor - it is absent in bacterial CDO, which also
differs by featuring a stable octahedral geometry in the resting state.
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1.B.iii. Characterization of the nitrosyl adduct of cysteine dioxygenase
Because ferrous iron is generally spectroscopically inactive and oxygen-based
intermediates are unstable, nitric oxide (NO) is often used as a probe to characterize the
active site and mimic how molecular oxygen binds. Electron paramagnetic resonance
(EPR) spectroscopy was used to characterize the nitrosyl adduct of resting-state and
substrate-bound CDO in order to determine its electronic structure. First, nitric oxide
was added to CDO in the absence of the L-cysteine substrate. This resulted in axial S =
3/2 EPR signal with characteristic g-values of gx > 4.0 and gy,gz = 2.0 (Figure 1.8). This
spectrum was identical to that of other known {FeNO}7 (S=3/2) species. The notation
{FeNO}7, called the Enemark-Feltham notation, is used to describe the number of d
electrons in the complex. There was an extra feature at g = 1.98, which was assigned to
free NO in solution. However, this S = 3/2 species only accounted for a small amount,
approximately 15%, of the total iron concentration. Increasing the amount of NO added
did not improve this percentage, but instead caused denaturation of the protein. Addition
of cysteine into this sample lead to sharp feature at g = 4.3, which is typical of high-spin
ferric iron (S = 5/2), with loss of the S = 3/2 species. Therefore, it was determined that in
the resting state of the enzyme, the ferrous active site has little reactivity toward NO, and
consequently little reactivity toward O2.7
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Figure 1.8.

X-band EPR spectrum after addition of NO to wild-type cysteine

dioxygenase. Figure obtained from Reference 6.

Alternatively, when nitric oxide was added to the substrate-bound form of CDO, a
signal appeared at g = 2.0, indicating the formation of an S = 1/2 species (Figure 1.9). A
trace amount of the {FeNO}7 (S = 3/2) species was observed in addition to a weak signal
at g = 4.3, which was assigned to high-spin Fe(III) (S = 5/2). Through simulation, it was
determined that the feature centered at g = 2 was comprised of two different S = 1/2
species, labeled A and B (Figure 1.10). Spectrum A is a sharp signal with g-values of
2.04, 2.03, and 2.01. This was reproduced by addition of NO to a solution of L-cysteine
and ferrous iron in the absence of CDO. It was determined that this signal arises from the
formation of the dinitrosyl complex, [Fe(NO)2(L)2], where L is the cysteine substrate.
Simulations determined that this signal accounted for only 4% of total iron concentration.
Spectrum B arises from the NO adduct of CDO, with g-values of 2.07, 2.02, and 1.98.
The hyperfine splitting constant, A, was calculated to be 60 MHz, which is in agreement
with previously published data for a nitrogen-based radical. This signal accounts for 67%
of total iron concentration. Therefore, reaction of CDO with NO exhibits a {FeNO}7 (S
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= 1/2) species, which is atypical of the usual {FeNO}7 (S = 3/2) species seen in other
non-heme iron dioxygenases. It is more common to see this S = 1/2 species in 5coordinate heme complexes.7
This unique {FeNO}7 (S = 1/2) species indicates that the ferrous iron is low-spin
(S = 0), coupled to the nitrosyl radical (S = 1/2), which was verified with DFT
calculations. {FeNO}7 species usually consist of a high-spin ferric center (S = 5/2)
antiferromagnetically coupled with the NO- anion (S = 1). However, there have been
previous reports of iron nitrosyl S = 1/2 species with complexes containing thiol and
amine ligands. It is still somewhat unclear what causes the ferrous center to be low-spin.
In general, thiols are categorized as weak-field ligands, which usually favor high-spin
systems. On the other hand, amines are considered to be strong-field ligands. Since the
coordination sphere is very rich in nitrogen donors, it is likely that this contributes to the
splitting of the d-orbitals of the ferrous center, causing the low-spin system.7
These studies confirmed that there is a specific binding order for the two
substrates, O2 (or NO) and L-cysteine (Figure 1.11). In the resting state, the active site
adopts a tetrahedral geometry with one solvent ligand that is stabilized by a hydrogen
bond with the Cys-Tyr cofactor. L-cysteine first binds to the ferrous center, stabilized by
electrostatic interactions with the conserved Arg60 residue. Only after this can O2 bind.7
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Figure 1.9. X-band EPR spectrum of the nitrosyl adduct of substrate-bound cysteine
dioxygenase. Figure obtained from Reference 7.

Figure 1.10. Close-up of the signal at g = 2 of the X-band EPR spectrum of the nitrosyl
adduct of substrate-bound CDO. There are two distinct species, labeled A and B. Figure
obtained from Reference 7.
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Figure 1.11.

Binding order of the two substrates, L-cysteine and O2, in cysteine

doxygenase. The substrate must bind first, followed by the binding and activation of O2.
Figure obtained from Reference 7.
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Magnetic circular dichroism (MCD) spectroscopy was used to further characterize
the NO adduct (Figure 1.12).

L-cysteine

was complexed to CDO first, then NO was

added. The spectrum showed some temperature-dependent features around 28,000 cm-1
that were very similar to what was observed in the spectrum before the addition of NO.
These features were assigned as the S à Fe(II) charge transfer transitions resulting from
a small amount of the Cys-bound CDO that did not react with NO. In addition to these
high-energy features, temperature dependent features at lower energies were also
observed. This indicated that NO binds directly to the ferrous center, which agrees with
the assignment of an {FeNO}7 (S = 1/2) species.

This study was also done with

selenocysteine (sec) as the substrate (Figure 1.12). Again, new features at lower energies
indicated NO bound to the ferrous center. These features are shifted from the Cys-CDO
features because of the different molecular orbital energies between Cys and Sec. The
EPR studies of both Sec- and Cys-CDO confirmed the similarities of these structures,
exhibiting spectra with almost identical g-values and hyperfine splitting.15
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Figure 1.12. Magnetic circular dichroism (MCD) spectra of Cys-CDO and Sec-CDO
reacted with nitric oxide. Features with an asterisk indicate unreacted Sec- or Cys-CDO.
Figure obtained from Reference 15.
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1.B.iv. Computational studies of cysteine dioxygenase and its catalytic mechanism
In order to obtain a greater insight into the active site of CDO, computations were
performed using DFT methods. Four different complexes were studied: Cys- and Secbound Fe(III)-CDO, and Cys- and Sec-bound Fe(II)-CDO. The active site models were
generated from the X-ray crystallographic coordinates of human Cys-bound CDO (Table
1.1). Generally, the geometric structures of the computational models were in good
agreement with the crystal structure.5

Table 1.1. Structural parameters of computational cysteine dioxygenase models. All
bond lengths are given in Å.5

Each model exhibits a trigonal bipyramidal active site, with His86, His88, and the
S of the cysteine substrate in the equatorial plane, and His140 and the N of the cysteine in
the axial positions. The optimized model of Cys-bound Fe(II)-CDO exhibits an Fe-S
distance that is longer than what is seen in the crystal structure (2.020 Å versus 2.257 Å),
but this distance is comparable to previously reported models with similar active sites.
Another notable feature is that the Fe-N distances are longer in the Fe(II) complexes, and
the Fe-substrate distances are shorter. One possible rationalization of this relates to
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hard/soft acid/base chemistry. Fe(II) is a softer acid than Fe(III), and therefore binds
more strongly to the soft S and Se atoms and not as strongly to the nitrogen.5
Based on the information gained from previous studies and comparison with wellcharacterized and studied enzymes, a mechanism was proposed (this will be referred to as
Mechanism 1) (Figure 1.13). The resting state (A) consists of Fe(II) bound to 3 histidine
residues and three water molecules. The substrate binds in a bidentate fashion dispersing
two of the water ligands (B). Hydrogen bonds with second sphere residues can help
stabilize this complex. Substrate binding requires deprotonation of the thiol, as well as
the ammonium cation to the neutral amine. This could possibly be facilitated by the CysTyr moiety of other surrounding residues, or surrounding water or hydroxide molecules.
Molecular oxygen then binds in an end-on fashion, with the release of the last water
molecule, to produce an iron(III)-superoxo species similar to what is seen in the other
non-heme iron enzymes (C). This superoxo complex increases the radical character on
the sulfur atom (D), causing a bond to form, and creating a cyclic peroxo intermediate
(E). Through hemolytic bond cleavage, a sulfoxy-cation radical is formed (F), which
then reacts with the oxyl ligand atom to form the metal-bound product (G).9

24

Figure 1.13. Proposed catalytic mechanism of the conversion of L-cysteine to L-cysteine
sulfinic acid catalyzed by cysteine dioxygenase (Mechanism 1). Figure obtained from
Reference 9.

This plausible mechanism was examined with computational methods by de
Visser and co-workers. As shown in Figure 1.14, energies were computed for each
transition state. The dioxygen bound complex (A) forms a hydrogen bond with the amine
nitrogen of the cysteine substrate, causing the dihedral angle to be almost 90˚. A ring
structure is formed when the terminal oxygen atom attacks the substrate sulfur, creating a
four-membered ring (B). The dioxygen bond then breaks to form intermediate C. This
complex has radical character on the sulfoxide group, which undergoes rotation around
the S-C bond, accompanied by an electron transfer. This causes the Fe-S bond to break,
and the second oxygen atom attacks the sulfoxide group (D). The quintet spin state
barriers were the lowest calculated transition states, and were used in the mechanistic
profile. The rate-determining step, with the highest energy transition state, involves
formation of the initial S-O bond activation (TSA). It is likely that the lifetimes of
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intermediates B, C, and D are very short, and may never be experimentally trapped and
characterized.

The bond distances calculated for these intermediates are in good

agreement with other non-heme iron dioxygenases.16

Figure 1.14. Potential energy profile calculated for the reaction catalyzed by cysteine
dioxygenase. Figure obtained from Reference 16.

In summary, the important results of this study are as follows: 1) The rate
determining step is the attack of the distal oxygen atom of superoxide on the sulfur atom
of the cysteine substrate, which subsequently weakens the O-O and Fe-S bonds, giving
rise to a sulfoxyl radical. 2) Rotation around the S-C bond, coupled with an electron
transfer to make the sulfur atom accessible to the second oxygen atom. 3) The second
oxygen-atom transfer leads to the cysteine sulfinic acid in a highly exothermic process.16
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Variations on this mechanism were also suggested as possible catalytic
mechanisms (Mechanisms 2 and 3) (Figure 1.15). Mechanism 2 mirrors mechanism 1 in
the first step, where a four-membered ring is formed. However, it differs in that an
iron(IV)=oxo species is formed as an intermediate, and one oxygen atom is bound to the
iron center in the product complex.

In mechanism 3, hydrogen bonding with the

hydroxyl group of the Tyr157 residue results in a different orientation of the dioxygen
molecule resulting in a 3-membered ring. Another ring structure is formed where both
oxygen atoms are bound to the sulfur, followed by cleavage of the O-O bond, and final
formation of the same product complex.17

Figure 1.15.

Other plausible mechanisms of sulfinate production in cysteine

dioxygenase. Figure obtained from Reference 17.
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Quantum

mechanics/molecular

mechanics

(QM/MM)

calculations

were

performed in order to determine if mechanisms B or C were more probable than
mechanism A.

QM/MM calculations were chosen because it allows the protein

environment to be taken into consideration. Previous studies with other enzymes have
shown that large errors can occur when the environment around the active site is not
taken into account.17
QM/MM computations started at the iron(II)-superoxo complex (A), which is the
starting intermediate for both mechanisms 2 and 3.

An interesting result of this

calculation was the O-O bond length (~1.3 Å). This length is comparable to values
reported for heme-based iron(II)-superoxo complexes. Hydrogen bonding interactions
with surrounding residues were also calculated (Figure 1.16). The distal oxygen forms a
hydrogen bond with the hydroxyl group of Tyr157 and the thiol of Cys93, along with the
amine group of the cysteine substrate. The proximal oxygen forms a hydrogen bond with
a hydrogen of His140, which forces the oxygen into a specific orientation.17
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Figure 1.16. Optimized geometry of the iron(II)-superoxo species. Hydrogen bonding
with the residues around the active site are shown as dotted lines (Od = distal oxygen, Op
= proximal oxygen). Figure obtained from Reference 17.

The calculations following mechanism 2 resulted in similar data to the DFT
calculations seen for mechanism 1. The rate determining step and product distributions
were the same in both cases.

In addition, both reactions were highly exothermic.

Calculations using QM/MM suggested that an iron(IV)-oxo complex forms after cleavage
of the O-O bond.17
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Alternatively, calculations of mechanism 3 resulted in intermediates that were
higher in energy than seen in mechanism 2. Because of this, mechanism 2 is favored
over mechanism 3.17
In is still unknown whether an Fe4+=O or Fe3+-O- intermediate is formed during
the catalytic cycle. It was recently proposed by Simmons and co-workers that a threemembered Fe-S-O ring, as seen in mechanism 3,18 is involved in the catalytic cycle after
they observed it in their crystal structure of CDO. However, it was proven that this
species is not catalytically active.17,19

1.B.v. Homologues of cysteine dioxygenase
Cysteine dioxygenase is only on of a few enzymes that catalyze the oxidation of a
thiol. Another known enzyme is cysteamine (2-aminoethanethiol) dioxygenase (ADO).
ADO, also in the cupin family, was discovered around the same time as CDO, but has not
received much attention because of the efforts directed towards understanding CDO.
ADO catalyzes the oxidation of cysteamine to hypotaurine (Figure 1.17). Cysteamine is
a product of the degradations of coenzyme A, and is thought to play a role in regulating
immune system activity. It has potential for being a therapeutic agent for Huntington’s
disease.20
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Figure 1.17.

Conversion of cysteamine to cysteamine sulfinic acid catalyzed by

cysteamine dioxygenase.20

Figure 1.18. Two different pathways of the production of taurine by CDO and ADO.20

Because of the similarities of the reactions catalyzed, it was hypothesized that the
active site structures of CDO and ADO have many similarities. It was found that ADO
and CDO have comparable kinetics and share 14.2% sequence homology. ADO was
then tested to see if it could oxidize L-cysteine. L-cysteine sulfinic acid was not produced,
and it was not an inhibitor of ADO activity. This suggests that cysteine does not bind to
the metal center. Another substrate similar to cysteamine, 2-mercaptoethanol, was also
tested as an inhibitor of ADO activity. This substrate differs from cysteamine in that the
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thiol group is replaces with a hydroxyl moiety. Again, this substrate was not an effective
inhibitor of ADO activity. The active site of ADO must have a high degree of specificity
for cysteamine.20
Analysis of the active site was performed with plasma emission spectroscopy
indicating that iron is present in the active site, with an occupancy of 96.1%. Small
amounts of zinc (1.5%) and nickel (1%), and trace amounts of copper were also detected.
To test the specificity of iron binding and its requirement for catalysis, His95 was
replaced with an alanine. This histidine residue was chosen because it is a highly
conserved residue near the active site in cupin proteins. It was found that this mutation
greatly decreased iron content and catalytic activity. This suggests that His95 is involved
in the binding of the metal in the active site, and that iron is needed for cysteamine
dioxygenase activity.20
CDO and ADO provide different pathways for the production of the same
molecule, taurine (Figure 1.18). The CDO pathway converts cysteine to cysteine sulfinic
acid, which is then converted to hypotaurine and finally taurine. Similarly, the ADO
pathway converts cysteamine to hypotoaurine, then taurine. However, it is still unknown
how much taurine is produced from each pathway.20
Another homologue of CDO is 3-mercaptopropionate dioxygenase (3MDO), and
enzyme that catalyzes the initial step of 3-mercaptopropionate catabolism in bacteria that
break down 3,3-thiodipropionic acid (TDP). It was hypothesized that bacteria could use
the products of this biodegradation as a source of carbon and energy. TDP is cleaved by
an unknown enzyme to produce 3-hydroxypropionic acid as well as 3-mercaptopriopionic
acid (3MP). 3MP then is converted to 3-sulfinopropionic acid by 3MDO. Reaction with
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coenzyme A generages sulfite, and the resulting propionyl molecule is further
metabolized as a source of energy (Figure 1.19). The regulation of levels of 3MP is
important because this molecule is toxic in mammals, inhibiting the oxidation of fatty
acids as well as inhibiting certain neurotransmitters, causing deformation and seizures. It
also causes resistance to antibiotics.21

Figure 1.19. Pathway of the biodegradation of 3,3-thiodipropionic acid.21

The structure of 3MDO also contains the cupin motif and is very similar to that of
CDO, but the conserved Arg60 residue found in CDO is replaced by a glutamine. This
results in different substrate specificity. There is a conserved tyrosine residue, Tyr159,
near the iron active site along with 3 histidine residues. However, there is no evidence
that this tyrosine is involved in a covalent crosslink as seen in CDO. The iron center in
the resting state of the enzyme adopts a distorted octahedral geometry, with three labile
water ligands. Superposition of the active site of 3MDO and CDO reveal that the active
sites are in slightly different positions, but the distances from the conserved Tyr residues
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are approximately the same. When the two iron centers are aligned, there is a large
difference between Arg60 and Gln62 (Figure 1.20). Again, this probably plays a role in
substrate specificity.22
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Figure 1.20. Superposition of the active site of 3MPO and CDO. A) The peptide
backbones of the two enzymes are aligned B) The iron centers of the two enzymes are
aligned. Figure obtained from Reference 22.
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3MPO was tested for CDO activity by using L-cysteine as the substrate. Cysteine
sulfinic acid was produced upon the addition of O2. The rate and amount of this product
formed was consistent with the data known for CDO. As in CDO, other potential
substrates, N-acetyl-L-cysteine,

D,L-homocysteine,

and cysteamine were not effective in

inhibiting the oxidation of L-cysteine.22
Mössbauer spectroscopy was used to compare the substrate binding of 3MPO and
cysteine-bound 3MPO. The two spectra exhibited the same isomer shift, suggesting that
the thiol is bound to the iron in both cases. However, the quadropole splitting shown in
the two spectra are quite different, with a difference of -0.39 mm s-1. This could be due
to the different charges of the complex, different binding geometries, or a combination of
both. It was also suggested that the 3MP might only be bound by the thiol sulfur.22
It was proven that the bacteria were not able to grow with 3MP as the sole source
of carbon, but they were able to grow with cysteine as the sole source. Mutation studies
were performed, but this did not prevent the growth in the presence of cysteine. This
suggests 3MPO is not essential for thiol catabolism, and that another enzyme is present
for this function. The physiological role of 3MPO is still unknown.22
The last known homologue of cysteine dioxygenase is mercapotosuccinate
dioxygenase. Mercaptosuccinate (MS) is a versatile organic compound used in a variety
of fields. For example, MS is used in bioimaging for the detection of markers in breast
cancer cells, as a stabilizing agent in the formation of quantum dots, and is used in drug
delivery systems. As seen in all CDO homologues, MS dioxygenase couples O2 with the
substrate to produce its suflinic acid derivative. Through desulfination, succinate and
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sulfite are produced, and the latter is converted to sulfate (Figure 1.21). No other enzyme
is needed for this last transformation, indicating the unstability of sulfinosuccinate.23
Again part of the cupin superfamily, MS dioxygenase has a similar overall
structure to CDO. As seen in 3MPO, the conserved Arg60 residue observed in CDO is
replaced, but this time with an alanine. Cys93 is also replaced by an alanine, indicating
that the conserved tyrosine residue found near the active site does not participate in any
crosslink.23
To test for the substrate specificity of this enzyme, cysteine, dithiothreitol, 2mercaptoethanol, and 3-mercaptopropionate were tested for activity. No catalytic activity
was observed when these were the sole substrates, and when MS was pre-complexed, no
inhibition was observed. In addition, no inhibition was observed in the presence of the
products, succinate and sulfite. This indicates very high affinity for the MS substrate.
The apo-enzyme was substituted with a variety of different metals, such as cobalt,
copper, iron(III), magnesium, manganese, nickel, and zinc, and tested for catalytic
acitivity. MS dioxygenase only showed activity with the native iron(II), and none of the
other tested metals showed any activity. When these metals were added in the presence
of iron(II), the activity of the enzyme was not affected. Therefore, only iron(II) is
capable of binding to the active site.23
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Figure 1.21. The reaction catalyzed by mercaptosuccinate dioxygenase.23

1.B.vi. Biomimetic models of cysteine dioxygenase
There have been few previously published synthetic models of cysteine
dioxygenase.

First in 2010, Goldberg and co-workers synthesized a complex with

structural similarities to CDO. This complex employed a tetradentate ligand with one
sulfur and three nitrogen donors bound to iron(II) ([Fe(N3S)(OTf)], complex 1). A few
key considerations were taken into account when synthesizing this complex. First, three
neutral nitrogen donors were incorporated to mimic the 3His facial triad found in CDO.
Second, the iron(II) center needed to be stabilized by the ligation. Third, a thiolate donor
was needed to mimic the cysteine substrate.

Lastly, steric protection against the

formation of unwanted biproducts, such as O- or S-bridged Fe complexes. These criteria
were met through a bis(imino)pyridine (BIP) ligand with a pendant thiolate donor. This
complex reacted with O2 to produced an S-oxygenated product ([Fe(LN3SO3)], compex
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2). This reaction can be seen in Figure 1.22. This is the first reported Fe(II)-thiolate
complex that reacts with O2 to produce an S-oxygenated complex, as opposed to disulfide
formation or iron oxidation.24

Figure 1.22. Synthesis of complex 2 and its oxygenation to form complex 2. Figure
obtained from Reference 24.

This reaction was studied by laser-desorption ionization mass spectroscopy
(LDIMS), which indicated loss of the starting material and a new peak corresponding to
the triply-oxygenated product. At short reaction times, a peak corresponding to the
doubly oxygenated product appears, but disappears as the reaction proceeds. EPR studies
of the oxygenated complex indicated a high-spin Fe(III) center, but integration shows that
this signal only accounts for approximately 5% of total iron content, suggesting that the
iron center is still in its +2 oxidation state. Additionally, an isotopic labeling study with
18

O2 was done in order to gain insight into the mechanism. Addition of 18O2 to 1 resulted
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in [Fe(LN3S(18O)3)]+. None of this complex, or any 18O coordination, was observed when
H2(18O) was added to 1.24
These studies suggested that there could be two possible catalytic mechanisms.
The first option is the incorporation of one molecule of O2 before or after the addition of
a single O atom, referred to as 2 + 1 addition. Alternatively, three oxygen atoms could be
added stepwise, known as 1 + 1 +1 addition. To try to differentiate between these two
mechanisms, another isotopic study was done with an

18

O2/16O2 mixture.

LDIMS

simulations of both pathways concluded that the 2 + 1 mechanism is the major pathway.
The fact that no singly oxygenated complex was ever detected suggest the first one
dioxygen molecule is added, followed by a single oxygen atom.24
The role of the iron center was still unknown, so a study with Zn(II) incorporated
into the complex instead of Fe(II) was performed to see if the metal center needs to be
redox active. After exposure of this zinc complex to O2 for several days, no reaction was
observed, indicating that Fe(II) is crucial for catalysis.24
Computational studies were performed on 1 in order to formulate a plausible
catalytic mechanism. First, the energies required for the binding of O2 directly to the
sulfur atom versus the binding of O2 to the iron center were compared. It was found that
binding of dioxygen to the iron center was much more energetically favorable. This
iron(III)-superoxo moiety was used as the starting point for further calculations. The
mechanism of the oxidation of the thiolate group was modeled after the computational
study of cysteine dioxygenase, as discussed previously.

Starting with the iron(III)-

superoxo moiety, the distal oxygen atom attacks the sulfur atom to form a four-membered
ring. The dioxygen bond then breaks to form a sulfenate ligand and an iron(IV)-oxo unit.
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This species has been identified and characterized using X-ray crystallography,
spectroscopic methods, and DFT calculations.25,26 Rotation of the S-O group leads to the
second oxygen atom transfer. The potential energy diagram, calculated for the singlet,
triplet, and quintet states (Figure 1.23) is similar to the one calculated for CDO, with the
same rate-determining step.27

Figure 1.23. Potential energy diagram of the reaction catalyzed by complex 1. Figure
obtained from Reference 27.

Two more biomimetic complexes were synthesized by Goldberg and co-workers,
but these complexes involved an untethered thiolate ligand: [Fe(iPrBIP)(SPh)(Cl)]
(complex 3) and [Fe(iPrBIP)(SPh)(OTf)] (complex 4) (Figure 1.24). The reactivity of
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these complexes with molecular oxygen were examined and compared with their nonthiolated analogues to discern the effect the sulfur moiety has on reactivity.28
The reaction of 3 with O2 was monitored by UV-Vis spectroscopy. A feature at
λmax = 715 nm disappeared as the reaction progressed, and a new feature appeared at λmax
= 690 nm. This spectrum is very similar to a previously reported [(BIP)Fe4+(oxo)]
complex, which exhibited a feature at λ = 660 nm. LDIMS also gave evidence that a
high valent iron(IV)-oxo species was formed.

1

H NMR spectroscopy determined that a

disulfide bond was formed during the reaction. The product was determined to be
[Fe4+(iPrBIP)(O)(Cl)]. The formation of an iron(IV)-oxo species from iron(II) and O2
required an external reductant. In this case, the thiolate ligand served this purpose.28
The reaction of 4 with O2 followed a very different path. Reaction of 4 with O2
resulted in the S-oxygenated product, [Fe(BIP)(PhSO3)], as confirmed by LDIMS and 1H
NMR spectroscopy.28
The O2 reactivities of the non-thiolated analogues, [Fe(BIP)(Cl)2] and
[Fe(BIP)(OTf)2], were also explored.

These complexes were completely unreactive

toward O2. Therefore, the thiolate ligand clearly plays a crucial role in the activation of
O2 by these complexes.28
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Figure 1.24. Synthesis of complexes 3 and 4. The X group of 3 is Cl, the X group of 4
is OTf, and Ar = 2,6-ipr2C6H3. Figure obtained from Reference 28.

Table 1.2. Redox potentials for the complexes 3 and 4 and related complexes. E1/2
values are given in V, referenced to Fc+/Fc.28

To try to rationalize these observations, the redox potentials of all of these
complexes were examined (Table 1.2). The thiolated complexes have more negative
potentials compared to the non-thiolated analogous, rationalizing their O2 reactivities.
These redox potentials were compared to a known complex, [Fe(TMC)(OTf)2], TMC =
1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane, which reacts with O to produce
an iron(IV)-oxo species.28
The question of why 3 reacted with O2 so differently than 4 still needed to be
answered. The crystal structures of these two complexes revealed one key difference
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between the structure of these two complexes (Figure 1.25). In complex 3, the SPhligand is trans to the open coordination site, where O2 is theoretically bound during the
catalytic cycle.28 Alternatively, complex 4 shows the SPh- ligand to be cis to this site.
This puts the sulfur atom in a position to react with the bound oxygen, allowing the Soxygenated product to be formed.28
Based on this information obtained, general catalytic mechanisms for both
complexes 3 and 4 were proposed. For comples 3, O2 binds to the vacant coordination
site, followed by an electron transfer to the bound O2, which goes on to form the
iron(IV)-oxo species along with the disulfide molecule. In the mechanism for 4, the same
iron(III)-O2- intermediate would directly react with the sulfur atom, creating a fourmembered ring. This would eventually lead to release of the triply-oxygenated product
(Figure 1.26).28
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Figure 1.25. Thermal ellipsoid plots obtained from the crystal structures of complexes 3
(top) and 4 (bottom). Figure obtained from Reference
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Figure 1.26. Catalytic mechanisms of complexes 3 (a) and 4 (b). Figure obtained from
Reference 28.

In order to try to improve complexes 1 and 4, a pentadentate ligand with 4nitrogen donors and 1-sulfur donor was synthesized to try to better model the CDO active
site. [Fe(N3PyS)(CH3CN)]BF4 (complex 5) was synthesized and reacted with O2 to
produce a doubly-oxygenated sulfinato complex (Figure 1.27). SCN- was added as a
labile ligand for the open coordination site of the product in order to stabilize it.29
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Figure 1.27. Reaction of complex 5 with O2 and NCS-. Figure obtained from Reference
29.

The crystal structure of the oxygenated product was obtained (Figure 1.28). It
was also characterized by UV-Vis and IR spectroscopies, all of which agree with the
crystal structure. Isotope labeling studies with 18O2 were done in order to gain some
insight on the mechanism. When complex 5 was reacted with 18O2, 14% of the procut
contained a mixture of S16O18O, while 2% contained S18O2. This suggests that molecular
oxygen is not the only source of O atoms during the reaction, and that most likely H2O
undergoes exchange as the reaction progresses. To test this, the reaction was carried out
using H2(18O). This produced 70% S18O2 and 28% S16O18O. H2(18O) was also added to a
solution of the already oxygenated complex. No exchange occurred in this case, so it is
likely that the exchange occurs for an intermediate. Sulfenato complexes ([M(RS)(O)])
have been shown to undergo this type of exchange with H2O.29
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Figure 1.28. Thermal ellipsoid plot of the oxygenated form of complex 5. Figure
obtained from Reference 29.

The reactivity of complex 5 with nitric oxide was also studied to further prove
that O2 reacts with the iron active site instead of directly with the sulfur ligand. As
mentioned in the previous sections, the {FeNO}7 adduct of CDO is unique because it is
an S = 1/2 system, instead of the more common S = 3/2 species. It is important for the
biomimetic complexes to exhibit this same feature to be an accurate representation of the
enzyme. Reaction of complex 5 with NO lead to the nitrosyl adduct (Figure 1.29) in
good yield (~75%). The crystal structure of this adduct was obtained and showed that
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NO did in fact bind directly to the iron center. The all-N analogue of this complex was
also reactive toward NO, and the crystal structure was similar.30
The Fe-N(pyridine) distances in the nitrosyl adduct were elongated compared to
starting complex 5, with an average increase of 0.0739 Å. The amine Fe-N distance was
the most effected with a change in 0.144 Å. This rationalized by the trans-influence that
NO exhibits. The IR spectrum of the nitrosyl adduct of 5 showed two ν(N-O) bands at
1753 and 1660 cm-1. Both of these bands shifted upon addition of 15N18O, to 1677 and
1587 cm-1. Alternatively, the all N-analogue only exhibits one feature, at 1672 cm-1. It is
unknown why the nitrosyl adduct of 5 exhibits two features, instead of the expected one
feature. The EPR spectra of the nitrosyl complexes indicated they are both S = 1/2
species. The g- and A-values (g = 2.047, 2.007, 1.962; A = 40, 59, 40) are in good
agreement with the nitrosyl adduct of CDO (g = 2.071, 2.022, 1.976, A = 27, 60, 28).
This is the first time this type of electronic structure was seen in a synthetic complex with
an N4S ligation environment. Therefore, it is an accurate structural and electronic model
of CDO.30

Figure 1.29. Reaction of complex 5 with nitric oxide. Figure obtained from Reference
30.
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DFT calculations were done to understand the electronic distribution of this
{FeNO}7 (S = 1/2) species. There are theoretically three possibilities: low-spin iron(II)
(S = 0) coupled to an NO radical (S = 1/2), low-spin iron(III) (S = 1/2) coupled to the NO
anion (S = 0), or intermediate-spin iron(III) (S = 3/2) coupled antiferromagnetically to the
NO anion (S = 1). The calculation suggested that this species is low-spin iron(II) coupled
to the NO radical.30
Overall, Goldberg and co-workers synthesized a structural and electronic model
of cysteine dioxygenase. The nitrogen rich ligation environment around the ferrous
active site, along with one sulfur donor, is very similar to what is seen in the enzyme.
Upon addition of nitric oxide, a rare {FeNO}7 (S = 1/2) species was formed, instead of
the usual S = 3/2 species seen in synthetic non-heme iron complexes. This unique
electronic structure is also seen in the nitrosyl adduct of CDO.30
Another series of biomimetic complexes was synthesized by Limberg and coworkers. A well-known tris(pyrazolyl)borato ligand system was used to model the 3histidine active site of CDO. Again, it was important to protect against the Fe-O-Fe
byproduct that can form upon oxygenation, and the sterics of this ligand system
accomplished this. L-cysteine ethyl ester (HCysOEt) was used as the cysteine substrate to
form the complex [Fe(TpPh,Me)(CysOEt)] (complex 6) (Figure 1.30). The crystal structure
of complex 6 revealed a distorted trigonal bipyramidal geometry around the ferrous
center.31
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Figure 1.30. Synthesis of complex 6 [Fe(TpPh,Me)(CysOEt)]. Figure obtained from
Reference 31.

The reaction of complex 6 with dioxygen in anhydrous conditions was studied by
UV-Vis spectroscopy. As the reaction progressed, the feature at λmaz = 356 nm slowly
disappeared. This feature is attributed to the sulfur à Fe(II) ligand to metal charge
transfer (CT) transition. The disappearance of this band suggests that the sulfur-iron
bond breaks during catalysis. Analysis of the reaction with electrospray ionization mass
spectrometry (ESI-MS) showed a product peak at 742.19 m/z, corresponding to
[(Fe(TpPh,Me)(CysOEt) + O2) + Na]+, indicating a doubly-oxygenated complex. However,
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there was also a peak at 1258.38 m/z, probably originating from a diiron complex,
[Fe2(TpPh,Me)2(CysOEt) + O2], which is a byproduct of the reaction containing a bridging
CysOEt ligand. To confirm these assignments, the reaction with 18O2 was performed, and
all of the peaks shifted as expected. To determine if both oxygen atoms in the product
come from the same dioxygen molecule, a reaction with a mixture of 16O2 and 18O2 was
carried out. Two intense signals corresponding to [(Fe(TpPh,Me)(CysOEt) +
Na]+ and [(Fe(TpPh,Me)(CysOEt) +

18

16

O16O) +

O18O) + Na]+ were observed, and no peak was

observed for the mixed complex, [(Fe(TpPh,Me)(CysOEt) + 16O18O) + Na]+. This proves
that both oxygen atoms come from the same dioxygen molecule.

NMR analysis

suggested that only ferrous iron was present at the end of the reaction, and EPR
spectroscopy confirmed this. The EPR spectrum of the oxygenated product showed a
small peak at g = 4.3 corresponding to the ferric iron, but this only accounted for less
than 2% of the total iron concentration.31
The product of this reaction was then isolated. Four different products were
considered (Figure 1.31). The first option is the selective oxygenation of the Tp ligand,
in which case cysteine ethyl ester would be isolated. Second, if the cysteine ligand was
doubly oxygenated, the cysteine sulfinic acid derivative would be produced. Two other
options were also considered, although they disagree with the ESI-TOF results. These
possibilities are the triply-oxygenated product and the disulfide bond formation.
Comparison of the 1H NMR spectrum of the product isolated from the reaction to the
spectra of the possible products indicated that cysteine sulfinic acid ethyl ester was
formed.31
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Figure 1.31. Possible products of the oxygenation of complex 6. Figure obtained from
Reference 31.

The DFT computations were done to explore the reaction mechanism for the
reaction between complex 6 and O2. As seen for complex 1 and CDO, dioxygen binds to
the metal center in an end-on fashion, orientating itself to interact with the sulfur atom
through a series of rotations. Then, one oxygen atom binds to the sulfur of the substrate
to form a four-membered ring. The dioxygen bond then cleaves. The second oxygen
atom is then transferred to the sulfur, and the sulfur-iron bond breaks.

The rate-

determining step was calculated to be the initial binding of dioxygen to complex 6.32
Based on this information, a mechanism was proposed (Figure 1.32).

The

dioxygen molecule binds to the iron center cis to the sulfur atom (A’). The sulfur-iron
bond dissociates as the distal oxygen attacks the sulfur (B). Cleavage of the oxygen bond
results in an iron(IV)-oxo complex and sulfoxide (C). The sulfoxide then binds to the
iron center via the oxygen donor (D), followed by transfer of the second oxygen atom.
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The product complex involves an η2-O,O-binding mode with the sulfinic acid group. The
reaction of A’ to B is the rate determining step.32
Complex 6 proved to be a good model of cysteine dioxygenase. It has structureal
similarity in that the Tp ligand models the 3-histidine facial coordination of the CDO
active site. It also mimics CDO functionality by doubly oxygenating the sulfur atom of
the cysteine substrate.32
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Figure 1.32. Calculated reaction mechanism for complex 6 with O2. Figure obtained
from Reference 32.

55

A similar complex was synthesized using cysteamine (CSH) as the substrate
instead of cysteine ethyl ester. This complex models the active site of cysteamine
dioxygenase.

The same tris(pyrazolyl)borato ligand scaffold was used to make the

complex [Fe(TpPh,Me)(CS)] (complex 7), where CS is the cysteamine anion (Figure 1.33).
The crystal structure of this complex was very similar to that of complex 6, with
comparable substrate bond lengths.33

Figure 1.33.

Synthesis of complex 7, [Fe(TpPh,Me)(CS)].

Figure obtained from

Reference 33.

The reaction of complex 7 with O2 under anhydrous conditions was performed
and monitored by UV-Vis spectroscopy. As seen in the oxygenation of complex 6, the
feature attributed to the S à Fe(II) CT transition at 360 nm disappeared as the reaction
progressed.

ESI-MS analysis confirmed a doubly-oxygenated product that shifted

accordingly when 18O2 was added. The EPR spectrum did not show a signal, confirming
that iron(II) is contained in the product. Again, the product of the reaction was isolated
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and compared to the 1H NMR spectra of the possible products (Figure 1.34). The
possible products arethe oxygenation of the Tp ligand resulting in cysteamine as the
product, the sulfinic acid derivative, the sulfenic acid derivative (singly-oxygenated), the
sulfonic acid product (triply-oxygenated), or the formation of a disulfide bond. The 1H
NMR spectrum of the product closely matched the sulfinic acid spectrum.33

Figure 1.34. Possible products of the reaction of complex 7 with O2. Figure obtained
from Reference 33.
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Complex 7 is a good model of the active site of cysteamine dioxygenase (ADO).
Although not much is known about the active site of this enzyme, the function of this
model matches the function of the enzyme. This further supports that the active site of
ADO is similar to that of CDO.33
Although a great deal of work has been done in this area over the past couple of
years, there are still many unanswered questions. Though there have been proposed
mechanisms and calculations to support them, the actual mechanism of the reaction
catalyzed by CDO is still unknown because of the inability to trap intermediates.

1.C. Cobalt analogues of mononuclear non-heme iron dioxygenases
Because iron is objectively spectroscopically inactive (i.e. weak absorption
features, EPR silent), metal substitution with a more spectroscopically accessible divalent
metal ion is often performed. This allows for more complete electronic characterization,
and in turn more insight into the catalytic mechanism. Cobalt is often chosen for this
type of study because the starting Co(II) complex has large absorption features (good for
studies with IR, UV-Vis, and resonance Raman spectroscopies) and the O2 adducts have
non-integer spins (good for studies with EPR spectroscopy). Although the cobalt(II)substituted analogue of cysteine dioxygenase was inactive,34 using this substitution can
still give insight into the mechanism.

1.C.i. Cobalt analogue of homoprotocatechuate 2,3-dioxygenase
One MNID that has been thoroughly studied with cobalt substitution is
Homoprotocatechuate 2,3-dioxygenase (HPCD), which is an extradiol-cleaving catechol
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dioxygenase that converts homoprotocatechuate (HPCA) to 5-carboxymethyl-2hydroxymuconic semialdehyde (5-CHMSA) by cleaving the C2-C3 bond (Figure 1.35).
The active site of HPCD consists of the commonly seen 2-histidine-1-carboxylate
(2H1C) facial triad, along with three labile water ligands.35

Figure 1.35.

Extradiol ring cleavage of HPCA by homoprotocatechuate 2,3-

dioxygenase. Figure obtained from Reference 35.

However, it was found that not all homoprotocatechuate 2,3-dioxygenases have
an iron center. HPCD from Arthrobacter globiformis was found to contain a manganese
center (MndD). HPCD and MndD have very similar structures, sharing 82% amino acid
sequence. However, the redox potentials of the metal centers differ greatly, 0.77 V vs
SHE for Fe(III/II) couple and 1.56 V for Mn(III/II) couple. Studies were done by
swapping the metal centers, producing Fe-MndD and Mn-HPCD. All four of these
enzymes, the wild types and the metal substituted, exhibited nearly the same activity.
The X-ray crystal structures of Mn-HPCD and Fe-HPCD were nearly identical, which
suggests that the protein does not tune the potentials of the metal center.35
This ability to incorporate different metals without disrupting the activity of the
enzyme is unique to extradiol dioxygenases and related enzymes. This suggests that the
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catalytic mechanism is not solely dependent on the metal redox potential, as seen with
heme enzymes.35

Figure 1.36. Comparison of the activity of metal-substituted HPCD in air-saturated
(light blue bars) and oxygen saturated (red bars) buffer. Figure obtained from Reference
35.
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Figure 1.37. Correlation between cobalt concentration and specific activity. The black
lien was obtained from a linear regression fit (R2 = 0.87).

Figure obtained from

Reference 35.

To further study this paradigm, different divalent metals were incorporated into
the active site of HPCD, and the activity was tested. Along with Fe2+ and Mn2+, Co2+
showed catalytic activity.
(Figure 1.36).

Alternatively, Ni2+, Cu2+, and Zn2+ showed no reactivity

Not only did Co-HPCD show reactivity, it showed the highest catalytic

turnover in oxygen-saturated buffer. Additionally, Co-HPCD showed good correlation
between metal content and specific activity (Figure 1.37), unlike the Ni2+, Cu2+, and Zn2+.
Therefore, these catalytically inactive metals are not considered any further.35
A potential explanation for the high activity seen with Co-HPCD is that the
structure of the active site may differ slightly than the wild type enzyme, thereby altering
the redox potential. Four strong irregular difference peaks corresponding to the positions
of the four active sites in Co-HPCD are observed in the X-ray diffraction data. The
comparison of the resting states of the different metal-substituted analogues shows that
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the identity of the metal has no effect on the overall protein structure. The cobaltsubstituted structure showed that the distorted octahedral coordination geometry was kept
intact, along with no changes in how the substrate ligand binds. These results suggest
that the structure of the protein does not tune the redox potential of the Co2+ center, and
the observed activity is due to the Co(II) with a much higher potential in the
corresponding Fe2+ site. Hence, any variation in activity of the enzyme must arise from
the electronic properties of the metal rather than structural properties. See Figure 1.38 for
direct structural comparisons.35
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Figure 1.38.

Superposition of the metal centers in the resting state of Fe-HPCD

(bronze), Mn-HPCD (gray), and Co-HPCD (color-coded). B) Structural overaly of the
active sites in the [Co-HPCD(4-NC)] complex (color coded) and [Fe-HPCD(4NSQ)superoxo] compelx (where 4-NSQ = 4-nitro-o-semiquinone) (bronze).
obtained from Reference 35.

Figure
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Next, spectroscopy was used to compare the different metal-substituted analogues
of HPCD. The UV-Vis of Co-HPCD was studied extensively (Figure 1.39). There is a
well-established correlation between the coordination number and the extinction
coefficients of the d-d transition. As the coordination number and symmetry decrease,
the intensities of the d-d transitions increase due to greater p-d orbital mixing.

6-

coordinate Co(II) complexes tend to have molar absortivities below 50 M-1cm-1, while 5coordinate complexes exhibit molar coefficient between 60 M-1cm-1 and 250 M-1cm-1,
and present a salmon pink color.36-38

According to these generalities, either a 5-

coordinate or highly distorted 6-coordinate high-spin Co(II) center is present because of
the pink color and a molar absorptivity of 60 M-1cm-1.

Additionally, the addition of

HPCA to Co-HPCD does not change the spectrum, indicating no change in coordination
environment. This data are in agreement with what was observed in the crystallography
studies – there is a distortion of the cobalt ligand environment away from the idealized
octahedral geometry.35
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Figure 1.39. UV-Vis spectrum of Co-HPCD (blue solid line) and [Co-HPCD(HPCA)]
(red dashed line). Figure obtained from Reference 35.

Electron paramagnetic resonance (EPR) spectroscopy was also used to gain more
information on the electronic structure of the Co active site. Spectra of Co-HPCD and
[Co-HPCD(HPCA)] were collected and compared (Figure 1.40).

Co-HPCD exhibits a

dominant rhombic signal with g-values of 6.7, 3.4, and 2.4. The low-field signal exhibits
well-resolved eight-pattern hyperfine splitting due to the 59Co(II) nucleus (I = 7/2). The
addition of HPCA leads to an increase of the rhombicity of the signal and the magnitude
of the hyperfine splitting.

Comparison of this data with related cobalt complexes

supports a coordination number of six for both complexes, consistent with the data
obtained from X-ray crystallography.35
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Figure 1.40.

Top: EPR spectra obtained at 20 K for Co-HPCD (top) and [Co-

HPCD(HPCA)] (bottom). Bottom: Magnification of the low-field regions of Co-HPCD
(top) and [Co-HPCD(HPCA)] (bottom). Figure obtained from Reference 35.
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Based on this combined data, a catalytic mechanism has been proposed for Mn,
Fe, and Co containing HPCD (Figure 1.41). In the resting state, the metal adapts a 6coordinate structure coordinated by the 2-histidine-1-carboxylate facial triad, along with
three cis-labile solvent ligands (A). The substrate then binds as a monoanionic bidentate
ligand, displacing at least two solvent ligands (B).

O2 can now bind to form the

commonly observed ferric superoxo intermediate (C). The catechol substrate is thought
to donate an electron to the metal center, generating a radical-Fe(II)-superoxide species
(D). C-O bond then forms between the semiquinone radical and the superoxide, leading
to an alkylperoxo-Fe(II) speces (E), which breaks down via a lactone intermediate (F).
Lastly, the ring cleaved product is made (G).35

Figure 1.41.

Proposed reaction mechanism for the extra-diol cleaving catechol

dioxygenase. Figure obtained from Reference 34.
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The fact that Mn2+ and Co2+ show reactivity is quite notable since the proposed
catalytic mechanism suggests a change in oxidation state, as seen in structure C (Figure
1.41). These metals have aqueous M(III/II) potentials that span a range of 1.2 V (E˚ of +
1.92 V vs SHE for Co(III/II), + 1.51 V for Mn(III/II), and +0.77 V for Fe(III/II). Based
in this, it would be expected that the electron transfer step would happen much faster for
Fe-HPCD than Co-HPCD or Mn-HPCD. However, it was observed that Fe-HPCD and
Mn-HPCD have similar rates, whereas Co-HPCD exhibits faster rates. It was then
suggested that the metal may not play a redox-active role (no intermediate C, Figure
1.41), or the metal center acts as a channel for electron transfer between the substrate and
O2 (very short-lived intermediate C). The expected higher potentials of the Mn(II)- and
Co(II)-HPCD enzymes would make them poorer reducing agents in the reductive oxygen
binding, but the resulting intermediate would be a stronger oxidizing agent, expediting
the oxidation of the substrate. The results of this would be that the rate of conversion
from the M(II)-catecholate to the reactive semiquinone-superoxo intermediate would
ultimately be unaffected by the specific identity of the metal, as long as the O2 adduct
could form. The electron donor is the substrate ligand, and the electron acceptor is the O2
moiety, so the potential of the metal center has no effect on the position of the
thermodynamic equilibrium, provided that the M(III)-superoxo state is available.35
This experiment was compared to other studies done on Co(II)-substituted
dioxygenases. Quercetin 2,3-dioxygenase (QueD) substituted with cobalt also resulted in
the active enzyme. This enzyme uses a mechanism where the substrate and O2 bind and
are activated simultaneously, thereby allowing for metals over a range of potentials to be
used.

On the other hand, taurine/α-ketoglutarate dioxygenase (TauD) generates a
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Fe(IV)=O intermediate. This large change in metal oxidation state suggests that the
mechanism would be very sensitive to the redox potential.

Indeed, Co-TauD was

inactive.35
In summary, these studies do not suggest that Co-HPCD uses a different
mechanism than seen in Figure 1.41, but only the lifetimes of the intermediates differ.
This allows for different metals to be used in the active site, as long as the M(III)superoxo species can be formed.35
More recently, computational studies have been done with Co-HPCD in order to
more fully understand the catalytic mechanism. QM/MM calculations were done with
the electron rich HPCA and electron poor 4-nitrocatechol (4NC). These studies showed
that the Co-O2 adducts have doublet ground states with a CoIII-O2- character when 4NC
was used. The DFT functional used in the QM part was found to have a large effect on
the relative energies of the doublet and quartet states in the case with HPCA. B3LYP
predicts a quartet SQé-CoII-O2-ê ground sate for Co-O2 adducts, while TPSSh predicts a
doublet CoIII-O2- ground state. The energy barriers were predicted to be 21.5 kcal/mol
for Co-HPCD/4NC and 12.0 kcal/mol Co-HPCD/HPCA, which aligns with experimental
observations.39

1.C.ii. Conclusion
Although not all MNIDs exhibit the same catalytic activity with metal-substituted
active sites, using a more spectroscopically active divalent metal ion is a common
strategy used to gain more insight into the enzyme. This approach was used with the
enzyme

homoprotocatechuate

2,3-dioxygenase,

a

mononuclear

non-heme

iron
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dioxygenase that catalyzes the extradiol ring cleavage of homoprotocatecuate. These
studies gave more insight into the electronic structure of the enzyme and the catalytic
mechanism.

1.D. 2-Aminophenol 1,6-Dioxygenases and their synthetic models

1.D.i. Discovery and characterization of 2-aminophenol 1,6-dioxygenase
2-aminophenol 1,6-dioxygenase (APDO) was first discovered and characterized
in 1993.40 It was found to convert 2-aminophenol to 2-aminonuconic acid semialdehyde.
This enzyme takes part in the degradation pathway of 2-nitrobenzene (Figure 1.42).41
Two other enzymes have been reported to catalyze the ring cleavage of 2aminophenol. Catechol 1,2-dioxygenase catalyzes this reaction, but at 0.1% of the rate of
the native reaction.

Similarly, 2-aminophenol was catalyzed by catechol 2,3-

dioxygenase, but in this case at 0.01% of the rate of reaction with the catechol substrate.
This indicates that 2-aminophenol is not a natural substrate of these enzymes. This is the
first example of an enzyme that uses 2-aminophenol as the primary substrate.41
The mass of this enzyme was measured at 140 kDa, consisting of two types of
subunits, referred to as a and b. Subunit a has a mass of 35 kDa, whereas subunit b has a
mass of 39 kDa. APDO has a heterotetramer structure of a2b2.41
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Figure 1.42. Pathway of nitrobenzene degredation and formulation of picolinic acid
from the ring cleaved product. The empty arrow indicates a nonenzymatic step. Figure
obtained from Reference 41.

Table 1.3. Substrate specificity of 2-aminophenol 1,6-dioxygenase.41
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APDO shows activity with only a select few substrates. A large variety of
substrates tested can be seen in Table 1.3. With the exception of catechol, only some oaminophenols substituted with a methyl or chloro group served as adequate substrates for
APDO (Figure 1.43). Aromatic compounds without the ortho-positioning of the amino or
hydroxyl groups had no inhibitory effect on the catalytic turnover. Studies of these ringcleaved products suggested that they were unstable, and spontaneously converted to the
corresponding picolinic acid.41

Figure 1.43. Other substrates successfully converted to the picolinic acid by APDO.
Empty arrows signify a nonenzymatic step. Figure obtained from Reference 41.

72

Other metal ions were added to APDO and tested for activity (Table 1.4). Only
ferrous iron in combination with ascorbic acid increased the active over 100%.
Copper(II) and zinc(II) completely inhibited activity. The iron/enzyme ratio was 2.2 ±
0.2 mol of ferrous iron per enzyme, indicating two iron cofactors.41 It was not until 2013
that this enzyme was found to have the 2-histidine-1-carboxylate facial triad (2H1C),
with the carboxylate coming from a glutamate.44

Table 1.4. Effects of inhibitors and activators on APDO.41

A catalytic mechanism was suggested by Liu et al (Figure 1.44). First, the
substrate binds to the iron center, displacing two water molecules (b). Dioxygen then
takes the sixth coordination site (c). An electron is transferred from the substrate to
dioxygen through the iron, leading to a substrate radical-Fe2+-superoxide (d). The distal

73

oxygen attacks the substrate, forming an Fe2+-alkylperoxo species (e).

Criegee

rearrangement then occurs, resulting in the O-O bond fission and C-C bond cleavage to
generate a lactone intermediate (f). This then proceeds to form the ring opening product
(g).45
This reaction mechanism was recently examined by QM/MM calculations by Lai
and co-workers. In this mechanism, it was proposed that the distal oxygen does not
attack, and a conserved histidine residue in the second coordination sphere (His195) acts
as an acid/base catalyst (Figure 1.45). Additionally, it was found that the binding mode
of the substrate, monodentate versus bidentate, played a crucial role in reactivity. The
substrate bound in a monodentate fashion facilitates the electron transfer from the
substrate to the iron center, where as a bidentate substrate facilitates the Fe3+-superoxo
adduct. The Fe2+-O(H)O intermediate (4) is responsible for the attack on the substrate.
The production of this intermediate involves a two step proton coupled electron transfer
(PCET): transfer of a proton from the amino group to His195 coupled with the transfer of
an electron form the substrate to the iron center, and transfer of a proton from His195 to
the proximal oxygen coupled with the transfer of an electron from the substrate to the
dioxygen. The O-O bond then cleaves, leading to an epoxide intermediate. The reaction
then proceeds by the C1-C6 bond cleavage, attach of the OH on C1, ring opening through
the breaking of the C1-Od bond, and a transfer of a proton from His195 to the NH group,
yielding the final semialdehyde product.45

74

Figure 1.44. Catalytic mechanism proposed by Liu et al. Figure obtained from Referece
45.

Although there have been advances in the understanding of the enzyme 2aminophenol 1,6-dioxygenase and its catalytic cycle, no reactive intermediates have been
trapped or detected. As seen with cysteine dioxygenase, biomimetic models were used in
order to more fully understand the active site and the catalytic mechanism.
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Figure 1.45. Suggested catalytic mechanism based on calculations. Figure obtained
from Reference 45.

1.D.ii. Biomimetic models of 2-aminophenol 1,6-dioxygenase
The first synthetic model of 2-aminophenol 1,6-dioxygenase was prepared by our
lab in 2012. Again the tris(pyrazolyl)borate ligand with phenyl groups in the 3 and 5
positions (TpPh2) was used to mimic the 2H1C facial triad found in the enzyme. 2-amino4,6-di-tert-butyl phenol (tBu2APH) was used as the substrate ligand to form the complex
[Fe(TpPh2)(tBu2APH)]. The X-ray crystal structure exhibited features typical of fivecoordinate high-spin ferrous complexes (Figure 1.46).46
This complex was then reacted with 2,4,6-tri-tert-butylphenoxy radical (TTBP) at
room temperature, which resulted in a distinct change in the absorption spectrum. This
product was crystallized, and the X-ray crystal structure revealed a neutral fivecoordinate complex with a distorted trigonal-bipyramidal geometry. The amine of the
substrate is now monoprotonated, confirming that this complex is generated by
abstraction of an H atom. The C-C bond distances in the aromatic ring of the substrate
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exhibit the “four long/two short” distortion observed for quinoid moieties. The N-C and
O-C bonds are short, also characteristic of iminosemiquinone (ISQ-) anionic ligands. The
EPR spectrum of this species (Figure 1.47) features a peak at g = 6.5, along with a broad
derivative-shaped feature centered near g = 1.8. This is typical of an S = 3/2 with large
and rhomic zero field splitting parameters. This combined data indicates that this species
contains a high-spin Fe2+ center (S = 2) antiferromagnetically coupled to the
radical anion. This assignment was corroborated by computations.46

tBu2

ISQ
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Figure 1.46. Synthesis and thermal ellipsoid plot of [Fe(TpPh2)(tBU2APH)]. For clarity,
the 5-phenyl substituents were omitted and only the amino hydrogens are shown. Figure
obtained from Reference 46.
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Reaction of [Fe(TpPh2)(tBu2ISQ)] with acetylferrocenium provided a new species.
Treatment of this new species with a reducing agent regenerated the starting complex. Xband EPR showed no features in both parallel and perpendicular modes, indicating an
integer spin system. Computations were employed to help understand the electronic
structure of this species.

DFT results suggested that the structure lies somewhere

between the Fe3+-tBu2ISQ and Fe2+-tBu2IBQ structures, where IBQ is a neutral
iminobenzoquinonate ligand. It was still uncertain what the exact electronic structure
was.46

Figure 1.47. X-band EPR spectrum of [Fe(TpPh2)(tBu2ISQ)] at 20 K. The feature at g =
4.3 arises from a minor ferric impurity, and the feature at g = 2.0 is due to residual
TTBP. Figure obtained from Reference 46.
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Figure 1.48. Supporting ligands and substrate ligands used by Bittner et al. Figure
obtained from Reference 48.

Next, studies were performed on a series of related complexes, utilizing not only
the 4,6-di-tert-butylaminophenol substrate, but also the corresponding catechol and
phenylenediamine (Figure 1.48). This was done in order to determine if the oxidation of
the complex is Fe- or ligand-based (or some permutation of both). Instead of the TpMe2
supporting ligand used above, TIPPh2 was used instead (TIPPh2 = tris(4,5-diphenyl-1methylimidazol-2-yl)phosphine), which has also been used by our group to mimic the
non-heme enzyme active site. These complexes exhibited different reactivities with O2
(Figure 1.49). Starting with the catechol complex (Figure 1.49 top), the absorbance
spectrum exhibited two features upon the addition of O2, at 700 and 905 nm with ε-values
of ~1100 M-1cm-1. This spectrum is characteristic of ferric-catecholate2- complexes, and

80

specifically arise from the Cat à Fe(III) ligand-to-metal charge transfer transition. EPR
and Mössbauer spectroscopies helped further characterize this species, concluding that it
is [Fe3+(TIPPh2)(tBuCat)](OTf). This species then further reacts with O2, resulting in the
decay of the features at 700 and 905 nm, indicating the oxidation of the catecholate
ligand.

The cleavage products were isoliated via an acidic workup, and 1H NMR

indicated the production of 4-tert-butyl-2-pyrone and 5-tert-butyl-2-pyrone generated in a
40:60 ratio.48
[Fe(TIPPh2)(tBu2APH)]+ showed different spectral changes upon addition of O2,
generating peaks in the absorption spectrum at 790 and 420 nm (Figure 1.49 middle).
This spectrum is identical to the one produced from the reaction with a one-electron
oxidant. This then undergoes decomposition, but at a much slower rate compared to the
catechol complex.48
The o-phenylenediamine complex, [Fe(TIPPh2)(tBu-PDA)]+ was the least reactive
with O2. Whereas the other complexes need hours for complete conversion, this complex
required days (Figure 1.49 bottom).

Based on a combination of spectroscopic and

computational studies, this species can be best described as [Fe2+(TIPPh2)(tBuDIBQ)]2+,
where DIBQ = (diimino)benzoquinone.48

81

catechol

aminophenol

phenylenediamine

Figure 1.49.

Time resolved absorption spectra for the [Fe(TIPPh2)(tBuCatH)]+ (top),

[Fe(TIP)(tBu2APH)]+ (middle), and [Fe(TIPPh2)(tBuPDA)]+ (bottom) at room temperature
in O2-saturated CH2Cl2. Figure obtained from Reference 48.
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Kinetic analysis showed that the rates of these reactions varied widely, by a factor
of 105 across the series, with the substrate ligands dictating the rate of catechol >
aminophenol > phenylenediamine. This is inversely related to the electron-donating
abilities of the ligands, which is somewhat counterintuitive. Additionally, these rates do
not correlate to the Fe2+/3+ redox potentials of the complexes. These results can be
resolved by considering the role of proton transfer (PT) in the O2 reaction.
[Fe(TIPPh2)(tBuCatH)]+ can undergo hydrogen atom transfer with TEMPO, which is a very
weak H-atom acceptor, suggests that electron and proton transfer processes are tightly
coupled in the reaction with O2. The lower acidity of the aromatic amines prevents
proton transfer in the initial interaction of O2 with the other two complexes.
Deprotonation of these ligands most likely requires complete oxidation of the metal
center first to lower the pKa of the amine groups. Accordingly, it was proposed that the
reaction of [Fe(TIPPh2)(tBu2APH)]+ with O2 involves a stepwise ET-PT-ET mechanism. 48
In summary, these results suggests how the substrate ligand facilitates the
reactivity of the complexes. The complex containing the catechol undergoes one-electron
oxidation, producing the ferric complex.

The aminophenol substrate is more redox

active, and therefore this complex undergoes a two-electron oxidation, Fe- and ligandbased. Finally, the phenylenediamine solely participates in ligand oxidation (Figure
1.50).48
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Figure 1.50. Redox chemistry of [Fe(TIPPh2)(tBuCatH)]+ (top), [Fe(TIPPh2)(tBu2APH)]+
(middle), and [Fe(TIPPh2)(tBuPDA)]+ (bottom). Figure obtained from Reference 48.
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Paine et. al. synthesized another biomimetic model of APDO.

This model

incorporated a tetradentate supporting ligand, tris(6-methyl-2-pyridylmethyl)amine (6Me3TPA), and 2-amino-4-tert-butylphenolate (4-tBu-HAP). The crystal structure of this
complex revealed a six-coordinate iron center, with the substrate ligand bound in a
bidentate fashion along with the tetradentate ligand (Figure 1.51).49
This complex reacted with molecular oxygen rapidly, exhibiting new features in
the UV-vis spectrum at 366, 600, and 934 nm (Figure 1.52a). The EPR spectrum
indicated a high-spin iron(III) S = 5/2 species.

This then further reacted with O2,

resulting in the disappearance of the features at 934 and 600 nm, and a new feature
arising at 660 nm, which slowly decays (Figure 1.52b). Workup of this reaction did
produce the corresponding picolinic acid, as detected by

1

H NMR and mass

spectroscopy.49

Figure 1.51. ORTEP plot of [Fe(6-Me3TPA)(4-tBu-HAP)] with 40% thermal ellipsoids.
Most hydrogen atoms have been removed for clarity. Figure obtained from Reference
51.
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Figure 1.52. Spectral changes over the course of the reaction of [Fe(6-Me3TPA)(4-tBuHAP)] with O2 in acetonitrile at 298 K. a) reaction during the first two minutes b)
reaction for the next six hours. Inset: plot of absorbance versus time. Figure obtained
from Reference 49.
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A series of different substrate ligands were then incorporated, and their
corresponding reactions with O2 were studied. Seven substrates were used: 2-amino-4nitrophneolate (4-NO2-HAP), 2-aminophenolate (HAP), 2-amino-3-methylphenolate (3Me-HAP), 2-aminoo-4-methylphenolate (4-Me-HAP), 2-amino-5-methylphenolate (5Me-HAP), and 2-amino-4,6-di-tertbutylphenolate (4,6-di-tBu-HAP) (Figure 1.53). The
influence of the differing structural and electronic properties of these substituents on
reactivity with oxygen was explored.50

Figure 1.53.

Synthesis of the series of Fe2+-aminophenolate complexes.

obtained from Reference 50.

Figure
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These various complexes were reacted with O2 over 22 hours, and the products
were isolated and characterized using 1H NMR and GC-MS (including additional
experiments with isotopically labeled

18

O2). [Fe(6-Me3-TPA)(4-NO2-HAP)]+ was not

sensitive toward O2. The complex with the unsubstituted aminophenolate, [Fe(6-Me3TPA)(HAP)], showed reactivity with dioxygen, but the product was not the expected
picolinic acid.

The auto-oxidation product formed, 2-amino-3H-phenoxazin-3-one

(Figure 1.54).

On the other hand, the methyl-substituted complexes showed different

reactivity. The absorption spectra of these reactions revealed three distinct steps. First,
the feature at 400 nm in the starting material decreases, along with the formation of two
new bands, at 620 and 935 nm (Figure 1.55a). As the reaction progresses, the band at
935 disappears, with the formation of a band at 635 nm (Figure 1.55b) after about 12
minutes. Finally, this feature decays over the course of 16 hours (Figure 1.55c).

The

products of these reactions were then isolated. With the use of 1H NMR and mass
spectroscopy, these products were proven to be the corresponding picolinic acids.50
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Figure 1.54.

Reaction of [Fe(6-Me3-TPA)(HAP)]+ with O2.

Figure obtained from

Reference 50.

Figure 1.55. Spectral changes during the reaction of [Fe(6-Me3-TPA)(3-Me-HAP)]+
with O2 for a) five minutes b) over the next 12 hours c) for the next 16 hours. Figure
obtained from Rference 50.
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[Fe(6-Me3-TPA)(4-tBu-HAP)]+ reacted with dioxygen to yield the picolinic acid
as the only product. Upon addition of O2, the absorption spectrum showed three new
features, at 366, 600, and 934 nm, very similar to the species that forms with the reaction
with an oxidizing agent, indicating an iron(III) species. Conversely, the reaction of
[Fe(6-Me3)(4,6-di-tBu-APH)]+ showed different reactivity. During the reaction, the band
at 402 nm in the starting material decays, and two new bands at 520 and 665 nm appear
over the course of 10 minutes (Figure 1.56a).

The EPR spectrum of this species

exhibited a signal at g = 4.2, indicative of high-spin iron(III), along with a sharp feature
at g = 1.99, indicating a ligand-based radical (Figure 1.57). The new bands in the UV-vis
spectrum, along with the EPR signal at g = 1.99 disappear as the reaction progresses
(Figure 1.56b). The product of this reaction was isolated and characterized. The 1H
NMR spectrum revealed that two products were present – 4,6-di-tBu-2H-pyran-2-imine
(35%) and 4,6-di-tBu-2-picolinic acid (65%). This was confirmed by mass spectroscopy.
It was postulated that the isosemiquinone (ISQ) species for this complex is formed
directly from the iron(II)-aminophenolate species via ligand oxidation. The two tertbutyl groups stabilize the resulting ISQ complex, which is not seen in any of the other
complexes.50
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Figure 1.56. Spectral changes during the reaction of [Fe(6-Me3-TPA)(4,6-di-tBu-HAP)]+
with O2 a) over 10 minutes b) over the next 22 hours. Figure obtained from Reference
49.
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Figure 1.57. X-band EPR spectral changes during the reaction of [Fe(6-Me3-TPA)(4,6di-tBu-HAP)]+ with O2. Parameters: Temp = 77 K; microwave frequency = 9.10 GHz;
microwave power = 0.998 mW; modulation amplitude = 100 kHz; modulation width = 1
mT; time constant = 0.03 s. Figure obtained from Reference 50.

Based on this information and DFT calculations, a catalytic mechanism was then
proposed (Figure 1.58).

The iron(II)-aminophenolate complex (A) reacts with oxygen

to form an iron(III)-2-amidophenolate species (B). Dissociation of one of the pyridyl
arms results in a five-coordinate complex (C). Iron(II)-iminobenzosemiquinonate (C’),
an isomer of C, reacts further with oxygen to form the iron(III)-peroxide (D).
Protonation of this species (E) leads to the formation of the lactone intermediate (F).
Muconic semialdehyde is formed by hydrolysis by the metal-coordinated hydroxide
moiety. Rearrangement followed by loss of a water molecule forms the picolinic acid
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product. In the case of [Fe(6-Me3-TPA)(4,6-di-tBu-HAP)]+, loss of CO from the lactone
yields the pyranimine product.50

Figure 1.58. Proposed catalytic mechanism for the aromatic C-C bond cleavage of 2aminophenols. Figure obtained from Reference 50.

Paine and co-workers then used a different set of supporting ligands along with
the 4,6-di-tBu-HAP substrate ligand. These ligands, tBu-LMe = [bis(6-methyl-pyridin-2yl)-methyl]-3-tBu-urea and BA-LMe = benzyl-[bis(6-methyl-pyridin-2-yl)-methyl]-amine,
can be seen in Figure 1.59.51
The reaction of [Fe(tBu-LMe)(4,6-tBu-HAP)]+ with O2 again produced two
products, 4,6-di-tert-butyl-2H-pyran-2-one (20%) and 4,6-di-tert-butyl-picolinic acid
(67%).

[Fe(Ba-LMe)(4,6-di-tBu-HAP)]+ exhibited similar reactivity, producing 20%

pyranone and 80% picolinic acid. These reactions were performed again, but this time in
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the presence of an acidic buffer (ammonium acetate/acetic acid 1:1, pH = 5.5). Under
these conditions, there was quantitative yield of the picolinic acid for both complexes
(Figure 1.60).50

Figure 1.59.

Supporting ligands and substrate ligand used by Paine et al. Figure

obtained from Reference 51.
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t

Bu-LMe

BA-LMe

Figure 1.60.

Reaction of [Fe(tBu-LMe)(4,6-tBu-HAP)]+ and [Fe(BA-LMe)(4,6-tBu-

HAP)]+ with O2 with and without the acid buffer. Figure obtained from Reference 51.

[Fe(tBu-LMe)(4,6-tBu-HAP)]+, which contains the urea group, showed catalytic
reactivity, whereas [Fe(BA-LMe)(4,6-tBu-HAP)]+, which lacks that urea moiety, does not
exhibit catalytic activity under similar experimental conditions. This suggests that this
“second-sphere” hydrogen bond donor is critical for catalytic turnover.51

1.D.iii. Conclusion
2-aminophenol 1,6-dioxygenase is a metalloenzyme that catalyzes the ring
cleavage of 2-aminophenols to the semialdehyde, which then loses a water molecule to
form the picolinic acid in a nonenzymatic step. This enzyme contains the commonly
seen 2-histidine-1-carboxylate facial triad coordinated to the ferrous center along with
three labile water ligands. The substrate binds to the active site in a bidentate fashion,
displacing the solvent ligands, followed by the binding and activation of O2.
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To better understand the catalytic mechanism of this enzyme, biomimetic models
have been synthesized and characterized extensively. These various complexes proved to
be both structural and functional models. However, the reactive intermediates in the
reaction with dioxygen have yet to be detected and characterized.

1.E. Discovery and Characterization of Sulfoxide Synthases

1.E.i. Types of sulfoxide synthases
Sulfoxide synthases (SOS) are another class of mononuclear non-heme iron
dioxgyenases that has recently gained more attention. In 2010, Seebeck studied a series
of reactions catalyzed by unknown enzymes to produce larger biological molecules
(Figure 1.61).

Ergothioeine (Egt) (also known as 2-histidyl-γ-glytamyl cysteine), a

histinde derivative with a thiol group on the C2 atom of the imidazole ring, is found in
certain fungi and mycobacteria (shown as 1 in Figure 1.61). The exact purpose of this
molecule is not totally understood, but it has recently been found to play a role in human
physiology. The human body absorbs Egt from dietary sources and concentrates it in
specific areas of the body, including the liver, kidneys, central nervous system, and red
blood cells. However, the function is still unknown. The production of Egt has also been
debated, but it was postulated that S-adenosyl methionine (SAM)-dependent
methyltransferases, an iron(II)-dependent oxidase, and a pyridoxal 5-phosphate (PLP)dependent β-lyase may be the catalysts involved in this biosynthesis.52
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Figure 1.61. Reaction sequcnce of ergothioneine biosynthesis, including intermediates.
A previously suggested abbreviated pathway is shown in green. Figure obtained from
Reference 52.

EgtB, the enzyme that catalyzes the C-S bond formation between cysteine and
histidine, and subsequent oxygenation of that sulfur atom was thought to be an iron
containing enzyme oxygenase. To test this, the recombinant protein was assayed with
FeSO4, 2-carboxyethyl phosphine, and γ-glutamylcysteine.

The HPLC analysis and

molecular mass were consistent with the formation of 3 in Figure 1.61.

Metal

substitutions were also made, with copper(II), manganese(II), and zinc(II), but it was
fount that the enzyme was only active with iron(II).52
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A similar biosynthetic pathway was observed for another molecule, ovothiol A (5histidylcysteine) (Figure 1.62). However, in this case, the cysteine is bound to the 5position of the histidine moiety (instead of at the 2 position in the EgtB pathway).
Ovothiols are effective radical and peroxide scavengers, with probable roles in the redox
defense of different organisms.53

Figure 1.62. Biosynthesis of ovothiol A (1). Figure obtained from Referencd 53.
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Based on the very similar chemistries, it was thought that the active sites of these
two enzymes, EgtB and OvoA, are very closely related. As seen with EgtB, the activity
of OvoA was found to be dependent on iron(II). It was found that there is a highly
conserved motif of two histidines and one glutamate, and mutating any one of these
diminishes OvoA activity.

This suggests a 2-histidine-1-carboxylate facial triad for

binding iron.53
A catalytic mechanism was then proposed (Figure 1.63). After O2 binds, a high
valent iron(IV)-oxo species is formed (step a).

The next step has three different

possibilities. First, there could be the formation of the histidyl sp2 radical (step b).
Second, a histidyl π-radical could form (step c). Lastly, the C-S bond could form by
electrophilic attack of the iron-coordinated cysteine sulfoxide on histidine (step d).53
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Figure 1.63. Possible catalytic mechanisms for the enzyme OvoA. Figure obtained from
Reference 53.
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Computations were performed by Gauld and co-workers in order to figure out
which of these different mechanisms takes place. Many different conformations of each
intermediate were examined, and their relative free energies of electron or proton coupled
electron transfer were compared. For example, seven different conformations of the
ferric-superoxo adduct and their energies were studied (Figure 1.64 and Table 1.5). It
was found that when PCET was incorporated, the reduction of A became exothermic.
However, the imidazole requires 171.0 kJ/mol to be oxidized; therefore, none of these
ferric-superoxo species are adequate oxidants for this reaction and were not considered
further.54

Figure 1.64. Five- and six-coordinate ferric-superoxo complexes considered in these
calculations. Figure obtained from Reference 54.
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Table 1.5.

Adiabatic free energies (kJ/mol) for reduction of the ferric-superoxo

complexes (A) by electron transfer (ET) or proton coupled electron transfer (PCET).54

This process was done for the remaining intermediates. Based on these studies, a
new set of catalytic intermediates was proposed (Figure 1.65). An important result of this
was gaining understanding of why the sulfoxide forms. The formation of this moiety is a
consequence of the formation of a more powerful oxidant in the model Fe-O-O-S
complex.54

Figure 1.65. Proposed intermediates for the formation of the histidyl sulfoxide base on
these complutational studies. Figure obtained from Reference 54.
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A wide variety of substrates were used with OvoA in order to determine substrate
specificity. The results suggests that OvoA does not require an amino acid moiety on the
sulfur acceptor. Additionally, OvoA converts D-histidine into a mixture of C2 (seen in
EgtB) and C5 (seen in OvoA) derived products. This indicates product specificity is
dependent on the substrate positioning in the active site.55
It was found that OvoA also catalyzes two additional cysteine oxidation reactions:
the conversion of cysteine to cysteine sulfinic acid (as seen in cysteine dioxygenase) and
the conversion of cysteine to cystine. When studying the products of the catalytic
reaction, the 1H NMR assay showed that the coupling product only accounted for ~40%
of the O2 consumption rate. Therefore, there must be other side reactions taking place.
Another product was detected, isolated and characterized. This product was assigned as
cysteine sulfinic acid. When hercynine was incorporated instead of histine, cysteine
sulfinic acid was the major product. When no histidine was added to the reaction, only
cystine was formed (Figure 1.66).56
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Figure 1.66.

OvoA-catalyzed cysteine oxidation reactions, incorporating hercynine,

histidine, or cysteine as the substrate ligands. Figure obtained from Reference 56.
The cysteine dioxygenase activity seen in OvoA is unique for a few reasons. The
CDO activity of OvoA is dependent on histidine or hercynine. When these are absent,
only the disulfide product cystine is formed. Also, CDO and OvoA belong to different
classes on MNIDs. OvoA has the 2H1C facial triad, while CDO exhibits the 3-histidine
facial triad. OvoA was mutated in order to incorporate this 3His triad. However, all
catalytic activity, both OvoA and CDO, was lost.56
Finally, in 2015, the crystal structure of EgtB was obtained by Seebeck and coworkers. This structure can be seen in Figure 1.67. Residues 7-150 fold into a four-helix
bundle with long linkers between helices 1 and 2 (18 residues), 2 and 3 (34 residues), and
3 and 4 (7 residues). The fourth helix is followed by an extended two-stranded β-sheet
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(residues 151-210) wrapped around the C-teminal domain, which adopts a C-type lectin
fold. This fold contains a dense array of ionic interactions, such as salt bridges.57

Figure 1.67. Diagram of EgtB in complex with iron (brown) and trimethyl-histidine
(pink). It consists of an N-terminal domain (gray), a two-stranded β-sheet (black), and a
C-terminal domain (cyan/orange). The active site is shown in green. Figure obtained
from Reference 57.
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Figure 1.68. The active site of EgtB in the ternary compex. Water molecules are shown
in red. Figure obtained from Reference 57.

The active site of EgtB is house in a tunnel, 15 Å deep and 10 Å wide, lined by
residues 375-425. Three histidine residues (51, 134, and 138) surround the active site
iron (Figure 1.68). This is different than the earlier prediction that the active site contains
the 2H1C facial triad. The susbstrate imidazole and two water molecules finish off the
octahedral active site coordination environment.

The substrate imidazole ring is

stabilized by a second sphere tyrosine residue (Tyr380) through a water-mediated
hydrogen bond. Additionaly, the 1-carboxylate group is loosely connected to Arg87 by a
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bridging water molecule. An N-α-methyl group also interacts with the amide side chains
of Gln137 and Asn414.57
Based on this crystal structure, a new catalytic mechanism was proposed (Figure
1.69). First, the γ-GC substrate binds to the active site along with O2 which results in a
ferric-superoxo intermediate (step a). This then may form a peroxide anion and a thiyl
radical (step b).

The peroxide is stabilized by Tyr377.

The thiyl radical attacks

tehimidazole ring to form an iminyl radical (step c). This goes through a deprotonation
and ligand-to-metal charge transfer (step d). Sulfoxidation redues the iron(II) peroxo to
the EgtB resting state (step e).57

Figure 1.69. Proposed catalytic mechanism for EgtB-catalyzed C-S bond formation and
sulfoxidation. Figure obtained from Reference 57.
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Mutation of the Tyr377 residue completely changed the reactivity of EgtB. This
residue was replaced with a phenylalanine, so the hydrogen binding interaction is
disrupted. Upon this mutation, EgtB solely acted as CDO, producing cysteine sulfinic
acid as the only product, at a similar rate. These observations can be explained by using
a mechanistic model suggesting that the sulfoxide synthase and cysteine dioxygenase
share a common catalytic intermediate, most likely a ferric-superoxo species. Also,
protonation by Tyr377 is essential for sulfoxide synthase activity. This is the first
example of an MNID that can be engineered to complete an entirely different reaction.58
Recently, computations were performed to more fully understand the catalytic
mechanism of EgtB. There are two feasible mechanisms, depending on which bond
forms first, the S-O bond (Figure 1.70) or the S-C bond (Figure 1.71). Calculations
suggested that the S-O bond forms initially. In this reaction, O2 binds to the ferrous
center, generating a ferric-superoxo species. The S-O bond then forms and creates a
ferrous thiyl peroxide intermediate. The O-O bond cleaves homolytically to form an
RSO--Fe(IV)=O species. Next, a proton transfers from Tyr377 to the Fe(IV)=O species,
followed by another proton transfer from the substrate imidazole to Tyr377, facilitated by
two water molecules. This results in radical character on the imidazole, which helps the
following S-C bond formation, leading to a tetrahedral species. Tautermerization of this
leads to the formation of the product by stepwise proton transfer from the imidazole
carbon to the neighboring N atom, facilitated by Tyr377. This is the rate limiting step,
which is in good agreement with kinetic data.60
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Figure 1.70. Suggested mechanism of EgtB based on calculations. Figure obtained from
Reference 60.

Figure 1.71. Alternative mechanism, facilitated by a thiyl radical. Figure obtained from
Reference 60.

The alternative route has a barrier of 32.4 kcal/mol, which decreases to 25.8
kcal/mol when the imidazole gets deprotonated by Tyr377. This barrier is 7.9 kcal/mol
higher than ther previously discussed mechanism, and therefore is less favorable.60
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1.E.ii. Conclusion
There has been great progress in recent years regarding two types of sulfoxide
synthases, EgtB and OvoA. It wasn’t until 2015 that the crystal structure was finally
solved, leading to more vigorous studies on the enzyme. The exact catalytic mechanism
is still unknown.
To the best of our knowledge, there has been no reports on any synthetic models
of these enzymes. Synthetic models could be the tools needed to fully understand these
enzymes.

1.F. Specific aims of this project
Using a biomimetic approach, this project will address important questions
regarding the catalytic activity and mechanism of cysteine dioxygenase, aminophenol
dioxygenase, and sulfoxide synthase, further studying the effect of the 3-Histidine facial
triad. Specific aims of this project include:
• Additional

studies

on

the

complexes

synthesized

by

Limberg,

[Fe(TpMe,Ph)(CysOEt)] and [Fe(TpMe,Ph)(CS)], using spectroscopic techniques,
such as UV-Vis absorption, electron paramagnetic resonance (EPR), and
infrared (IR) spectroscopies.
• Generate

a

series

of

new

biomimetic

complexes

of

CDO

using

tris(imidazole)phosphane ligands (TIPPh2) (Figure 1.72) with different substrates
to model CDO, ADO, and 3MDO. This previously published ligand scaffold
has proven to be a faithful mimic of the 3-His facial binding motif.46
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Figure 1.72. Structure of the tris(imidazolyl)phosphine ligand.

• Characterize the geometric and electronic structures of these complexes with a
combination of methods, such as X-ray crystallography, spectroscopic
techniques (NMR, UV-Vis, IR, EPR, and magnetic circular dichroism (MCD))
and electrochemical techniques.
• Study the reactivity of these complexes with molecular oxygen and analyze the
oxidized products, using UV-Vis and 1H NMR spectroscopies and electrospray
ionization mass spectrometry (ESI-MS).
• Incorporate cobalt into the active site of these model enzymes in order to more
fully characterize the active site and reactive intermediates.
• Use these same ligand scaffolds and techniques to generate a series of models of
aminophenol dioxygenase, and study their structures and reactivities with O2.
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• Synthesize and characterize the first series of biomimetic models of sulfoxide
synthase. Different ligand scaffold, referred to as LK and BIPA, will be used
here (Figure 1.73).62

Figure 1.73. Structure of the ligand scaffolds Lk (top) and BIPA (bottom).
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• This tetradentate LK ligand will be used along with a monodentate substrate
ligand containing a thiolate donor.
• These complexes will be studied extensively with the processes described
above.

Overall, the purpose of this project will elucidate: i) the effect of the TIP versus
Tp ligation to the ferrous center, and, therefore, the significance of the neutral 3-His
facial triad versus the more common monoanionic 2-His-1-carboxylate binding motif, ii)
the catalytic mechanism of these enzymes by characterizing intermediates, and iii) the
effect of the second-sphere interactions on O2 reactivity.
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CHAPTER 2
Synthesis, X-ray Structures, Electronic Properties, and O2/NO Reactivities
of Thiol Dioxygenase Active Site Models

(Fischer, A.; Stracey, N.; Lindeman, S.; Brunold, T.; Fiedler, T. Inorg. Chem., 2016, 55, 11839-11853)

Abstract
Mononuclear non-heme iron complexes that serve as structural and functional mimics of
the thiol dioxygenases (TDOs), cysteine dioxygenase (CDO) and cysteamine
dioxygenase (ADO), have been prepared and characterized with crystallographic,
spectroscopic, kinetic, and computational methods. The high-spin Fe(II) complexes
feature the facially coordinating tris(4,5-diphenyl-1-methylimidazol-2-yl)phosphine
(Ph2TIP) ligand that replicates the three histidine (3His) triad of the TDO active sites.
Further coordination with bidentate L-cysteine ethyl ester (CysOEt) or cysteamine
(CysAm) anions yielded five-coordinate (5C) complexes that resemble the substratebound forms of CDO and ADO, respectively. This chapter includes detailed electronicstructure descriptions of the [Fe(Ph2TIP)(LS,N)]BPh4 complexes, where LS,N = CysOEt (1)
or CysAm (2), which were generated through a combination of spectroscopic techniques.
Complexes 1 and 2 decompose in the presence of O2 to yield the corresponding sulfinic
acid. Though the O2 reactivities of the Ph2TIP- and Ph,MeTp-based complexes are quite
similar, the supporting ligand perturbs the energies of Fe 3d-based molecular orbitals and
modulates Fe− S bond covalency, suggesting possible rationales for the presence of
neutral 3His coordination in CDO and ADO.
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Reproduced with permission from Inorg. Chem. 2016, 55, 11839-11853. Copyright 2016
American Chemical Society.
https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.6b01931

2.A. Introduction
While the previous biomimetic studies of cysteine dioxygenase (CDO) and
cysteamine dioxygenase (ADO) have yielded many exciting results, the models reported
to date lack either the facial geometry or neutral charge of the 3His triad. As part of our
efforts to prepare faithful β-diketone dioxygenase (Dke1) and getnisate dioxygeanse
(GDO) models, our group has found that easily prepared tris(imidazolyl)phosphine (TIP)
ligands nicely replicate the fac arrangement of three imidazole donors found in the active
sites.63-66 Here, I report the synthesis and structural characterization of two TDO models:
[Fe(TIPPh2)(CysOEt)]BPh4 (1) and [Fe(TIPPh2)(CysAm)]BPh4 (2), where TIPPh2 is
tris(4,5-diphenyl-1-methylimidazol-2-yl)phosphine (Figure 2.1). These complexes are
related to the TDO mimics of Limberg and co-workers, [Fe(TpPh,Me)(CysOEt)] (3) and
[Fe(TpPh,Me)(CysAm)] (4) (Figure 2.1), the critical difference is that 1 and 2 feature a
neutral TIP scaffold, whereas 3 and 4 employ a monoanionic TpPh,Me ligand. Our
previous studies of Dke1 models indicated that TIP ligands accurately reproduce the
coordination environment and donor strength of the 3His triad, whereas the properties of
Tp− ligands align better with the 2H1C triad.63

Since the two sets of models are

complementary, we have conducted parallel studies of 1/2 and 3/4 with the goal of
illuminating the role of 3His coordination in promoting CDO/ADO catalysis. Therefore,
this chapter describes and compares the geometric structures, electronic properties, and
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O2 reactivities of complexes 1−4, as revealed through a combination of crystallographic,
spectroscopic, kinetic, and computational methods. The similarity of these models to the
enzyme active site is evaluated by juxtaposing their structural and spectroscopic features
to those reported in previous studies of CDO.

Figure 2.1. Supporting ligands and substrate ligands used in these studies.

Formation of an iron−superoxo intermediate is the putative first step of O2
activation in both TDOs and related complexes; however, the spin state and degree of Sradical character in the Fe/O2 adduct remain matters of debate. In this chapter, the nature
of O2-bound 2 and 4 in various spin states has been probed via density functional theory
(DFT) calculations, with a particular focus on the effect of ligand charge (TIP vs Tp−) on
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energetics and Fe−S covalency. We have also explored the surprisingly complicated
reactivity of 1 and 2 with NO, a well-established surrogate for O2. Electron paramagnetic
resonance (EPR) and IR experiments revealed that multiple Fe/NO species (both highand low-spin) are formed, including a cationic dinitrosyl iron complex (DNIC). These
results highlight the hemilability of scorpionate chelates, as well as the critical role of the
active-site pocket in controlling the relative positioning of first-sphere ligands in CDO
and ADO.

2.B. Results and Discussion

2.B.i. Synthesis and Solid State Structures
Complexes 1 and 2 were synthesized by first treating the previously reported
[Fe(TIPPh2)(MeCN)3](OTf)2 precursor with either CysOEt·HCl or CysAm·HCl and 2
equivalents of triethylamine in CH2Cl2. After solvent removal, the resulting triflate salts
were dissolved in MeOH and addition of NaBPh4 caused immediate precipitation of 1
and 2 as bright yellow solids. X-ray quality crystals of 2 were grown by layering
concentrated 1,2-dichloroethane (DCE) solutions with MeOH. In the case of 1, this
procedure yielded analytically pure but poorly diffracting needles; however, crystals
suitable for X-ray analysis were eventually obtained by allowing the decanted mother
liquor to sit for 1 week. The resulting crystal structure revealed that, during this time, the
CysOEt

ligand

had

undergone

transesterification

to

give

the

complex

[Fe(TIPPh2)(CysOMe)]BPh4 (1Me) instead (Figure 2.2). Despite this, 1H NMR spectra of
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the first crop of crystals, which were employed in all spectroscopic and reactivity studies,
indicated retention of the ethyl substituent (vide infra).

S1
N5
N4

Fe

N3

N7

N1

N6

P1

N2

Figure 2.2. Thermal ellipsoid plot (50% probability) obtained fro the X-ray crystal
structure of 1Me. The BPh4- counteranion, non-coordinating solvent molecules, and most
hydrogen atoms have been omitted for clarity.
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S1

N5
N4

Fe
N7

N3

N6

N1

N2
P1

Figure 2.3. Thermal ellipsoid plot (50% probability) obtained from the X-ray crytstal
structure of 2. The BPh4- counteranion, non-coordinating solvent molecules, and most
hydrogen atoms have been omitted for clarity.
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Table 2.1. Select bond distances (Å) and bond angles (˚) for complexes 1-4 and the Cysbound CDO active site as determined by X-ray crystallography.

Ia

Reference 9.

b

Reference 10

c

Obtained from an X-ray structure of Cys-bound CDO

(PDB 4JTO; 2.0 Å resolution).

The X-ray structures of 1Me and 2 (Figure 2.3) reveal the presence of 5C
monoiron(II) complexes with a bidentate S,N-cysteinato anion and κ3–TIPPh2 chelate. In
each case, the thiolate donor forms a hydrogen bond with a MeOH solvate molecule. The
Fe(II) coordination geometries lie halfway between the square-pyramidal and trigonal
bipyramidal limits, as quantified by the τ-values of 0.54 (1Me) and 0.55 (2). Significantly,
the facial coordination mode of the TIPPh2 ligand ensures that a vacant site for O2-binding
is available cis to the thiolate ligand, a known requirement for dioxygenation of the sulfur
atom. Selected metric parameters for the solid-state structures of 1Me and 2 are provided
in Table 2.1, in addition to previously reported values for 3 and 4 as well as CDO itself.
The Fe−NTIP bond distances are typical for high-spin Fe(II) complexes and fall within a
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narrow range of 2.15−2.20 Å. The Fe−NTp distances in 3 and 4 are slightly shorter on
average, while also displaying greater variation with two short bonds of 2.12 Å (av) and
one long bond near 2.275 Å. The Fe−S1 and Fe−NCys bond distances change little across
the 1−4 series with average values of 2.31 and 2.26 Å, respectively.
The superposition of complex 1Me upon the active-site structure of Cys-bound
Fe(II)−CDO in Figure 2.4 highlights the structural similarities between the synthetic and
enzymatic coordination environments. The most noticeable discrepancy concerns the
relative orientations of the imidazole rings. The His donors in the enzyme active site
possess greater rotational freedom than their synthetic counterparts, as the latter are
tethered to a central P atom at the 2-position. The CDO crystal structure exhibits Fe−NHis
distances of 2.20, 2.11, and 1.89 Å (Table 2.1); the smallest value (corresponding to
His86) is much shorter than expected based on synthetic CDO models and typical
Fe−NHis bond distances in proteins. The Fe−NCys and Fe−SCys bond distances of CDO
nicely match those measured for 1Me, and the orientations of the cysteinato ligands with
respect to the facial N3 triad are quite similar, although CDO lies somewhat closer to the
square-pyramidal limit (τ-value of 0.46). The high degree of structural resemblance
between CDO and 1Me suggests that these five-coordinate sites are similarly primed for
O2 activation.
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Figure 2.4. Comparison of the Cys-bound active site of CDO (pink) and the crystal
structure of 1 (gray).

2.B.ii. Solution-state Spectroscopic Properties
Examination of CDCl3 solutions of 1 and 2 using the Evans NMR method
provided effective magnetic moments of 5.16 and 5.02 µB, respectively, consistent with
mononuclear, high-spin (S = 2) ferrous complexes. The 1H NMR spectra of 1 and 2
exhibit paramagnetically shifted peaks in the 15 to − 20 ppm range (Figures 2.5 and 2.6).
The three imidazole donors are spectroscopically equivalent due to dynamic averaging of
the CysOEt/CysAm positions on the NMR time scale. Based on our prior analysis of
TIPPh2-based Fe(II) complexes,64 the intense downfield peak at 15 ppm is assigned to the
N-1-CH3 groups, while the broad upfield peak near −18 ppm is attributed to ortho protons
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of the 4-Ph substituents. Resonances arising from the CysOEt and CysAm ligands
experience only modest shifts and broadening upon ligand binding to Fe. The splitting
pattern due to the ethyl ester moiety is clearly discernible in the spectrum of 1, indicating
that the CysOEt ligand remains intact. In short, the 1H NMR data confirm that the
solution- and solid-states structures are essentially the same.

Figure 2.5.

1

H NMR spectrum of complex 1 measured at room temperature in CDCl3.

The peaks marked with an asterisk are due to residual NEt3.
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Figure 2.6. 1H NMR spectrum of complex 2 measured at room temperature in CDCl3.

Solutions of 1 and 2 in CH2Cl2 are pale yellow due to the presence of overlapping
absorption bands (ε ∼ 1000 M−1 cm−1) in the near-UV region that are attributed to S →
Fe(II) charge transfer (CT) transitions (vide infra) (Figure 2.7).

To obtain further

information regarding the electronic excited states of these complexes, magnetic circular
dichroism (MCD) spectra of 1 and 2 were measured in frozen 3:7 solutions of
CH2Cl2:butyronitrile. The absorption and MCD spectra of the two complexes are nearly
identical, suggesting that the MCD spectra exhibit two intense, positive features near
23,800 and 26,800 cm−1. The broadness of the lower-energy band suggests that it is
composed of at least two electronic transitions. In all cases, the intensities of the MCD
bands increase with decreasing temperature, displaying the C–term behavior expected for
paramagnetic S = 2 systems. Significantly, the MCD spectra of 1 and 2 also exhibit a
temperature dependent band at 11,270 cm−1 (887 nm) that is barely perceptible in the
absorption spectra. Based on its large C0 /D0 ratio of ∼ 2.0 (where C0 and D0 are related to

124

the MCD and absorption intensities, respectively), this peak likely arises from an Fe(II)
d−d transition. This assignment is supported by previous spectroscopic studies, which
revealed that the highest energy d−d transition of 5C Fe(II) complexes lies between 8,400
and 13,500 cm−1.71
For the sake of comparison, Figure 2.7 also displays the absorption and MCD
spectra of complex 4 measured under identical conditions. Only two S→Fe(II) CT bands
are apparent, and these are blue-shifted by 2700 cm−1 relative to those of complex 2. The
d−d band experiences a smaller energy increase of 300 cm−1. Similar shifts in band
energies are observed when spectra of CysOEt-containing 1 and 3 are compared (Figure
2.8).
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Figure 2.7. Electronic absorption and MCD spectra collected for complexes 2 (top) and
4 (bottom). The absorption spectra were measured at room temperature in CH2Cl2. The
MCD spectra were obtained from frozen, glassy solutions in a 3:7 mixture (v/v) of
CH2Cl2:butyronitrile at 4 K with a magnetic field of 7 T.
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Figure 2.8. Electronic absorption and MCD spectra collected for complexes 1 (top) and
3 (bottom). The absorption spectra were measured at room temperature in CH2Cl2.
MCD samples consisted of frozen, glassy solutions in a 3:7 mixture of CH2Cl2:
butyronitrile; spectra were collected at a temperature of 4 K with a magnetic field of 7 T.
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2.B.iii. Computational Analysis
The spectroscopic results were interpreted with the aid of time dependent DFT
(TD-DFT) studies that employed the cam-B3LYP range-separated hybrid functional.72
These calculations were performed with geometry-optimized structures of 2 and 4 that
are in good agreement with the crystallographic structures (Table 2.2). Consistent with
the experimental data, the TD-DFT computed absorption spectrum for 2 is dominated by
three S→Fe(II) CT transitions in the region below 30,000 cm−1 (Figure 2.10). The
energy-level diagram provided in Figure 2.10 depicts the ligand- and Fe(II)-based
molecular orbitals (MOs) involved in the relevant transitions. The donor MOs are
localized on the CysAm ligand and contain primarily S(3p) character: the Sσ MO lies
along the Fe−S bond, while the Sπ MO is perpendicular to the bond. The two lowestenergy CT bands in the TD-DFT spectrum arise from Sπ→Fe(dxz)/Fe(dyz) transitions
centered around 25,000 cm−1, which nicely matches the experimental band at
23,800cm−1. To higher energy, TD-DFT predicts a Sσ→Fe(II) (σ→σ*) transition at
29,100 cm−1 that likely corresponds to the experimental feature at 26800 cm−1. The
highest-energy Fe d−d transition, attributed to the Fe(dxy)→Fe(dx2−y2) excitation, is
predicted to appear as a weak feature at 13,750 cm−1. Thus, the calculated energies agree
reasonably well with the experimental values, with a root-mean-square deviation of only
2100 cm−1 for the bands observed by MCD.
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Table 2.2. Comparison of metric parameters obtained by X-ray crystallography and
DFT-calculations of complexes 2 and 4.

.
a

data obtained from reference 10.
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Figure 2.9.

Energy-level diagram for the spin-down (β) molecular orbitals (MOs)

obtained from a spin-unrestricted DFT calculation for complex 2. MOs are labeled
according to their principal contributor. DFT-generated isosurface plots of the MOs are
provided.

Comparison of the DFT results obtained for 2 and 4 indicate that substitution of
neutral TIPPh2 with anionic TpPh,Me causes a nearly uniform 4450 cm−1 increase in the
energies of the Fe 3d set of orbitals. Hence, the S→Fe(II) CT bands experience a
substantial blue-shift upon conversion of 2→4, while the highest-energy d−d transition is
largely unaffected, consistent with the spectroscopic data described above.

The

Sσ→Fe(II) (σ → σ*) transition of complex 4, predicted to occur at 33,270 cm−1, is likely
obscured by the onset of π−π* transitions in the near-UV region, which explains the
presence of only two CT bands in the absorption/MCD spectra of 3 and 4. Moreover, an
analysis of the relative compositions of the half-occupied Fe 3d-based MOs indicates that
the Fe−S bond in 2 is more covalent than its counterpart in complex 4, which is also
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reflected in the minor differences in the Mulliken spin populations predicted for the S
atom (0.19 spin in 2 and 0.15 spin in 4). This finding is consistent with the fact that TIP
based complexes exhibit more intense S→Fe(II) CT transitions than the Tp-based
complexes (Figures 2.7 and 2.8), given that CT intensity is proportional to the amount of
- the ligand character in the metal-based MOs.
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Figure 2.10.

Top: TD-DFT computed absorption spectrum of 2 compared to

experimental absorption (red solid line) and MCD (gray dashed line) specra. The black
stics and numbers mark the energies and intensities of computed transitions. Bottom:
Electron density difference maps (EDDMs) for computed transitions. The green and gray
regions indicate gain and loss of electron density, respectively.
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Substrate-bound Fe(II)−CDO likewise exhibits two S→Fe(II) CT bands in its
MCD spectrum; however, both of these features appear above 30,000 cm−1, much higher
in energy than the corresponding bands of complexes 1−4.5 This large discrepancy in CT
energies is rather surprising given the high degree of structural similarity between the
first coordination spheres of 1 and Cys-bound Fe(II)−CDO, as discussed above .
Noncovalent (e.g., electrostatic) interactions within the active site of CDO presumably
modulate the relative energies of the thiolate- and Fe 3d-based MOs, thereby increasing
the CT energies.

2.B.iv. O2 Reactivity: Experimental Results
Not surprisingly, the O2 reactivity of the TIPPh2-based complexes closely mirrors
that reported previously by Limberg and co-workers for 3 and 4. As shown in Figure
2.11, treatment of 1 with O2 results in the slow decay of the S→Fe(II) CT bands to
eventually yield a featureless spectrum, indicating loss of the iron−thiolate bond. Similar
spectral changes were observed upon O2 exposure of complexes 3 and 4,31,33 as well as
Cys-bound Fe(II)−CDO.5 The reaction products were isolated after stirring solutions of 1
and 2 in O2-saturated CH2Cl2 for 6 h, followed by acidic workup.

1

H NMR spectra

revealed that the 1 + O2 reaction yields the ethyl ester of L-cysteine sulfinic acid as the
only observable CysOEt-derived product (Figure 2.12). Similarly, exposure of 2 to O2
yields hypotaurine (HTau) as the dominant product, although an unidentified CysAmderived compound is also present in smaller amounts (HTau:unknown ratio of 4:1; Figure
2.13). The identities of the sulfinic acid products were confirmed by comparison to
literature spectra (cysteine sulfinic acid ethyl ester) or commercial samples (HTau), in
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addition to mass spectrometric analysis. Thus, each complex in the 1−4 series behaves as
a structural and functional TDO mimic.

Figure 2.11.

Time-resolved absorption spectra for the reaction of complex 1

(concentration = 0.53 mM) with O2; the spectra shown here were collected at intervals of
30 minutes. The reaction was performed at 20˚C in CH2Cl2. The path length of the
cuvette was 1.0 cm. Inset: Plots of absorption intensity as a function of time for the
reaction of 1 and 3 with O2-saturated CH2Cl2. The wavelengths monitored were 360 and
355 for 1 and 3, respectively. Absorption intensities were normalized using the equation
provided in the plot.
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Figure 2.12.

1

H NMR spectrum (solvent = CD3OD) of the products isolated from the

reaction of 1 + O2 at room temperature. The peak indicated with an asterisk arises from
residual toluene, while the peak marked with a triangle is due to 4,5-diphenyl-1methylimidazole.

Figure 2.13.

1

H NMR spectrum (solvent = CD3OD) of the products isolated from the

reaction of 2 with O2 at room temperature.
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Rate measurements for the reaction of 1 and 3 with O2 were generally performed
in O2-saturated CH2Cl2 solutions ([O2] = 5.8 mM at 20 ° C) with Fe(II) concentrations of
less than 0.60 mM. Under these conditions, the decay in absorption intensity versus time
followed first-order behavior past three half-lives (Figures 2.11 and 2.14) for both
complexes, and initial rates increased linearly with O2 concentration (Figure 2.15). Thus,
the reactions are first-order with respect to both Fe and O2, permitting a detailed kinetic
analysis. At 20°C, the 1 + O2 reaction proceeds with a pseudo-first-order rate constant
(k1) of 1.9(4) x 10−4 s−1. The 3 + O2 reaction exhibits a smaller k1 - value of 1.2(3) x
10−4 s−1. Thus, the identity of the LN3 supporting ligand has only a modest impact on the
O2 reaction rate, with the neutral TIPPh2 ligand offering a slight rate advantage over the
anionic TpPh,Me ligand.

Figure 2.14. First-order kinetics plot for the reactions of 1 (lower trace, black circles)
and 3 (upper trace, red squares) with O2 saturated CH2Cl2 at 20˚C. Absorption intensities
were monitored at 360 and 355 nm for 1 and 3, respectively.
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Figure 2.15. Plots of initial rates versus O2 concentration for the reaction of complex 1
with O2 at room temperature in CH2Cl2. The Fe concentration was fixed at 0.30 mM.

Activation parameters for the 1 + O2 reaction were determined by monitoring
rates at temperatures between 35 and − 30 ° C. Analysis of the linear Eyring plot (Figure
2.16) provided an activation enthalpy (ΔH⧧) of 12(1) kcal/mol and activation entropy
(ΔS⧧) of − 25(4) cal/(mol· K), resulting in an activation free energy (ΔG⧧) of 19(2)
kcal/mol at 293 K. These values are similar to previously reported parameters for O2
activation by mononuclear Fe complexes,73 including closely related 5C complexes with
TIPPh2 and Tp− ligands.48,74 The large negative value for ΔS⧧ indicates that the ratedetermining step has an associative nature, which is common for reactions involving O2.
However, as discussed in the next section, the activation parameters likely reflect
multiple elementary reactions, and thus the values must be interpreted with caution.
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Figure 2.16. Eyring plot for the reaction of 1 with O2 in O2-saturated CH2Cl2 over a
temperature range of 35 to -30˚C. Secon-order rate constants (k2) were obtained by
dividing the pseudo-first-order rate constant by [O2] at the specified temperature.

2.B.v. O2 Reactivity: Computational Results
The first step in the proposed O2 activation mechanisms of CDO and related
model complexes is the generation of an iron−superoxo species, followed by nucleophilic
attack of the distal O atom on the thiolate ligand to give a four-membered Fe−O−O−S
ring. Computational studies suggested that this second step is rate-limiting in both the
enzyme and complex 3.17,32 To better understand the kinetic data reported above, we
have examined the thermodynamics of O2 binding and O−S bond formation via DFT
calculations for complexes 2 and 4. These calculations employed the PBE functional
with 10% HF exchange, which has been shown to provide reliable geometries and
relative energies for Fe/O2 species.75
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Table 2.3. Selected bond distances (Å) for [FeO2] species for complex 2 obtaiened from
DFT calculations.

Table 2.4. Selected bond distances (Å) for [FeO2] species for complex 4 obtained from
DFT calculations.

The adduct that forms upon O2 binding to a high-spin Fe(II) complex has three
possible spin states: triplet (S = 1), quintet (S = 2), or septet (S = 3). The septet and
quintet states are best described as high-spin Fe(III) centers coupled to a superoxide
radical (O2•−) in either a ferromagnetic or antiferromagnetic manner, respectively. The
triplet state arises from antiferromagnetic coupling between a high-spin Fe(II) center and
a neutral O2 ligand. However, we also considered the possibility that the S = 1 Fe/O2
adduct consists of a low-spin Fe(III) ion ferromagnetically coupled to O2•−, as this
configuration yielded the lowest-energy Fe/O2 model in de Visser’s study of complex 3.32
The resulting computational models are labeled spin [2-O2](HS, LS) and spin [4-O2](HS,LS),
where HS and LS indicate whether the Fe center is high-spin or low-spin, respectively.
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Metric parameters of the geometry-optimized structures are provided in Table 2.3.
Whereas de Visser found that O2 binding to 3 triggers dissociation of a pyrazole donor
regardless of spin state,32 nearly all of our optimized Fe/O2 models are 6C with Fe−
NTIP/Tp bond lengths ≤ 2.31 Å, the only exceptions being the S=3 [2-O2]HS and S=2 [2O2]HS models, in which one of the Fe−NTIP bonds elongates to ∼ 2.4 Å during geometry
optimization to yield quasi-6C structures (Table 2.3, 2.4).
Table 2.5 summarizes the computed thermodynamic parameters for the eight
Fe(II) + O2 → Fe/O2 reactions examined here. For both [2-O2] and [4-O2], the four spin
states lie within 3 kcal/mol of each other. This result is typical of ferric−superoxo
species, which commonly possess a large number of close-lying electronic states.76 The
enthalpic (ΔHrxn) contributions to O2 binding are generally insignificant or slightly
favorable, yet the overall process is endergonic (ΔGrxn = 8−13 kcal/mol) due to the
unfavorable entropic effects characteristic of bimolecular reactions.

Although the

differences are within the uncertainty of the methodology, the computed ΔGrxn-values are
uniformly smaller for the [4-O2] models relative to their [2-O2] counterparts, suggesting
that the Tp-based complexes have a higher affinity for O2 than the TIP-based complexes.
This conclusion is supported by the fact that the computed ν(O−O) frequencies for the [4O2] models are 15−25 cm−1 lower in energy compared to their counterparts in the
analogous [2-O2] models (Table 2.5), implying that the TpPh,Me ligand promotes greater
charge transfer from Fe(II) to O2. Analysis of the Mulliken populations revealed that the
S-donors in the Fe/O2 adducts possess a significant amount of spin-density, with alphaspin-values of 0.33 and 0.27 in the S = 2 structures of [2-O2] amd [4-O2], respectively.

140

This partial radical character, which is consistently larger in the TIP-containing models,
likely promotes formation of the S−O bond in the next step of the mechanism.

Table 2.5. Energetic parameters computed for O2 binding to complexes 2 and 4, and
comparison of superoxo stretching frequencies in the resulting [FeO2] adduct.

a

Stot is the overall spin of the [FeO2] adduct, whereas HS and LS indicate the spin state of

the Fe center itself.

b

Thermodynamic parameters in the resulting [FeO2] adduct.

The majority of computational studies of CDO and synthetic mimics suggest that
formation of the critical Fe(II)−O−O−S cyclic intermediate occurs along the S = 2
potential energy surface (PES).17,27,32 Our DFT calculations revealed that conversion of
S=2 [2-O2]HS and S=2 [4-O2]HS to the corresponding peroxo species occurs with overall
transition-state barriers of 25 and 23 kcal/mol, respectively, relative to the Fe(II) and O2
starting materials (Figure 2.16). The barrier of ∼ 12 kcal/mol for Od−S bond formation is
in line with previous DFT studies of WT CDO and related models, which reported values
around 10 kcal/mol for the same mechanistic step.27,77 The difference in transition-state
energies between S=2 [2-O2]HS and S=2 [4-O2]HS lies within the estimated error of the
computations (± 2 kcal/mol), consistent with our experimental finding that the identity of
LN3 does not have a major impact on dioxygenation rates. Significantly, the computed
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activation parameters for S=2 [2-O2]HS (ΔH⧧ = 10.5 kcal/mol, ΔS⧧ = − 48 cal/(mol· K))
are in reasonably good agreement with the experimentally determined values of ΔH⧧ =
12(1) kcal/mol, ΔS⧧ = − 25(4) cal/(mol· K).

In the DFT-optimized transition-state

geometry derived from S=2 [2-O2]HS (Figure 2.17), the O−O bond is positioned directly
over the Fe−S bond, giving rise to a S···Od distance of 2.18 Å. The O−O and Fe−S
bonds are elongated by 0.040 and 0.212 Å, respectively, compared to the S=2 [2-O2]HS
adduct. The degree of S-radical character in the transition state, as indicated by Mulliken
spin populations, is significantly greater for TIP-based 2 (0.18 spins) than Tp-based 4
(0.11 spins). The distribution of unpaired spin density in the transition-state structure
(Figure 2.17) indicates that the S−Od bond is formed via the overlap between the S-based
pz-orbital and the O2-based π* orbital oriented along the S−Od axis.
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a

Geometry-optimized structures of

S=2

[2-O2]HS (left) and

S=2

[2-O2]TS (right) are also

provided, and select bond lengths are indicated in angstroms (Å).
Figure 2.17. Relative energies in kcal/mol for the initial steps in the reaction of 2 (red
lines) and 4 (blue lines) with O2 at 298.15 Ka.
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For the sake of completeness, we also examined the cyclization reaction along the
S = 1 PES originating from the S=1 [2-O2]LS and S=1 [4-O2]LS species, as this process
yielded the lowest-energy transition state in de Visser’s study of complex 3.32 However,
the barrier for the S = 1 route is nearly 10 kcal/mol higher in energy than the S = 2
pathway, suggesting that the former is not a viable option for the dioxygenation
mechanism if the Fe center remains six coordinate.

Figure 2.18. Contour plot of unpaired spin-density in the structure of

S=2

[2-O2]TS (i.e.,

the transition state of the S-Od bond forming reaction). The green and gray regions
indicate regions of excess spin-up (α) and spin-down (β) electron density, respectively.
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Figure 2.19. Relative energies (in kcal/mol) for the initial steps in the reaction of 2 (red
lines) and 4 (blue lines) with O2 at 298.15 K. Geometry-optimized structures of
O2 ]

HS

(left),

s=2

[2-O2]

TS

S=2

[2-

(middle), and the transition-state for the O-O bond cleavage

(right) are also provided and select bond lengths are indicated in angstroms (Å).

As shown in Figure 2.19, the energies of the resulting Fe(II)−O−O−S cyclic
intermediates on the S = 2 PES are roughly equal to those of the preceding Fe/O2
adducts. The next step in the mechanism requires O−O bond cleavage to yield a highspin oxoiron(IV) unit bound to a sulfoxide ligand. Our DFT calculations indicate that the
transition-state barrier for O−O bond cleavage is quite small (∼ 2 kcal/mol; Figure 2.19),
providing further evidence that formation of the Fe−O−O−S species is the rate-limiting
step in the dioxygenation mechanism.
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2.B.vi. Nitric Oxide Reactivity: Experimental Results
Using nitric oxide (NO) as a surrogate for O2 is a common strategy for gaining
insights into the electronic structures of ferrous centers in MNIDs and related complexes,
since the reaction gives rise to an EPR-active {FeNO}7 species (using the
Enemark−Feltham notation, where the superscript indicates the sum of Fe 3d and NO π*
electrons). A notable feature of CDO is that the enzyme−substrate complex binds NO to
yield a low-spin (S = 1/2) Fe/NO adduct, as opposed to a high-spin (S = 3/2) adduct as is
generally observed for MNID enzymes with the 2H1C triad.6
Our studies found that exposure of 1 and 2 to NO yields different species
depending on the temperature of the reaction. For both complexes, the Fe/NO adducts
generated at −70 ° C (1NO and 2NO) feature two absorption bands near 440 and 660 nm.
As shown in Figure 2.19, these spectra closely resemble those reported previously for
high-spin, six-coordinate (6C) {FeNO}7 complexes with similar ligand sets, such as [Fe(NO)(4-TIPPh)(acac)]+

and

[Fe(NO)(TpPh2)(acacPhF3)]

(where

4-TIPPh

=

tris(2-

phenylimidazol-4-yl)phosphine and acacPhF3 = anion of 4,4,4-trifluoro-1-phenyl-1,3butanedione; the structure of the latter complex was verified crystallographically). The
corresponding X-band EPR spectra (Figure 2.20; inset) exhibit an axial S = 3/2 signal (g
∼ 4.0, 2.0), also characteristic of 6C {FeNO}7 species.78

The intensity of the S = 3/2

signal was measured between 10 and 50 K for 1NO, and simulation of the data provided a
D-value of 6.7(3) cm−1 and E/D-ratio of 0.005. We also generated Fe/NO adducts of 3
and 4 (3NO and 4NO, respectively), as Limberg and co-workers did not report NO-binding
studies for these complexes. The electronic absorption and EPR data of 3NO and 4NO (not
shown) are nearly identical to those obtained for 1NO and 2NO, indicating that the LN3
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ligand has little effect on NO reactivity or the spectroscopic features of the resulting
species. Therefore, only the iron−nitrosyl adducts derived from 1 and 2 will be discussed
in detail.

Figure 2.20. Absorption spectrum of 1NO (black solid line) generated via reaction of 1
with NO at =70˚C in CH2Cl2.
Ph

Previously reported UV-vis spectra of [Fe(NO(4-

+

TIP )(acac)] (blue dashed line) and [Fe(NO)(TpPh2)(acacPh,F3)] (red dashed line) in
MeCN and CH2Cl2, respectively, are shown for comparison (these spectra have been
shifted upward for clarity). Inset: X-band EPR spectrum of 1NO in frozen CH2Cl2.
Parameters: frequency = 9.380 GHz; power = 2.0 mW; modulation amplitude = 2.0 G; T
= 10 K.
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In addition to the dominant S = 3/2 resonances arising from 1NO and 2NO, EPR
spectra of samples exposed to NO at low temperatures contained variable amounts of a
minor S = 1/2 signal (Figures 2.21 and 2.22). The concentrations of the low-spin species,
labeled 1NO-LS and 2NO-LS, were generally less than 10% of total Fe as determined by
double integration of the signal at 77 K. Notably, these rhombic spectra exhibit 1:1:1
triplet superhyperfine splitting in each of the three g-values, corresponding to a

14

N

nucleus with Ax,y,z = 36, 37, and 45 MHz in the case of 2NO-LS (the complete set of spinHamiltonian parameters is provided in Table 2.6). This pattern converts to a 1:1 doublet
when the samples are prepared with

15

NO (Figures 2.21 and 2.22), confirming that the

splitting is due to the N-atom of a single NO ligand. Therefore, we can rule out the
possibility that the 1NO-LS and 2NO-LS signals are due to formation of a DNIC. Possible
structures for these S = 1/2 species derived from DFT calculations will be discussed in
the next section.
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Figure 2.21. EPR spectra of 1NO-LS (black solid line) generated via reaction of 1 with
14

NO (top) or

15

NO (bottom) at -70˚C in CH2Cl2. Parameters: frequency = 9.512 GHz;

power = 2.0 mW; modulation amplitude = 1.0 G; T = 77 K.

Simulations of the

experimental data (gray lines) were generated using the spin-Hamiltonian parameters
listed in Table 2.6.
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Figure 2.22. EPR spectra of 2NO-LS (black solid line) generated via the reaction of 2
with

14

NO (top) or

15

NO (bottom) at -70˚C in CH2Cl2. Parameters: frequency = 9.492

GHz; power = 2.0 mW; modulation amplitude = 1.0 G; T = 77 K. Simulations of the
experimental data (gray lines) were generated using the spin-Hamiltonian parameters
listed in Table 2.6.
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The reaction of 1 (or 2) with NO at room temperature (RT) initially generates a
chromophore with absorption features matching those observed at −70°C. However, 1NO
and 2NO are not stable at elevated temperatures, quickly converting to the same new
species (RTNO) characterized by a weak absorption band at 910 nm (Figure 2.23). Timedependent absorption spectra for this reaction display an isosbestic point at 820 nm,
indicating clean conversion of 1NO or 2NO to RTNO without the buildup of intermediates
(Figure 2.24). EPR spectra collected for frozen solutions of RTNO exhibit a sharp,
rhombic S = 1/2 signal that lacks hyperfine splitting (Figure 2.23, inset), along with a
very weak peak at g = 4.0 arising from residual 1NO or 2NO. Unfortunately, despite
repeated attempts, we were unable to grow crystals of RTNO suitable for X-ray
crystallography.
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Figure 2.23. Electronic absorption (top, black) and MCD (bottom, red) spectra of RTNO
prepared via reaction of NO with complex 1 at ambient temperature. The absopriton
spectrum was measured in 1:1 (v/v) CH2Cl2:butyronitrile at a temperature of 4 K and a
magnetic field of 7 T. Inset: X-band EPR spectrum (blue line) of RTNO in frozen CH2Cl2.
Parameters: frequency = 9.497 GHz; power = 0.5 mW; modulation amplitude = 1.0 G; T
= 77 K.
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Figure 2.24. Time-dependent absorption spectra showing the decay of 1NO (λmax = 640
nm) into RTNO (λmax = 910 nm) at room temperature in CH2Cl2.

Notably, the absorption and EPR features of RTNO are quite similar to those
reported for cationic, dinitrosyl iron complexes (DNICs) with the general formula
[Fe(NO)2(LN2)]+ (where LN2 is a neutral N,N-donor).79-82

Like RTNO, these S = 1/2

{Fe(NO)2}9 species commonly exhibit a rhombic g –tensor centered at 2.03 and a broad
absorption band in the near-IR region with an extinction coefficient of ∼100 M−1 cm−1.
To determine whether RTNO corresponds to a DNIC, IR spectra of NO-treated 1 and 2
were measured at room temperature. The resulting spectra display two intense peaks at
1745 and 1817 cm−1, both of which downshift by ∼ 34 cm−1 upon

15

NO substitution

(Figure 2.25). These frequencies and isotope shifts are consistent with prior studies of
[Fe(NO)2(LN2)]+ complexes, which revealed that the out-of-phase and in-phase
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combinations of ν(NO) modes occur within energy ranges of 1720−1770 and 1790− 1840
cm−1, respectively.

Furthermore, the separation between NO stretching frequencies

(ΔνNO) is diagnostic of coordination number and nuclearity, and the ΔνNO-value of 72
cm−1 measured for RTNO is typical of four-coordinate (4C) {Fe(NO)2}9 species.79-82

Table 2.6. Experimental and computed EPR parameters for low-spin {FeNO}7 species.

a

In most cases, the orientations of the computed g- and A-tensors do not align. Thus,

spectral simluations with the computed Euler angles were used to determine the A-value
corresponding to each g-value.
32.

d

Reference 23.

b

References 35.

c

OEP = octaethylporphyrin; refs 30 and
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Figure 2.25. IR spectra measured after treatment of CH2Cl2 solutions of 1 or 2 with NO
(black solid lines) or

15

NO (blue dashed lines) at room temperature. Spectra of NO-

treated 1 (top) feature an intense ν(C=O) stretching mode at 1728 cm-1 arising from the
ester group of the CysOEt ligand.
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The formation of {Fe(NO)2}9 DNICs from Fe(II)−thiolate precursors requires
formation of 0.5 equivalents of disulfide to provide the additional electron. Analysis with
GC−MS found that L-cystine ethyl ester was the only CysOEt-derived product generated
during the 1 + NO reaction at RT. Thus, our collective experimental results suggest that
DNIC formation occurs via the reaction
[Fe(NO)(TIPPh2)(CysOEt)]+ (1NO) + NO à [Fe(NO)2(TIPPh2)]+ (RTNO) + 1/2 RS-SR

where R = −CH2CH(NH2)CO2Et. This conclusion is supported by the fact that the
spectroscopic parameters of RTNO are identical regardless of whether 1 or 2 serves as the
precursor, indicating that the thiolate ligand is no longer attached to the iron-containing
product.
To further probe the electronic properties of RTNO, we collected MCD spectra for
frozen solutions in 1:1 (v/v) CH2Cl2:butyronitrile. Whereas the absorption spectrum of
RTNO exhibits few well-defined features, the MCD spectrum measured at 4 K and 7 T
shows four distinct bands between 10,000 and 25,000 cm−1 (Figure 2.23). Variabletemperature variable-field (VTVH) MCD data collected at 907 nm (Figure 2.26) confirm
that the MCD bands arise from a S = 1/2 species, consistent with the EPR results. To the
best of our knowledge, these data represent the first MCD analysis of a DNIC. The
origins of the observed absorption/MCD features were elucidated with the help of TDDFT calculations, as discussed in the following section.
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Figure 2.26. Experimental VTVH-MCD data collected at 907 nm for RTNO in a frozen
solution of 3:7 CH2Cl2:butyronitrile, plotted against βH/2kT. The experiments were
performed by measuring the signal intensity at five temperatures (2, 4, 8, 15, and 25 K) as
a function of magnetic field between 0 and 7 T. The observed superposition of the
magnetization curves is indicative of a S = 1/2 ground state.

2.B.vii. Nitric Oxide Reactivity: Computational Results
DFT calculations for Fe/NO species derived from complexes 1 and 2 utilized
either the nonhybrid BP86 or hybrid meta-GGA TPSSh functionals, which are known to
provide accurate geometries and spectroscopic parameters for both mono- and dinitrosyl
iron complexes.82 Geometry optimizations of the high-spin {FeNO}7 adduct obtained
upon NO binding to 2 yielded quasi-6C structures, labeled S=3/2 [2-NO]6C, with an
elongated distance of 2.5 Å for the Fe−NTIP bond trans to the nitrosyl (Table 2.7),
indicative of the strong trans influence of NO ligands.83 Interestingly, during the BP86
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geometry optimizations of the low-spin {FeNO}7 adduct, the trans imidazole fully
dissociated and formed an intramolecular H-bond with the amine group of CysAm,
yielding the 5C structure S=1/2 [2-NO]5C. In order to generate a low-spin 6C model (i.e.,
S=1/2 [2-NO]6C), it was necessary to constrain the trans Fe−NTIP bond distance to 2.3 Å.
The structures and relative energies of the three BP86-optimized models are provided in
Figure 2.26. The S=1/2 [2-NO]5C structure is more stable than both S=3/2 [2-NO]6C and
S=1/2 [2-NO]6C by several kcal/mol. When the TPSSh functional is employed instead of
BP86, a low-spin {FeNO}7 species with a quasi-6C structure (trans Fe−NTIP distance of
2.41 Å) was found to exist in a local minimum. While the three TPSSh-generated
structures are fairly close in energy, the S=1/2 [2-NO]5C structure remains the most stable
(Figure 2.27).

Table 2.7. Selected bond distances (Å) and angles (˚) for Fe/NO species obtained by
DFT calculations.

a

The Fe1-N5 bond was constrained to a distance of 2.30 Å in the geometry of
6C

NO]

with the BP86 functional.

S=2

[2-
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Figure 2.27. DFT optimized structures and relative energies (in kcal/mol) of the S=3/2[2NO]6C,

S=1/2

[2-NO]6C, and

S=1/2

[2-NO]5C models computed using the BP86 and TPSSh

functionals. The structures were derived from the BP86 calculations.
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To determine whether the S=1/2 [2-NO]5C structure corresponds to the
mononitrosyl S = 1/2 species observed via EPR spectroscopy (Figure 2.22), we
calculated g-values and 14N A tensors using both functionals. We also performed parallel
calculations for [Fe(NO)(N3PyS)]+, a structurally characterized 6C, low-spin {FeNO}7
complex prepared by Goldberg and co-workers.

As shown in Table 2.8, our DFT

methodology accurately reproduces the EPR features of this complex, namely, its
rhombic g-tensor centered near ge = 2.00 and large Ay-value.

Importantly, the

calculations are consistent with prior studies of low-spin {FeNO}7 complexes, both heme
and non-heme, which have revealed that certain spin-Hamiltonian parameters are
diagnostic of coordination number.84-87 Specifically, the gx-values of 6C species are
always less than the free-electron value (ge = 2.002), whereas gx > ge for 5C {FeNO}7
species. Additionally, the A-tensors of 6C complexes exhibit relatively large anisotropy
and a dominant Ay-value, whereas 5C complexes possess relatively isotropic

14

N A-

tensors in which the Ax-value is the largest component (Table 2.8). The EPR parameters
of 1NO-LS and 2NO-LS closely align with those computed for S=1/2 [2-NO]5C, as well as
those observed for 5C NO adducts of ferrous−porphyrin complexes.84-87

Thus, we

conclude that the observed low-spin signal is due to dissociation of the trans imidazole
donor in a fraction of the {FeNO}7 adducts prepared at low temperature.
We also generated computational models with the formula [Fe(NO)2(TIPMe)]+ to
further confirm that RTNO

corresponds to a cationic DNIC.

These calculations

employed the broken-symmetry approach to generate the proper S = 1/2 wave function,
best described as a high-spin Fe(III) center coupled antiferromagnetically to two NO− (S
= 1) ligands. Regardless of the functional used, geometry optimizations of the DNICDFT
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models converged to four-coordinate (4C) structures with a κ2-TIP ligand, further
demonstrating the hemilability of the TIP framework.

The computed spectroscopic

properties of the DNICDFT models are summarized in Table 2.7. DFT is known to
overestimate ν(NO) frequencies, with hybrid functionals generally performing worse than
nonhybrid functionals.82,87 While our results follow this pattern, the BP86 functional
proved quite effective in estimating the energy splitting between the in-phase and out ofphase combinations of ν(NO) modes of RTNO. Both functionals yielded rhombic gtensors centered near g = 2.03, consistent with our EPR data and prior studies of
DNICs.79-82 The computed A-tensors are highly anisotropic with two small A-values
(<10 MHz) and one moderate value of 25 or 39 MHz, in accordance with the absence of
any detectable 14N hyperfine splitting in the experimental RTNO EPR spectrum.

Table 2.8. Comparison of computed spectroscopic parameters for DNICDFT models with
experimental values measured for RTNO.
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Consistent with the experimental absorption spectrum of RTNO, TD-DFT
calculations of DNICDFT predict a series of weak bands (ε -values < 400 M−1 cm−1) in the
visible region (Figure 2.28, top). The donor MOs for these transitions contain
approximately equal amounts of Fe 3d and NO π* character due to the highly covalent
nature of the iron−nitrosyl bonds. In contrast, the acceptor orbital is the Fe(dx2−y2)based MO that lies in the NTIP−Fe−NTIP plane and lacks contributions from the NO
ligands (Figure 2.28, bottom). Thus, the transitions have both ligand-field and NO−à
Fe(III) CT character, but their intensities are limited by the poor spatial overlap between
donor and acceptor MOs.
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Figure 2.28. Top: TD-DFT computed absorption spectrum of DNICDFT compared to the
experimental absorption spectrum of RTNO (red solid line).

The black sticks and

numbers mark the energies and intensities of computed transitions. Bottom: Electron
density difference maps (EDDMs) for computed transitions. The green and gray regions
indicate gain and loss of electron density, respectively.
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2.C. Conclusions
In this chapter, I have reported the syntheses, X-ray crystallographic structures,
electronic properties, and O2/NO reactivities of two novel TDO active site models (1 and
2). These 5C Fe(II) complexes consist of a bidentate “substrate” ligand (CysOEt or
CysAm) and the facially coordinating TIPPh2 supporting ligand (Figure 2.1). In our
estimation, 1 and 2 are the most structurally accurate models of the CDO and ADO active
sites prepared to date, as the TIPPh2 supporting ligand reproduces the neutral charge and
all-imidazole coordination of the 3His triad. The electronic structures of 1 and 2, along
with those of the previously reported TpPh,Me-based TDO models (3 and 4), were
elucidated with spectroscopic (absorption, MCD) and computational (DFT) techniques.
These studies yielded specific assignments for the three overlapping S → Fe(II) CT
transitions in the near-UV region, and MCD analysis permitted observation of the
highest-energy d−d transition at ∼ 11,300 cm−1.

In addition, they revealed that

substitution of neutral TIPPh2 with anionic TpPh,Me destabilizes the Fe 3d manifold by
∼0.13 eV and significantly reduces the covalency of the Fe−S bond.
Like similar complexes generated by the Limberg and Goldberg groups, 1 and 2
are functional TDO mimics that react with O2 to yield the corresponding sulfinic acid
product. Our kinetic studies determined that the identity of the LN3 ligand (TIPPh2 versus
TpPh,Me) has little effect on O2 reaction rates. DFT methods were then employed to
evaluate the energetics of formation of the Fe/O2 adduct and its conversion to the cyclic
Fe−O−O-S intermediate; the latter reaction is the putative rate-determining step in the
dioxygenation mechanism. These calculations indicated that O2 binding to the high-spin
Fe(II) centers of 2 and 4 is endergonic by 9−13 kcal/mol due to an unfavorable entropic

164

contribution. The transition state leading to the putative Fe−O−O−S intermediate along
the S = 2 surface is further uphill by ∼ 12 kcal/mol for 2 and 4, resulting in an overall
barrier of ∼24 kcal/mol relative to the starting complexes and O2. These computed values
are roughly consistent with the experimental activation parameters of ΔH⧧ = 12(1)
kcal/mol and ΔS⧧ = − 25(4) cal/(mol· K) measured experimentally for the reaction of 1
with O2. In both the Fe/O2 adducts and transition-state structures, the charge of the
supporting ligand modulates the amount of unpaired spin density on the S atom of the
thiolate ligand, with the TIP-based models exhibiting greater S-radical character than the
Tp-based models. This correlation offers a possible rationale for the preference of TDOs
for the 3His triad instead of the 2H1C triad, since the development of (partial) thiyl
radical character is thought to facilitate formation of the critical Fe−O−O−S species in the
enzymatic mechanism.15
Since our efforts to trap intermediates in the dioxygenation reactions were
unsuccessful, we explored the reactivity of 1 and 2 with NO, an established proxy for O2.
As summarized in Figure 2.28, initial NO binding generates a 6C, high-spin {FeNO}7
adduct (1NO and 2NO) that is metastable at reduced temperatures, but converts at RT to a
more stable 4C DNIC (RTNO) with concomitant formation of disulfide.

Samples

prepared at low temperatures also revealed a minor S = 1/2 signal (1NO-LS and 2NO-LS) that
was shown, through a combination of spectroscopic and computational analysis, to
correspond to a 5C species featuring a κ2-TIP ligand. The dissociation of the trans
imidazole donor may be required for the conversion of the 6C {FeNO}7 adducts into the
4C {Fe(NO)2}9 species.
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Figure 2.29.

Summary of the reaction of complexes 1 and 2 with NO, from low

temperature to room temperature.
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Interestingly, even though the first-sphere coordination geometries of 1 and 2 are
nearly identical to those of CDO and ADO, there are dramatic differences in electronic
structure, spectroscopic properties, and reactivity between the synthetic models and
enzyme active sites. For example, the S → Fe(II) CT transitions observed for CDO are
much higher in energy than those observed for complexes 1−4. In addition, whereas 1NO
and 2NO are high-spin and decompose at RT to form a DNIC, the 6C {FeNO}7 adduct of
CDO is low-spin and relatively stable.6 These differences highlight the importance of the
protein environment in fine-tuning the geometric and electronic structures of the nonheme iron active site. The rotational freedom of the imidazolyl and pyrazolyl donors
allows the TIPPh2 and TpPh,Me ligands to adopt κ2-N,N

binding modes, thereby

encouraging the formation of 5C and 4C Fe/NO adducts. In contrast, QM/MM studies
have determined that the binding of NO to substrate-bound CDO causes little change in
Fe−NHis bond distances,15 suggesting that the positions of the His ligands are fixed within
the active site. Thus, despite the considerable advantages of scorpionate ligands, our
future TDO modeling studies will employ more constrained ligands that prevent
elongation or breaking of the Fe−N bond trans to the O2/NO binding site. Moreover, the
incorporation of second-sphere donors capable of hydrogen bonding interactions would
serve to modulate spectroscopic features and stabilize reactive intermediates in a manner
similar to the protein environment.
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2.D. Synthetic model of 3-mercaptopropionate dioxgyenase
Similar to CDO and ADO, 3-mercaptopropionate dioxygenas (3MDO) reacts with
molecular oxygen to produce the corresponding sulfinic acid. The active site of 3MDO
also contains a 3-His facial triad and a bidentate substrate ligand. 3MDO, found only in
bacteria, catalyzes the initial step of 3-mercaptopropionate catabolism following the
break down of 3,3-thiodipropionic acid (Figure 2.30).

Figure 2.30. The pathway of the catabolism of 3,3-thiodipropionic acid. In the second
step, 3MDO react with O2 to form the sulfinic acid product.
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Figure 2.31. Supporting ligand and substrate ligand used to model 3MDO.
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In this section, I will describe the synthesis and characterization of a biomimetic
model of 3MDO incorporating the TIPPh2 ligand, similar to the studies discussed above.
In this case, methyl thiosalicylate (MTS) (Figure 2.31) was used as the bidentate
substrate ligand to form the model complex [Fe(TIPPh2)(MTS)]BPh4 (5). However, my
focus was on complexes 1 and 2 so these studies are not as in depth.

2.D.ii. Synthesis, solid state structures, and solution state spectroscopic properties
The synthetic route of this complex is very similar to complexes 1 and 2. Methyl
thiosalicylate was reacted with 1 equivalent of triethylamine in CH2Cl2 followed by the
addition of the precursor complex [Fe(TIPPh2)(MeCN)2](OTf)2. After solvent removal,
the residue was taken up in MeOH and treated with sodium tetraphenylborate,
immediately forming a bright yellow precipitate. The solid was collected, washed with
more MeOH, and dried. X-ray quality crystals were obtained by dissolving the triflate
salt of the product in CH2Cl2 and layering with pentane.
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Figure 2.32. Thermal ellipsoid plot (50% probability) obtained from the X-ray crystal
structure of 5.

The OTf counteranion, non-coordinating solvent molecules, and all

hydrogen atoms have been removed for clarity.
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Table 2.9. Selected bond lengths (Å) and angles (˚) for complex 5.

The crystal structure of 5 (Figure 2.32) reveals a 5-coorndinate mononuclear
iron(II) complex with a the MTS ligand bound through the thiol atom and the oxygen of
the carboxylate group. The structure consists of two symmetrically independent units.
The geometry of 5 lies between square pyramidal and trigonal bipyramidal, with an
average τ-value of 0.55. As seen in complexes 1 and 2, the facial coordination of the
TIPPh2 ligand nicely mimics the active site of 3MDO. Select bond lengths and angles can
be seen in Table 2.9. Again, these bond Fe-NTIP bond distnces are typical for high-spin
Fe(II) complexes, with a range from 2.09-2.25 Å.
The 1H NMR spectrum was obtained in CDCl3 at room temperature (Figure 2.33).
It displays a series of peaks from 45 ppm to -17 ppm, again suggesting that this complex
contains a high-spin Fe(II) center. The methyl group of the MTS ligand is apparent at 16
ppm, and the aromatic peaks are greatly shifted, appearing at 43.5, 37, -0.52, and -17.05
ppm. Similar to complexes 1 and 2, the N-CH3 of the TIPPh2 ligand 17.12 ppm. A
solution of complex 5 in CH2Cl2 is a bright greenish-yellow color, due to an intense
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absorption at 380 nm. As seen above, this feature is attributed to the S à Fe(II) charge
transfer transition.

Figure 2.33. 1H NMR spectrum of complex 5 measured at room temperature in CDCl3.

2.D.ii. Reactivity with O2
Upon addition of O2 to a solution of 5 in CH2Cl2, the feature at 380 nm
diminished slightly, but didn’t fully disappear, even over the course of 48 hours (Figure
2.34). This differs from complexes 1-4, which upon addition of O2 the S à Fe(II) CT
transitions completely disappeared
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Figure 2.34. UV-vis spectrum taken of complex 5 (red line) at room temperature in
CH2Cl2 reacted with O2 after 48 hours (blue line).

2.D.iii. Reactivity with NO
As discussed above, nitric oxide (NO) was used as a surrogate for O2 to try to
gain more insight into the electronic structure of the ferrous center. Again, different
species were observed at varying temperatures. The addition of NO at low temperature (70˚C) resulted in a spectrum similar to the low temperature 1NO and 2NO spectra. The
feature at 380 nm diminishes, and a broad feature at ~480 nm and a feature at 690 nm
appear (Figure 2.35).
The room temperature spectrum of the reaction of complex 5 with NO is very
similar to room temperature data collected for RTNO, suggesting that again a dinitrosyl
iron complex (DNIC) is again formed. The UV-vis spectrum of this reaction (Figure
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2.36) exhibits a feature at 910 nm, and the corresponding EPR spectrum (Figure 2.36,
inset) shows an S = 1/2 species with g-values of 2.07, 2.04, and 2.01, matching what was
observed for RTNO.

Figure 2.35. Absorption spectrum of complex 5 (red solid line) and 5NO (black dashed
line) at low temperature (-70˚C) in CH2Cl2.
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910 nm

Figure 2.36. Electronic absorption spectrum of RTNO at room temperature, measured in
CH2Cl2. Inset: X-band EPR spectrum of RTNO in frozen CH2Cl2. Parameters: frequence
= 9.507 GHz; power = 0.5 mW; modulation amplitude = 1.0 G; T = 77 K.

2.D.iv. Conclusion
Although there is much more work needed to be done, the preliminary work with
[Fe(TIPPh2)(MTS)]BPh4 suggests this could be a possible biomimetic model of
mercaptopropionate dioxygenase. The X-ray crystal structure revealed a 5-coordinate
structure, similar to other MNID synthetic models. However, more work needs to be
done to fully understand the function and electronic characteristics.
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2.E. Experimental

2.E.i. Materials
Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Dichloromethane (CH2Cl2) was purified and
dried using a Vacuum Atmospheres solvent purification system and stored under N2. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox equipped with a freezer set to −30 °C.
Nitric oxide (NO) from a cylinder (Airgas, Inc.) was purified by passage through an
ascarite II column, followed by a cold trap at −78 °C to remove higher NxOy impurities.
15

N-labeled NO was prepared via reaction of Na15NO2 with ascorbic acid and aqueous

Cu(II) chloride under an argon (Ar) atmosphere.89 The LN3 supporting ligand K(TpPh,Me)
and 2-TIPPh2 were prepared according to literature procedure. 31,33,64,90

2.E.ii. Physical Methods
Elemental analyses were performed at Midwest Microlab, LLC, in Indianapolis,
IN. UV−vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for experiments at reduced temperatures. Infrared (IR) spectra were measured
with a Nicolet Magna-IR 560 spectrometer. X-band EPR experiments were performed
using a Bruker EleXsys E650 instrument equipped with an ER4415DM cavity, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat. The
program EasySpin (version 5) was used to simulate the experimental spectra.91 1H NMR
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spectra were recorded in deuterated solvents using a Varian 400 MHz spectrometer.
Mass spectrometric data were measured using either an Agilent 6850 gas
chromatography−mass spectrometer (GC−MS) with a HP-5 column or a Bruker matrixassisted laser desorption/ionization (MALDI) time-of-flight (TOF) microflex instrument.
Magnetic circular dichroism (MCD) data were collected using a Jasco model J-715
spectropolarimeter, in conjunction with an Oxford Instrument SM-4000 8T
magnetocryostat. The samples for these studies were prepared in CH2Cl2 and then
diluted with butyronitrile to a final ratio of 3:7 (v/v), or 1:1 (v/v) for the NO-treated
samples, thereby yielding glassy solutions upon freezing in liquid nitrogen. Potential
artifacts due to glass strain were eliminated by taking the difference between spectra
collected with the magnetic field aligned parallel and antiparallel to the direction of light
propagation.
X-ray diffraction (XRD) data were collected at 100 K with an Oxford Diffraction
SuperNova kappa-diffractometer (Rigaku Corp.) equipped with dual microfocus Cu/Mo
X-ray sources, X-ray mirror optics, an Atlas CCD detector, and a low-temperature
Cryojet device.

The data were processed with the CrysAlis Pro program package,

followed by numerical absorption correction based on Gaussian integration over a
multifaceted crystal model and then empirical absorption correction using spherical
harmonics, as implemented in SCALE3 ABSPACK scaling algorithm. Structures were
solved using the SHELXS program and refined with the SHELXL program within the
Olex2 crystallographic package.92 X-ray crystallographic parameters are provided in
Table 2.10.
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2.E.iii. Synthetic Procedures
1-methyl-4,5-diphenylimidazole.

According

to

literature

procedure64,

4,5-

diphenylimidazole (15.0 g, 68 mmol) was dissolved in 200 mL anhydrous THF under
inert atmosphere. This solution was cooled to 0˚C, and NaH (60% dispersion in mineral
oil, 3.0 g, 78.3 mmol) was slowly added. This teal solution was stirred for three hours,
slowly warming to room temperature. The solution was then cooled back down to 0˚C,
and methyl iodide was added (4.24 mL, 68 mmol), and the solution was stirred 12 hours,
during which a color change to yellow was observed. 250 mL of deionized water was
added, and the mixture was stirred for one hour. The green powdery product was
collected by filtration and dried under vacuum (14.06 g, 88.1% yield).

1

H NMR (400

MHz, CDCl3): ∂ = 7.56 (s, 1H, C=N-C-H), 7.44 (m, 5H, Ar-H), 7.34 (m, 2H, Ar-H), 7.20
(m, 2H, Ar-H), 7.15 (m, 1H, Ar-H), 3.47 (s, 3H, CH3) ppm.

13

C NMR (400 MHz,

CDCl3): ∂ = 138.2, 137.4, 134.7, 130.7, 130.6 129.0, 128.9, 128.6, 128.1, 126.6, 126.3,
32.20 ppm.
2-TIPPh2. According to a procedure previously published by our group64, 2-methyl-4,5diphenylimidazole (14 g, 60 mmol) was dissolved in anhydrous THF under inert
atmosphere. This solution was cooled to -78˚C, and n-BuLi (2.5 M, 26.4 mL, 66.1
mmol) was added dropwise. This solution was stirred for 2 hours at -78˚C, warmed to
20˚C, and stirred for an additional 30 minutes. This brown solution was cooled back
down to -78˚C, and phosphorous trichloride (1.73 mL, 20 mmol) was added. This was
stirred for 12 hours, slowly warming to 20˚C. 200 mL of 30% ammonium hydroxide was
added, and the slurry was stirred 30 minutes. The layers were separated, and the aqueous
layer was extracted by 150 mL chloroform. The combined organic layers were washed
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with brine, dried with MgSO4, and the solvent was removed under vacuum.

The

resulting orange residue was washed with methanol, causing the white powdery product
to precipitate (4.1 g, 28.0 % yield). 1H NMR (400 MHz, CDCl3): ∂ = 7.48 (m, 12H, ArH), 7.40 (m, 6H, Ar-H), 7.17 (m, 12H, Ar-H), 3.64 (s, 9H, CH3) ppm.

13

C (400 MHz,

CDCl3): ∂ = 140.5, 140.0, 139.9, 134.8, 133.6, 131.1, 131.0, 129.2, 129.0, 128.2, 126.9,
126.5, 33.4 ppm.

31

P NMR (400 MHz): ∂ = -56.6 ppm.

[Fe(TIPPh2)(MeCN)3](OTf)2. According to a procedure previously published by our
group64, Ph2TIP (1.3 g, 1.8 mmol) and Fe(OTf)2 (0.67 g, 1.9 mmol) were mixed in CH3CN
(15 mL) and stirred until the solution became clear (about 3 hours). This solution was
then filtered, layered with excess Et2O, and put in the freezer at -10˚C. X-ray quality
crystals were formed after one day. The crystals were collected, washed with Et2O, and
dried under vacuum (1.3 g, 60% yield). 1H NMR (400 MHz, CDCl3): ∂ = 14.53 (br. s,
6H), 11.19 (s, 9H, CH3), 8.63 (s, 6H), 7.93 (s, 6H), 7.40 (s, 3H), 7.17 (s, 3H), 5.84 (s,
6H).
[Fe(TIPPh2)(CysOEt)]BPh4 (1).

L-cysteine ethyl ester hydrochloride (38 mg, 0.20

mmol) and triethylamine (62 µL, 0.44 mmol) were combined in CH2Cl2 and stirred until
all solid dissolved. A solution of [Fe(TIPPh2)(MeCN)3](OTf)2 (0.242 g, 0.20 mmol) in
CH2Cl2 was added dropwise. The resulting bright yellow solution was stirred for 30
minutes.

The solvent was removed under vacuum.

Counteranion metathesis was

performed. MeOH was added to the resulting yellow residue, and the solution was
filtered. A solution of NaBPh4 (68 mg, 0.20 mmol) in MeOH was added dropwise, and a
yellow precipitate immediately formed.

After stirring 15 minutes, the solvent was

removed under vacuum. The resulting yellow powder was taken up in a minimal amount
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of dichloroethane and layered with MeOH. A fluffy yellow powder formed after one
day. The powder was collected, washed with MeOH, and dried under vacuum (0.1384 g,
55.18% yield). X-ray quality crystals were grown from a dilute solution in DCE/MeOH
mixture after about 1 week. Elemental analysis calculated (%) for C74H65BFeN7PS: C,
75.19; H, 5.54; N, 8.29. Found: C, 76.02; H, 6.02; N, 7.89. IR (solution in CH2Cl2): ν =
1728.9, 1580.4, 1192.8 cm-1. 1H NMR (400 MHz, CDCl3): ∂ = 15.61 (s, 2H), 15.19 (s,
2H), 14.79 (s, 9H, CH3), 8.08 (s, 3H), 7.63 (s, 12H), 6.90 (s, 6H), 6.37 (s, 8H), 6.04 (s,
8H), 4.22 (s, 6H), 3.38 (s, 6H), 2.96 (q, 2H, -COOCH2CH3), 2.41 (br. s, 2H, -SCH2C-),
2.01 (s, 1H, -H2NCH-), 1.31 (t, 3H, -COOCH2CH3), -17.46 (br. s, 4H) ppm.
[Fe(TIPPh2)(CysAm)]BPh4 (2). Cysteamine hydrochloride (23 mg, 0.20 mmol) and
triethylamine (62 µL, 0.44 mmol) were combined in CH2Cl2 and stirred until all solid
dissolved. A solution of [Fe(TIPPh2)(MeCN)3](OTf)2 (0.242 g, 0.20 mmol) in CH2Cl2
was added dropwise. The resulting opaque orange solution was stirred for 30 minutes.
The solvent was removed under vacuum.

Counteranion metathesis was performed.

MeOH was added to the resulting yellow residue, and the solution was filtered. A
solution of NaBPh4 (68 mg, 0.20 mmol) in MeOH was added, and a yellow precipitate
was formed immediately. After stirring 15 minutes, the solvent was removed under
vacuum.

The resulting yellow powder was taken up in a minimal amount of

dichloroethane and layered with MeOH. X-ray quality yellow crystals were formed after
one day. The crystals were collected, washed with MeOH, and dried under vacuum
(0.0148 g, 17.7% yield). Elemental analysis calculated (%) for C77H69BFeN7O2PS: C,
73.74; H, 5.55; N, 7.82. Found: C, 72.56; H, 5.61; N, 7.70. IR (solution in CH2Cl2): ν =
1579.4 cm-1. 1H NMR (400 MHz, CDCl3): ∂ = 14.83 (s, 9H, CH3), 8.15 (s, 8H), 8.02 (s,
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4H), 7.24 (s, 6H), 6.81 (s, 6H), 6.00 (s, 3H), 5.90 (s, 3H), 4.04 (s, 5H), 3.86 (s, 3H), 3.17
(s, 6H), 2.63 (t, 1H, -CH2CH2-), 1.31 (t, 1H, -CH2CH2-), 1.23 (t, 1H, -CH2CH2-), 1.11 (t,
1H, -CH2CH2-), -19.26 (br. s, 4H) ppm.
[Fe(TpPh,Me)(CysOEt)] (3). K(TpPh,Me) (0.273 g, 0.50 mmol), Fe(OTf)2 (0.117g, 0.50
mmol), L-cysteine ethyl ester hydrochloride (93 mg, 0.50 mmol), and triethyl amine (153
µL, 1.1 mmol) were combined in CH2Cl2. This solution was stirred 12 hours. This
cloudy orange solution was filtered, resulting in a pale yellow filtrate. The solvent was
removed under vacuum, and the resulting solid was washed with MeOH, producing a
white solid (0.346 g, 92.3% yield). IR (solution in CH2Cl2): ν = 1727.9, 1597.8, 1194.7,
1010.5 cm-1. 1H NMR (400 MHz, CDCl3): ∂ = 51.83 (br. s, 2H, NH2), 36.85 (br. s, 1H),
21.86 (s, 9H, CH3), 11.42 (s, 1H). 10.66 (s, 1H), 6.15 (s, 6H), 5.91 (s, 4H), 5.07 (s, 4H),
3.82 (t, 1H, SCH2C-), 3.58 (t, 1H, SCH2C-), 3.14 (q, 2H, -COOCH2CH3), 1.91 (t, 1H,
NH2CHC-), 1.37 (t, 3H, -COOCH2CH3), -4.05 (br. s, 4H), -11.82 (s, 1H) ppm.
[Fe(TpPh,Me)(CysAm)] (4). K(TpPh,Me) (0.273 g, 0.50 mmol), Fe(OTf)2 (0.117g, 0.50
mmol), cysteamine hydrochloride (56 mg, 0.50 mmol), and triethyl amine (153 µL, 1.1
mmol) were combined in CH2Cl2. This solution was stirred 12 hours. This cloudy grey
solution was filtered, resulting in a yellow filtrate. The solvent was removed under
vacuum, and the resulting solid was washed with MeOH, producing a pale yellow solid
(0.170 g, 50.2% yield). X-ray quality crystals were obtained by dissolving the product in
a minimal amount of CH2Cl2 and layering hexane. IR (solution in CH2Cl2): ν = 1576.5,
1067.4, 1009.6 cm-1. 1H NMR (400 MHz, CDCl3): ∂ = 91.86 (s, 1H), 50.34 (s, 2H, NH2),
46.76 (s, 3H), 21.05 (s, 9H, CH3), 9.13 (br. s, 6H), 6.76 (br. s, 6H), 5.79 (s, 6H), 5.64 (s,
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4H), 3.70 (t, 1H, -CH2CH2-), 3.19 (s, 1H,-CH2CH2-), 1.80 (t, 1H, -CH2CH2-), 1.38 (t, 1H,
-CH2CH2-), -7.58 (br. s, 4H), -10.15 (s, 1H) ppm.
[Fe(TIPPh2)(MTS)]BPh4 (5). Methyl salicylate (27.5 µL, 0.20 mmol) and triethylamine
(30.7 µL, 0.22 mmol) were combined in CH2Cl2 and stirred for 30 minutes. A solution of
[Ph2TIPFe(MeCN)3](OTf)2 (0.242 g, 0.20 mmol) in CH2Cl2 was added dropwise. The
resulting red-orange solution was stirred for 1 hour. The solvent was removed under
vacuum. Counteranion metathesis was performed. MeOH was added to the resulting
orange residue, and the solution was filtered. A solution of NaBPh4 (0.068 g, 0.20 mmol)
in MeOH was added, and a yellow solid was formed immediately. After stirring 15
minutes, the solvent was removed under vacuum. The resulting yellow powder was
taken up in a minimal amount of dichloroethane, filtered, and layered with MeOH. An
orange-yellow solid formed after one day. IR (solution in CH2Cl2): ν = 1711.5, 1652.7,
1063,6, 1026.9 cm-1.

1

H NMR (400 MHz, CDCl3): ∂ = 43.60 (s, 1H), 36.82 (s, 1H),

17.21 (s, 9H, -NCH3), 16.50 (s, 3H, -OCH3), 8.77 (s, 9H), 8.53 (s, 3H), 7.76 (s, 9H), 7.29
(s, 4H), 6.73 (br. s, 5H), 5.83 (br. s, 3H), 4.85 (s, 6H), -0.524 (s, 1H), -17.06 (s, 1H) ppm.

2.E.iv. Dioxygen Reactivity Studies
Rate measurements were generally performed under conditions of O2 saturation
by bubbling O2 (Airgas, Inc.) through CH2Cl2 solutions of 1 or 3 for several minutes. For
both complexes, rates of reaction were measured four times at 20 °C, and changes in
absorption intensity at two wavelengths were fit to exponential curves using the program
IGOR. The reported k1 values and uncertainties correspond to the averages and standard
deviations, respectively, of the resulting pseudo-first-order rate constants.

The
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concentration of O2 in solution at various temperatures (T) was estimated using the
formula S = (LPO2)/(TR), where L is the Ostwald coefficient (0.257 for CH2Cl2), PO2 is
the partial pressure of O2, and R is the gas constant.14,40 The determination of PO2
accounted for the vapor pressure of CH2Cl2 (Psolv) as a function of T: PO2 = 1 atm −
Psolv. Lower concentrations of O2 were obtained by injecting anaerobic solutions of the
Fe(II) complex into O2-saturated solutions of CH2Cl2 in varying amounts. Following
established procedures,31,33 the products of the oxygenation reactions were isolated by
addition of 3M HCl to the reaction mixture and stirred for 3 h. The aqueous layer was
collected and the solvent removed under vacuum. The remaining residue was dissolved
in MeOH and stirred with Chelex for 12 h. The solvent was removed by vacuum after
filtration, and the resulting white solid was washed with toluene.

1

H NMR data of the

reaction products were interpreted with the aid of published spectra and/or by comparison
to spectra measured with commercially available material. Product of 1 + O2 reaction:
yield = 48%. 1H NMR (400 MHz, CD3OD): δ = 1.28 (t, 3H, −OCH2CH3), 2.49 (dd, 1H,
−CH2S), 2.61 (dd, 1H, −CH2S), 4.02 (m, 1 H, −CHNH2), 4.20 (q, 2H, −OCH2CH3) ppm.
MALDI-TOF data (m/z): {M}+ calcd for C5H11NO4S 181.21, found 180.94; {M − CH3}+
calcd for C4H8NO4S 166.18, found 165.76. Product of 2 + O2 reaction: yield = 61%. 1H
NMR (400 MHz, CD3OD): δ = 2.45 (t, 2H, −CH2S), 3.15 (t, 2H, −CH2NH2) ppm.

2.E.v. Density Functional Theory (DFT) Computations
Electronic-structure calculations were carried out using the ORCA 3.0 software
package developed by Dr. F. Neese (MPI for Chemical Energy Conversion).94
Computational models of 2 and 4 were obtained via unrestrained DFT geometry
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optimizations, using the Xray crystal structures as starting points.

For calculations

involving 2, the TIPPh2 ligand was truncated by replacing the 4,5-diphenyl-1methylimidazole donors with 4-methylimidazole rings; similarly, in calculations for 4 the
TpPh,Me ligand was modeled as TpMe,H. Numerical frequency calculations verified that all
structures corresponded to a local minimum with only real vibrational frequencies. The
zero-point energies, thermal corrections, and entropy terms (vibrational, rotational,
translational) were obtained from these frequency calculations. All calculations were
carried out spin-unrestricted and utilized the Ahlrichs valence triple-ζ basis set (TZV) and
TZV/J auxiliary basis set, in conjunction with polarization functions on main-group and
transition-metal elements (default-basis 3 in ORCA).95-97 Solvent effects were accounted
for using the conductor-like screening model (COSMO)98 with a dielectric constant (ε) of
9.08 for CH2Cl2.
The DFT calculations employed different functionals depending on the nature of
the species under examination and the property being computed. Geometric structures
for

the

Fe(II)

complexes

and

Fe/O2

adducts

were

optimized

using

the

Perdew−Burke−Ernzerhof (PBE) functional with 10% Hartree−Fock exchange.

The

“spin-flip” feature of ORCA46 was employed to generate broken-symmetric wave
functions for the Stot = 2 and 1 states of Fe/O2 adducts containing high-spin Fe centers.
The transition state for the S−Od bond forming reaction (where Od is the distal oxygen
atom of the iron−superoxo unit) was located by performing a relaxed surface scan along
the S···Od distance. The existence of the transition state was confirmed by the presence
of one imaginary frequency, corresponding to the ν(S−Od) mode.
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Calculations of the Fe/NO adducts employed either the Becke−Perdew
(BP86)100,101 or TPSSh functionals.102,103 In calculations of EPR parameters, the “core
properties” with extended polarization [CP-(PPP)] basis set108 was used for the Fe atom
and Kutzelnigg’s NMR/EPR (IGLO-III)105 basis set for the NO ligand. The contribution
of spin−orbit coupling to the g- and A-tensors was evaluated by solving the coupledperturbed self-consistent field (CP-SCF) equations.106-109

To compute the hyperfine

coupling constants, a high resolution grid with an integration accuracy of 7.0 was used
for the Fe and N atoms. Time-dependent DFT (TD-DFT) calculations employed the
cam-B3LYP range-separated hybrid functional,71 previously shown to yield good
agreement between experimental and TD-DFT computed absorption spectra for CDO.110
Absorption energies and intensities were computed for 40 excited states with the
Tamm−Dancoff approximation.111,112
prepared using the ChemCraft program.

Isosurface plots of molecular orbitals were
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Table 2.10. Summary of X-ray Crystallographic Data Collection and Structure
Refinement.

a

R1 = S ||Fo| - |Fc|| / S|Fo|; wR2 = [Sw(Fo2 - Fc2)2 / Sw(Fo2)2]1/2
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CHAPTER 3
Spectroscopic Studies of the Ferric Cysteine Dioxygenase Models Bound to
Substrate Analogues – Insights into the Putative Fe(III)-Superoxo
Intermediate

S = 5/2

S = 1/2

Abstract
A common strategy employed by (bio)chemists involves the use of small
molecules/anions that resemble O2 or superoxide (O2•−) to generate analogues of Fe/O2
adducts. To better understand the proposed ferrric-superoxide intermediate of CDO, our
active-site models were oxidized to the ferric state and treated with cyanide (CN–) and
azide (N3–) anions. Azide is often used to investigate Fe(III) sites because it has the same
charge as superoxide and a similar set of frontier orbitals. Likewise, the cyanide anion
readily binds to Fe(III) centers, yielding low-spin (S = 1/2) species that are well-suited
for examination with EPR and resonance Raman methods. This strategy appled to CDO
models 1-4, and the resulting iron(III)-cyano and -azido adducts were examined with
UV-vis, EPR, and rRaman spectroscopies. Thesse results yield insight into the nature of
related catalytic intermediates of CDO.
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3.A. Introduction
Prior to our efforts, the Brunold and Pierce groups treated the ferric form of CDO
with cyanide (CN-) and azide (N3-) with the aim of gaining insights into the geometric
and electronic structures of the CDO active site. Although Fe(III)-CDO is catalytically
inactive, it is more spectroscopically accessible than Fe(II)-CDO and can be
characterized by a variety of techniques, such as UV-vis absorption, resonance Raman,
and EPR spectroscopies. Cyanide and azide are small anions commonly used to mimic
the binding of superoxide to the metal center. The resulting adduct has a similar charge
and size of the Fe(III)-superoxo adduct of the catalytic cycle.7
The CN-Fe(III)-CDO adduct was specifically used to study the role of second
sphere interactions in modulating O2 binding within the active site. Unlike nitric oxide
(NO) or superoxide (O2-) that bind in a bent geometry, cyanide binds to the metal center
in a linear fashion. While this geometry is less desirable, the use of cyanide prevents
unwanted byproducts, such as dinitrosyl species, and exhibits cleaner spectra.
Additionally, the CN-Fe(III)-CDO adduct exhibits greater g-value anisotropy than the
NO counterpart, and thus EPR data of cyano-treated enzyme are more sensitive to subtle
changes in active-site structure.7
The EPR spectra of Fe(III)-CDO prior to addition of KCN exhibits a signal with
g-values of 4.47, 4.36, and 4.27 – a result consistent with high-spin (S = 5/2) substratebound Fe(III)-CDO. Addition of 0.5 equivalents of KCN resulted in a mixture of highspin and low-spin (S = 1/2) signals with the latter accounting for 22% of the total iron
(Figure 3.1A). This low-spin species was presumed to be the cyanide adduct. Addition
of 10 equivalents of KCN caused the feature centered at g ~ 4 to disappear, and an
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intense low-spin feature with g-values of 2.38, 2.23, and 1.93 appeared, accounting for
91% of the total iron (Figure 3.1B). The fact that excess KCN is required to fully
generate the cyano adduct suggests that the iron(III) center of CDO has poor affinity for
cyanide.7

Figure 3.1. X-band EPR spectra of Cys-bound Fe(III)-CDO after the addition of A) 0.5
eq KCN or B) 10 eq KCN. Parameters: microwave frequency, 9.64 GHz; modulation
frequency, 100 kHz; modulation amplitude, 0.9 mT; temp, 10 K; microwave power, 40
µW. Figure obtained from Reference 7.
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These same experiments were also performed on a sample in which only 50% of
CDO contained the Cys-Tyr crosslink within the active site (referred to as as-isolated
CDO, or AI-CDO). When KCN was added, two spectroscopically distinct S = 1/2
species were observed by EPR (Figure 3.2). One of these species matched the spectrum
observed previously, referred to as S1 (Figure 3.1B). The additional S = 1/2 signal
exhibits g-values of 2.34, 2.21, and 1.95, and is referred to as S2.

The relative

contribution of these species is 60% S1 and 40% S2. Pierce et al. hypothesized that S1
arises from the CDO containing the Cys-Tyr cofactor, while S2 arises from the CDO
lacking that crosslink. To prove this, samples of the CN adduct were prepared from a
C93A mutant. Only one low-spin ferric feature was observed with nearly identical
features to S2 (Figure 3.2).7
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Figure 3.2. X-band EPR spectra of the CN bound CDO prepared from as isolated (AICDO), fully modified (α-CDO), and C93A CDO enzymes. Simulations are shown as
dotted lines. Parameters: microwave frequency, 9.64 GHz; modulation frequency, 100
kHz; modulation amplitude, 0.9 mT; temperature, 10 K; microwave power, 6 µW. Figure
obtained from Reference 7.
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Similarly, azide was used to model the Fe(III)-superoxo intermediate because
these two moieties have similar frontier orbitals and the same charge. Upon the addition
of azide to AI-CDO, a new feature appeared at 24,000 cm-1 in the absorption spectrum
(Figure 3.3), and the EPR spectrum exhibited a signal with g-values at 4.20, 4.35, and
4.45 (Figure 3.4). This indicates that the Fe(III)-azide adduct remains high-spin (S =
5/2). This is the first instance of a small molecule binding to CDO in the absence of the
cysteine substrate.113

Figure 3.3. RT abs spectra of AI-CDO in the absence and presence of N3- (top) and 4.5
K MCD spectrum (bottom). Figure obtained from Reference 113.
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Figure 3.4. X-band EPR spectrum of AI-CDO in the absence (top) and presence
(bottom) of N3-, taken at 20 K. Figure obtained from Reference 113.

Azide was then added to a sample of Cys-Fe(III)-CDO (500-fold excess of azide),
and modest changes were observed in the absorption spectra. The broad band at 15,875
cm-1 undergoes a 725 cm-1 red-shift, while the high-energy component undergoes a 650
cm-1 blue-shift (Figure 3.5). It appears that the azide anion does not coordinate directly
to the iron center in the majority of the active sites.

Instead, azide likely binds

somewhere near the active site pocket, resulting in only slight changes in the absorption
spectra.113 EPR data suggest that only a small amount of N3-Cys-Fe(III)-CDO is present.
The low-field regions of EPR spectra of Cys-Fe(III)-CDO in the absence and presence of
azide are very similar (Figure 3.6). Each exhibits a feature at g = 4.3. However, when
azide is present, a new, very weak, signal appears with g-values of 2.47, 2.29, and 1.90.
This signal accounts for 15% of the total iron concentration and is consistent with a low-
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spin (S = 1/2) Fe(III) complex bound to azide.113 Collectively, these data suggest that
Cys-Fe(III)-CDO is coordinatively saturated. Azide readily binds in the absence of
cysteine, and does not bind when the substrate ligand is present. Calculations suggest
that the sixth coordination site is occupied by a hydroxide anion that must first be
displaced before azide can bind. Therefore, azide probably binds near the active site
pocket.

Figure 3.5. RT absorbance (top) and 4.5 k MCD (bottom) spectra of Cys-Fe(III) CDO in
the absence and presence of azide. Figure obtained from Reference 113.
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Figure 3.6. X-band EPR spectra at 20K of Cys-Fe(III)-CDO in the absence (top) and
presence (bottom) of azide. Simulations are shown as dotted lines. S2 and S3 refer to
two distinct species. Figure obtained from Reference 113.

Inspired by these previous enzymatic studies, we sought to prepare oxidized (i.e.,
ferric) derivatives of the CDO models reported in the previous chapter (1-4), and examine
their reactivity towards azide and cyanide. Multiple spectroscopic techniques were used
to characterize the resulting adducts species, including UV-Vis absorption, EPR, and
rRaman spectroscopies. Our results are then compared to those obtained with CDO.

196

3.B. Results and Discussion
3.B.i. Electrochemistry
To ascertain the viability of generating the oxidized speices, cyclic voltammetry
was performed on all complexes. The data experiments used a Ag/AgCl reference,
palladium as the auxiliary electrode, and a glassy carbon working electrode. Tetra-nbutylammonium hexafluoro-phosphate (100 mM) was the supporting electrolyte and
CH2Cl2 was used as the solvent.

Potentials were referenced to the more common

ferrocene/ferrocenium (Fc+/0) redox couple, which appears at 520 mV versus Ag/AgCl
under these conditions.

Figure 3.7. Cyclic voltammogram spectrum of [1]+, vs Fc+/0. Scan rate = 100mV.
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Complex 1 displayed two features during the positive potential sweep at 67 mV
and 478 mV vs Fc+/0 (Figure 3.7). The feature at 67 mV is attributed to the oxidation of
iron(II) to iron(III).

This assignment was made based on previous electrochemical

studies on high-spin five-coordinate Fe(II) complexes with the 2-TIPR2 ligand. The FeII/III
couple usually appears within 300 mV of the Fc+/0 reference.48 The second feature is
possibly due to the oxidation of the thiolate ligand to the thiol radical. This could be an
unstable complex, causing irreversible oxidation. No features were observed during the
potential sweep from 0 mV to -1500 mV, meaning this complex cannot be easily reduced
to iron(I). Strangely, the complexes 2-4 did not show any distinct oxidations.

3.B.ii. Chemical oxidation to generate the ferric species
Complex 1 was oxidized using one equivalent of 1-acetylferrocenium
tetrafluoroborate ([AcFc]BF4) to form the ferric complex. This reaction was monitored at
-78 oC using UV-Vis spectroscopy (Figure 3.8). Treatment of 1 with AcFc+ yields a
chromophore (1ox) with three features: a high intensity peak at λmax = 445 nm (ε = 3.93
mM-1cm-1), a peak with intermediate intensity at λmax = 595 nm (ε = 0.98 mM-1cm-1), and
a weak band at λmax = 815 nm (ε = 0.28 mM-1cm-1).

Both reactions triggered a color

change from bright yellow to orange. The EPR spectrum of 1ox was collected in frozen
CH2Cl2 at 10 K. This spectrum exhibits an intense derivative-shape feature at g = 4.3 and
a small peak at g = 9.0, which is characteristic of a high-spin ferric complexes (S=5/2) in
a rhombic coordination environment.
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Figure 3.8. UV-Vis spectra of 1 reacted with AcFc+ at -78˚C. Spectra were taken in
CH2Cl2.

Figure 3.9. EPR spectrum, taken in CH2Cl2 at 10K, of the one electron oxidized form of
complex 1. The small feature at ~2900 G arises from the background of the cavity.
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A similar pattern of absorption bands was observed for oxidized derivatives of
complexes 2-4. Addition of one equivalent of acetylferrocenium to 2 at low temperatures
results in a new species (2ox) with features at 450, 597, and 835 nm (Figure 3.10, top),
very similar to the spectrum of 1ox. Similarly, the 3ox spectrum consists of features at
463, 468 and 796 nm (Figure 3.10, bottom) that are only modestly shifted from those of
1ox and 2ox. The EPR spectra of 2ox and 3ox exhibit a sharp peak at g = 4.3 and a small
resonance at g = 9.0, again characteristic of a high-spin (S = 5/2) ferric center (the
spectrum for complex 2ox can be seen in Figure 3.11).
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Figure 3.10. Absorption spectra of 2ox (left) and 3ox (right). These spectra were
collected in CH2Cl2 at -78˚C.
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Figure 3.11. X-band EPR spectrum of 2ox in frozen CH2Cl2 taken at 7K.

3.B.iii. Cyanide-treated species
Tetrabutylammonium cyanide was used to probe the electronic structure and
potential superoxide binding of the Fe(III) center. When one equivalent of [NBu4]CN is
injected into a solution of 1ox at -70˚C, no change is observed in the absorption spectrum.
However, when 20 equivalents are added, a new band appears at 633 nm while the
feature 445 nm loses intensity (Figure 3.12, left). The cyanide addition is accompanied
by a color change from orange to green.
warming to room temperature.

These features only decay slightly upon

The addition of 50 equivalents of CN- causes more

pronounced spectral changes, increasing the intensity of the band at longer wavelength
(Figure 3.12, right). This suggests that an equilibrium is present, such that adding more
cyanide pushes this equilibrium towards the iron(III)-cyano adduct (1ox-CN). The feature

202

at 646 nm is typical of low-spin iron(III)-thiolate complexes and arises from a S→Fe(III)
charge transfer transition.4
The EPR spectrum of 1ox-CN adduct exhibits an S = 1/2 signal with g–values at
2.20, 2.16, and 1.99 (Figure 3.13). No high-spin S = 5/2 signal was observed, suggesting
that no unreacted high-spin ferric complex is left in solution. The binding of cyanide
causes the system to adapt a low-spin S = 1/2 state because it is a strong-field ligand,
which increases the energy gap between the eg and t2g orbitals of this octahedral complex.
This large energy gap overweighs the energy required to pair electrons, causing all five delectrons to occupy the lower energy t2g orbitals.

Figure 3.12. Absorbance spectra of 1ox reacted with 20 equivalents (left) or 50
equivalents (right) cyanide in CH2Cl2 at -78˚C.
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Figure 3.13. X-band EPR spectrum of 1ox reacted with 50 equivalents of CN- at -78˚C.
The spectrum was taken in frozen CH2Cl2.

The nature of 1ox-CN was also probed with resonance Raman spectroscopy. The
1ox-CN spectrum, obtained by excitation into the S→Fe(III) charge transfer transition
with 647.1 nm laser light, exhibits a series of peaks in the 300-550 cm-1 region (Figures
3.14 and 3.15). Peak assignments were made by examining samples prepared with the
isotopically-labeled cyanide anions:

13

C14N,

12

C15N, and

13

C15N (see Table 3.1). Based

on its lack of isotope sensitivity, the feature at 341 cm-1 is assigned to the ν(Fe-S) mode.
This frequency is similar to values reported for ν(Fe-S) modes in nonheme iron enzymes
with thiolate coordination, such as superoxide reductase (SOR). The peaks between 400
and 515 cm-1 have frequencies and isotope shifts characteristic of ν(Fe-C) and δ(Fe-C-N)
modes. Modes with ν(Fe-C) character are distiguished by large shifts upon isotopic
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substitution of both the carbon and nitrogen atoms of the cyano ligand, whereas the
frequencies of δ(Fe-C-N) modes only downshift upon isotopic substitution of the carbon
atom. Following this criterion, the intense peaks is 426 cm-1 is assigned to the ν(Fe-C)
mode, while the 499 and 513 cm-1 peaks correspond to δ(Fe-C-N) modes. Following the
3N-6 rule, complexes with linear FeCN geometries (i.e., Fe-C-N angles near 180o) feature
two δ(Fe-C-N) modes, whereas complexes with bent FeCN units can only display a
single δ(Fe-C-N) mode.

The presence of two δ(Fe-C-N) modes in the 1-CN spectra

therefore suggests that the cyano ligand adopts a linear geometry.
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Figure 3.14. Resonance Raman spectra of 1-CN in frozen CD2Cl2 prepared with natural
abundance KCN (top, black line) and K13CN (middle, blue line).

The difference

spectrum is shown on the bottom (red line). Spectra were collected using 647.1 nm laser
excitation with 40 mW at the sample. The concentration of 1-CN was 5.6 mM.
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Figure 3.15. Resonance Raman spectra of 1-CN in frozen CH2Cl2 prepared with natural
abundance KCN (top, black line), K13CN (blue line), KC15N (red line), and K13C15N
(bottom, green line). Spectra were collected using 647.1 nm laser excitation with 40 mW
at the sample. The concentration of 1-CN was 8.6 mM.
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Our analysis of the resonance Raman data is supported by DFT calculations of 1CN. The geometry optimized model features a linear FeCN unit with a Fe-C-N angle of
177o.

Vibrational calculations performed with the B3LYP functional provided

frequencies of 362 and 447 cm-1 for the ν(Fe-S) and ν(Fe-C) modes, respectively, in
excellent agreement with the experimental values in Table 3.1. The two modes with
predominantly δ(Fe-C-N) character have computed frequencies 420 and 454 cm-1 and
exhibit isotope shifts consistent with resonance Raman data (i.e., large Δ(12C-13C) and
small Δ(14N-15N) values). In addition, based on DFT-computed frequency of 423 cm-1
for the ν(Fe-NCysOEt) mode, we tentatively assign the isotopically-inactive peak at 464
cm-1 in the experimental spectrum to the Fe-NH2 stretching mode.

Table 3.1. Experimental frequencies, isotope shifts, and assignments for peaks observed
in the resonance Raman spectrum of 1-CN.
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3.B.iv. Azide adducts
The azide (N3-) anion was also employed to probe the ability of the ferric CDO
models to bind small anions related to superoxide. Upon addition of tetrabutylammonium
azide, [NBu4]N3, to a solution of 1ox in CH2Cl2 at -80˚C, only a slight change in the
absorbance spectrum was observed (Figure 3.16, top). This species exhibited features at
449, 374, and 758 nm. However, the reaction at 20˚C produced a new species, with
intense features at 362, 418, and 484 nm (Figure 3.16, bottom). EPR spectra of the
species generated via the low-temperature and room-temperature reactions are identical,
with a large feature at g = 4.3 and a small feature at g = 9.0, typical of a rhomic S = 5/2
species (Figure 3.17).
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Figure 3.16. Absorbance spectra of the reaction of 1ox with 50 equivalents of N3- at 80˚C (left) and 20˚C (right). The spectra were taken in CH2Cl2.
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Figure 3.17. X-band EPR spectrum of 1ox reacted with 50 equivalents N3- at 20˚C.
Spectrum taken in frozen CH2Cl2 at 10 K.

The resonance Raman spectrum of the azide adduct (1-N3) exhibits a peak at 377
cm-1 (Figure 3.18). This peaks shifts slightly (-4 cm-1) when isotopically labeled 15N14N2
was used, providing conclusive proof of azide coordination. The 377 cm-1 peak is
attributed to the Fe-S stretch based on its frequency. The corresponding peak in the
spectrum for cysteine bound Fe(III)-CDO appears at 340 cm-1.

This difference in

frequency suggests that the Fe(III)-S bond is tighter in the model complex than in the
enzyme active site, highlighting the impact of outer-sphere residues on the electronic
structure of the first coordination sphere.
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Figure 3.18. rRaman spectra obtained from the reaction of 1ox with N3+- (black solid
line) and 15N14N2- (red dashed line). The spectra were obtained in frozen CH2Cl2.

3.B.v. Comparison to cysteine dioxygenase
Both Fe(III)-CDO and complex 1ox exhibit spins of S = 5/2, however, their EPR
spectra differ in rhombicity. The EPR spectrum of Fe(III)-CDO exhibits a fairly axial
signal, with g-values of 4.47, 4.36, and 4.27, whereas the EPR spectrum of 1ox is
rhombic, with an intense feature at g = 4.3 and a weak feature at g = 9.0. This difference
in rhombicity is due to the different symmetries around the metal centers.
Upon the addition of cyanide to both Fe(III)-CDO and 1ox, new S = 1/2 species
are formed, with g-values of 2.38, 2.23, and 1.93 for Fe(III)-CDO-CN and g-values of
2.20, 2.16, and 1.99 for 1ox-CN. Again, there is a slight difference in rhombicity.
Whereas Fe(III)-CDO had a high affinity for azide in the absence of the cysteine
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substrate, 1ox reacted with azide to form a new adduct, 1ox-N3. The EPR spectrum of this
species exhibited an S = 5/2 signal with g-values of 9.0 (weak) and 4.3 (intense).

3.C. Conclusion
As discussed in chapter 2, complexes 1-4 are established structural and functional
models of the CDO active site. Reaction of these complexes with acetylferrocenium
tetrafluoroborate produced the corresponding ferric complexes (Xox). These oxidized
complexes react with small anions to generate species that resemble the Fe(III)-superoxo
intermediate of the catalytic cycle. The small molecules chosen were cyanide (CN-) and
azide (N3-), which are commonly used to mimic the superoxide ligand in enzyme
intermediate. These molecules are roughly the same size and charge as the superoxo
species, thereby giving more insight into how this intermediate forms. The oxidized
species, which are high-spin S = 5/2, react with cyanide to form an S = 1/2 adduct,
similar to the cyanide adduct of substrate-bound CDO. Azide binds to the ferric center as
well, however there is no change in the S = 5/2 spin states according to the EPR spectra.
The rRaman spectrum of 1-N3 exhibit the ν(Fe-S) mode at 377 cm-1, whereas the
corresponding peak in the spectrum of Fe(III)-CDO appears at 340 cm-1. This suggests
that the Fe(III)-S bond is stronger in the synthetic complexes versus the enzyme itself,
reiterating the fact that the second sphere does have an affect on electronic structure.

3.D. Experimental

3.D.i. Materials
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Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Dichloromethane (CH2Cl2) was purified and
dried using a Vacuum Atmospheres solvent purification system and stored under N2. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox equipped with a freezer set to −30 °C.
The syntheses of complexes 1-4 can be seen in chapter 2 section E.

3.D.ii. Physical Methods
UV-vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer attached to a cryostat manufactured by Unisoku Scientific Instruments
(Osaka, Japan) for measurements at reduced temperatures. Infrared (IR) spectra were
collected with a Nicolet Magna-IR 560 spectrometer.

X-band EPR spectra were

measured using a Bruker EMXplus instrument equipped with an ER4416DM cavity, an
Oxford Instruments ESR900 helium flow cryostat, and Oxford Instruments ITC503
temperature controller.

1

H NMR samples were prepared in deuterated solvents and

spectra were recorded on a Varian 400 MHz spectrometer. Cyclic voltammograms were
measured in the glovebox with an epsilon EC potentiostat (iBAS) at a scan rate of 200
mV s-1 with 0.1 M [NBu4]PF6 electrolyte.

The three-electrode cell consisted of a

Ag/AgCl reference electrode, a platinum auxiliary electrode, and a glassy carbon working
electrode. Under there conditions, the ferrocene/ferrocenium (Fc+/0) couple has an E1/2
value of +0.51 V in CH2Cl2.

3.D.iii. Synthetic procedures
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Preparation of 1ox-4ox.

Separate solutions of 1-4 in CH2Cl2 and AcFcBF4 in CH2Cl2

were prepared in the glovebox. These solutions were cooled to -78˚C in a dry ice/acetone
bath. The AcFcBF4 solution was injected into the ferrous solution and allowed to stir for
a few minutes, until a color change was observed.
Preparation of cyanide adducts. Following the procedure above, 1ox-4ox were prepared
in CH2Cl2. A solution of tetraethylammonium cyanide in CH2Cl2 was then introduced,
and an intense color change to teal green was observed, both at -78˚C or at room
temperature.

When isotopically active cyanide was used, KCN and K13CN were

dissolved in CH2Cl2 with the help of 18-crown-6-ether, and added to the oxidized
solution in the same manner.
Preparation of azide adducts. Following the procedure above, 1ox-4ox were prepared in
CH2Cl2. A solution of tetrabutylammonium azide in CH2Cl2 was then introduced, and an
intense color change to red orange was observed, both at -78˚C or at room temperature.
When isotopically active azide was used, KN3 and K15N14N2 were dissolved in CH2Cl2
with the help of 18-crown-6-ether, and added to the oxidized solution in the same
manner.
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CHAPTER 4
Spectroscopic and Computational Studies of Reversible O2 Binding by a
Cobalt Complex of Relevance to Cysteine Dioxygenase

(Fischer, A.; Lindeman, S.; Fiedler, A. Dalton Trans., 2017, 46, 13229-13241)

Abstract
The substitution of non-native metal ions into metalloenzyme active sites is a common
strategy for gaining insights into enzymatic structure and function. Two mononuclear
Co(II) complexes have been prepared with the general formula [Co2+(TpR2)(CysOEt)] (R
= Ph (6) or Me (7); TpR2 = hydrotris(pyrazol-1-yl)borate substituted with R-groups at the
3- and 5-positions, and CysOEt is the anion of L-cysteine ethyl ester). These Co(II)
complexes mimic the active-site structure of substrate-bound CDO and are analogous to
functional iron-based CDO models. Characterization with X-ray crystallography and/or
1
H NMR spectroscopy revealed that 6 and 7 possess five-coordinate structures featuring
faciallycoordinating TpR2 and S,N-bidentate CysOEt ligands. The electronic properties of
these high-spin (S = 3/2) complexes were interrogated with UV-visible absorption and Xband EPR spectroscopies. The air-stable nature of complex 6 replicates the inactivity of
cobalt-substituted CDO. In contrast, complex 7 reversibly binds O2 at reduced
temperatures. DFT calculations were used to evaluate the energetics of key steps in the
reaction mechanism. Collectively, these results have elucidated the role of electronic
factors (e.g., spin-state, d-electron count, metal–ligand covalency) in facilitating O2
activation and S-dioxygenation in CDO and related models.
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Reproduced from Dalton Trans., 2017, 46, 13229-13241 with permission from the Royal
Society of Chemistry. http://pubs.rsc.org/en/content/articlepdf/2017/dt/c7dt01600j

4.A. Introduction
Because high-spin Fe(II) centers in nonheme environments lack intense
absorption features in the visible region and possess integer spin (S = 2) ground states, as
found in CDO, it is not possible to directly examine these complexes with resonance
Raman (rRaman) or electron paramagnetic resonance (EPR) spectroscopies.

We

overcame this limitation by reacting the complexes with the O2 surrogate NO, which
generated a mixture of EPR-active Fe/NO adducts possessing S = 3/2 or 1/2 ground
states.4

Another well established strategy for probing the geometric and electronic

structures of nonheme iron enzymes (and related model complexes) involves replacement
of the Fe(II) center with a divalent metal ion that is more spectroscopically “accessible”,
such as Co(II), Mn(II), or Cu(II).117-120

In addition to enhancing the spectroscopic

features of the enzymes, metal-substitution experiments often yield valuable insights into
O2 activation mechanisms, as recently demonstrated by Que and Lipscomb in their
studies of Co(II)- and Mn(II)-substituted versions of homoprotocatechuate-2,3dioxygenase, a MNID that catalyzes the oxidative ring-cleavage of its catechol substrate,
as discussed in chapter 1, section.i.35,121-124
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Figure 4.1. Ligands employed in the Co-CDO modeling studies.

This chapter describes the synthesis, characterization, and O2 reactivity of Co(II)containing models of the CDO active site with the general formula [Co(TpR2)(CysOEt)],
where R= Ph (6) or Me (7) (Figure 4.1).

Our motivation for pursuing these Co-

containing mimics is three-fold. Firstly, as described below, comparative studies of Fe
and Co complexes highlight the impact of redox potential, spin-state, d-electron count,
and steric properties on O2 reactivity, and these findings have significant implications for
the enzymatic mechanism. Secondly, complexes 6 and 7, as well as the intermediates
derived from their reaction with O2, possess half-integer spin states and an abundance of
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absorption features in the visible region, thus permitting analysis with multiple
spectroscopic techniques (EPR, UV-vis absorption, rRaman, paramagnetic NMR) that
provide complementary electronic-structure information.

Finally, the cobalt-based

approach has allowed us to isolate and spectroscopically characterize a dioxygen-bound
adduct (7-O2), which is significant given that iron congeners of this species have eluded
detection in both CDO and related model complexes. Furthermore, cobalt(III)-superoxo
intermediates like 7-O2 are likely involved in numerous catalytic processes, including the
aerobic oxidation of organic compounds125,126 and oxygen-reduction reactions.127-129 To
gain a better understanding of the spectroscopic and chemical features of the Co- and FeCDO models, density functional theory (DFT) calculations were utilized to generate
molecular bonding descriptions, computed spectroscopic parameters, and potential
energies surfaces of putative O2 activation mechanisms.

Collectively, these results

furnish a convincing answer to the question of why CDO, unlike some other MNIDs,
lacks activity with cobalt, while simultaneously illuminating the essential role played by
iron in the native enzyme.

4.B. Results and Discussion

4.B.i. Synthesis of Cobalt-containing models
Firstly, cobalt-containing precursors were synthesized, which were then reacted
with the substrate ligand.

[Co(TpPh2)(OAc)(HpzPh2)] was synthesized following a

previously published procedure.130 CoII(OAc) was dissolved in a mixture of THF/MeOH,
giving a purple solution. KTpPh2 was dissolved in MeOH, and was added to the Co(OAc)
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solution slowly. This mixture was stirred for 4 hours then dried in vacuo. The remaining
residue was washed with ethanol multiple times. The solid was then taken up in CH2Cl2,
filtered through celite, then layered with hexane. Dark purple crystals formed after a few
days.

[Co(TpMe2)(OAc)] (8) was synthesized similarly.131

CoII(OAc)4H2O was

dissolved in MeOH, followed by an addition of a solution of KTpMe2 in THF. This
solution was filtered and solvent was removed. The product was then extracted with
CH2Cl2, followed by an additional extraction with MeCN. The remaining residue was
taken up in CH2Cl2 and layered with pentane. Purple crystalline solid was isolated after 3
days.
Complexes 6 and 7 were prepared by reaction of [Co(TpPh2)(OAc)(HpzPh2)]
(HpzPh2 = 3,5-diphenylpyrazole) or [Co(TpMe2)(OAc)] (8) precursors, respectively, with a
slight excess of

L-cysteine

ethyl ester hydrochloride (HCysOEtHCl) in CH2Cl2. The

reactions employed two equivalents of triethylamine as the base, followed by workup to
eliminate byproducts. The products were extracted with acetonitrile to eliminate the
Fe(TpR2)2 impurity, followed by an additional extraction with toluene to eliminate
triethylamine.

The resulting maroon (6) or purple (7) complexes exhibit effective

magnetic moments (µeff) of ~4.8µB in CDCl3, typical of mononuclear, high-spin (S = 3/2)
Co(II) complexes.132,133 Observation of an intense ν(CO) at 11729 cm-1 in the IR spectra
of both complexes confirms coordination of the CysOEt ligand (by comparison, the
highest-energy ν(CO) mode of the acetate precursors appears near ~1550 cm-1).130
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4.B.ii. Crystallographic Data
Dark brown crystals of 6 suitable for crystallographic analysis were obtained by
layering CH2Cl2 solution with MeCN. Complex 6 crystallizes in the chiral space group
P21 due to the presence of the chiral CysOEt ligand. Each unit cell consists of two
symmetrically-independent five-coordinate (5C) Co(II) complexes featuring different
conformations of the 3-Ph substituents of the TpPh2 ligand. Metric parameters for both
independent molecules are provided in Table 4.1, in addition to previously-reported
values for the iron analogue 1. The X-ray structure of 6 (Figure 4.2) reveals that the
monoanionic CysOEt ligand binds to Co(II) in a S,N-bidentate manner and the TpPh2
chelate exhibits facial κ3-coordination, thus reproducing the active-site structure of
substrate-bound CDO. The coordination geometry of 6 is best described as a trigonal
bipyramidal, as reflected in the average tau-value of 0.60. A five-coordinate complex
with ideal square-pyramidal geometry would have a τ-value of 0.0, while those with ideal
trigonal bipyramidal geometry would have a value of 1.0.136 The Co-NTp bond distances,
ranging between 2.08 and 2.20 Å, are characteristic of high-spin Co(II) complexes and
similar to those exhibited by complex 1 (Table 4.1). The Co-S1 and Co-N7 distances
involving the CysOEt ligand, however, are shorter than their counterparts in 1 by 0.055
and 0.085 Å, respectively, perhaps due to the smaller ionic radius of Co(II) compared to
Fe(II).
Our repeated efforts to grow X-ray quality crystals of 7 were not successful.
However, we are confident that complexes 6 and 7 share the same general
[Co(TpR2)(CysOEt)] structure based on similarities between their spectroscopic profiles,
which will be discussed in the following section.
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Figure 4.2. Thermal ellipsoid plot (50% probability) derived from the X-ray crystal
structure of 6. Most hydrogen atoms have been omitted for clarity.
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Table 4.1. Selected bond distances (Å) and bond angles (˚) for complexes 1 and 6 as
determined by X-ray diffraction (XRD) and DFT calculations.31
6

6
3

4.B.iii. Spectroscopic Characterization
The 1H NMR spectra of complexes 6 - 8 can be seen in Figure 4.3. Complex 8
exhibits peaks arising form the 3-Me and 5-Me pyrazole substituents at -41 and 35 ppm,
respectively, while the 4-pyrazole protons appear at 62 ppm. These chemical shifts are
consistent with previously-reported spectra of Tp-based Co(II) complexes.134,135 The
spectrum of 7 is more complex; in addition to the TpMe2-derived features, it displays a
series of peaks arising from the CysOEt ligand. Based on integrations, the resonances at
-5.3, -6.6, and -48 ppm (1H each) are assigned to the three protons attached to the Cα and
Cβ atoms of CysOEt. The peaks at -4.1 (3H) and 1.3 (2H) ppm are then attributed to the
–CH3 and –OCH2 units, respectively, of the ethoxide moiety. The same pattern of
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CysOEt-derived peaks is observed in the spectrum of 6 with only minor deviations in δ –
values, proving that the coordination geometries of 6 and 7 are equivalent. The TpPh2based features of 6 were assigned through comparisons to spectra reported for related
complexes.63,65,74

It is notable that, for each complex, the three pyrazole rings are

spectroscopically equivalent in solution, suggesting that the positions of the acetate (8) or
CysOEt (6 and 7) ligands are dynamically averaged on the NMR time scale.

6

7

8

Figure 4.3. 1H NMR spectra of complexes 6 (top, red), 7 (middle, blue), and 8 (bottom,
black) in CDCl3 at room temperature. Spectra were referenced using residual solvent
peaks (indicated by *) and tetramethylsilane (indicated by a triangle). Peaks marked with
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black dots () arise from the CysOEt ligand of 6 and 7. As indicated on the figure, some
peak intensities were increased for the sake of clarity.

6
7
8

Figure 4.4. Electronic absorption spectra of Co(II) complexes 6-8 measured at room
temperature in CH2Cl2. Inset: ligand-field transition observed in the visible region;
spectra are offset along the y-axis for the sake of clarity.
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4.B.iv. Electronic properties – absorption spectroscopy and time-dependent DFT
Electronic absorption spectra of complexes 6–8, measured in CH2Cl2 at room
temperature, are presented in Figure 4.4. All three complexes exhibit a series of features
in the 500-1100 nm region that arise from Co(II) ligand field (d-d) transitions, as
evidenced by their low intensities (ε < 150 M-1cm-1). Following assignments reported for
other trigonal bipyramidal Co(II) complexes,137-139 the closely-spaced peaks between 500
and 650 nm are attributed to transitions from the 4T1g(F) ground-state in the parent Oh
symmetry to components of the 4T1g(F) term that split dramatically in low-symmetry
environments.137,138 The ligand-field (LF) features of 6 and 7 are strikingly similar,
providing further confirmation that those two complexes possess nearly identical Co(II)
coordination geometries.
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Figure 4.5. Comparison of TD-DFT computed (black line) and experimental (red line)
absorption spectra obtained for a truncated [Co(TpR2)(CysOEt)] model. Features in the
computed spectrum arising from the S à Co(II) CT transitions are indicated with an
asterisk. Inset: enlargement of computed and experimental features in the visible region.

In addition to the LF features, complexes 6 and 7 exhibit two peaks of greater
intensity in the near UV-region (349 and 438 nm for 6; 328 and 395 nm for 7); a third
band appears as a shoulder on the more intense feature. These bands, which are absent in
the absorption spectrum of 8, arise from S à Co(II) charge transfer (CT) transitions.
This assignment is supported by time-dependent DFT calculations and literature
precedents.140-142 The CT bands of 7 are blue shifted by ~2000 cm-1 relative to those
observed for 6, reflecting the ability of the 3,5-pyrazole substituents to modulate the
donor strength of the TpR2 scaffold. Our results indicate that changes to the Tp ligand
cause the energies of the cobalt d-orbitals to shift uniformly; hence, the LF transition
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energies – unlike the CT transition energies – are largely unaffected by the replacement
of TpMe2 with TpPh2.
DFT methods provided further insights into the electronic structures of the CoCDO models. Using a truncated version of the crystallographic structure of 6 as a
starting point, geometry optimization yielded a computational model that accurately
reproduces the experimental Co-N/S bond angles and distances (Table 4.1). This model
was applied to time-dependent DFT (TD-DFT) studies employing the cam-B3LYP rangeseparated hybrid functional.72 In agreement with the experimental data, the TD-DFT
computed spectrum consists of a series of LF bands with λmax > 450 nm and three S à
Co(II) CT transitions in the 300-400 nm region (Figure 4.5). The LF and CT transitions
primarily involve the Co(II)- and ligand-based molecular orbitals (MOs) depicted in the
energy level diagram shown in Figure 4.6. The two spin-down (β) Co electrons are
localized in Co(dxz)- and Co(dyz)-based MOs, consistent with the trigonal bipyramidal
coordination geometries of 6 and 7. The donor MOs for the CT transitions are two S(3p)based MOs located on the thiolate donor; the Sπ MO is oriented perpendicular to the Co-S
bond, while the Sσ MO lies along the Co-S bond vector (Figure 4.6). Electron density
difference maps indicate that the lowest-energy CT band arises from a Sπ à Co(dx2-y2)
transition that lacks significant intensity due to poor probital overlap. In contrast, the
more intense CT band in the UV region exhibits Sσ à Co(σ – σ*) character. Similar
assignments were made for the series of S à Fe(II) CT transitions observed in our
previous study of the Fe(II)-based models 1 and 2.1
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Figure 4.6.

Energy-level diagram for the spin-down (β) molecular orbitals (MOs)

obtained from a spin-unrestricted DFT calculation of a truncated [Co(TpR2)(CysOEt)]
model. MOs are labeled according to their principal contributor. Inset: DFT-generated
isosurface plots of the CysOEt-based donor MOs involved in S à Co(II) CT transitions.
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4.B.v. Electronic Properties – EPR spectroscopy
Low-temperature (7.5 K) X-band EPR spectra of 6 and 7 in frozen CH2Cl2 are
shown in Figure 4.7. Both spectra are quite complex with multiple resonances observed
across a wide field range of 200 to >9000 G. As with the 1H NMR and UV-vis data, the
EPR spectra of 6 and 7 are similar in most respects. The primary difference is that
samples of 7 exhibit a sharp derivate-shaped feature in the g = 2 region (B ~ 3350 G) due
to a small amount of the dioxygnated complex 7-O2 (vide supra); this feature has been
truncated in Figure 4.7 for the sake of clarity. To rule out the possibility that some of the
observed resonances are due to residual amounts of the precursor complexes, EPR
spectra of [Co(TpPh2)(OAc)(HpzPh2)] and 8 were collected under identical conditions.
Based on the resulting spectra, it was verified that cobalt-acetate impurities do not
contribute to the EPR spectra of 6 and 7. The simulated EPR spectra (red lines in Figure
4.7) nicely reproduce the key features of the experimental data. The spin-Hamiltonian
parameters derived from these simulations (Table 2) are broadly consistent with those
reported by Tierney and coworkers for pentacoordinate Co(II) complexes with Tp
ligands.143
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6

7

Figure 4.7. X-band EPR spectra of complexes 6 (top) and 7 (bottom) measured in frozen
CH2Cl2 at 7.5 K. Parameters: frequency = 9.625 GHz; power = 2.0 mW; modulation
amplitude = 1.0 G. The corresponding simulations (red lines) assumed a S = 3/2 ground
state and utilized the spin-Hamiltonian parameters provided in Table 3.2. Simulated
contributions from the ms = ± 1/2 and ± 3/2 doublets are shown in red.
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Table 4.2. EPR simulation parameters for complexes 6 and 7.

6
7

The EPR spectra of 6 and 7 are dominated by features arising from the ms = ± 3/2
doublet of the S=3/2 manifold, indicative of a negative axial zero-field-splitting (zfs)
term (i.e., D < 0). The ms = ±3/2 doublet is responsible for the broad band at high-field
(g ~ 0.9), the derivative signal centered at g = 1.3, and the low-field peak near g = 8. The
latter displays hyperfine splitting from the 59Co nucleus (I = 7/2), in addition to poorlyresolved superhyperfine structure from ta single nitrogen atom. Signals from the higherenergy ms = ± 1/2 doublet are also evident in both spectra, namely, the derivative-shaped
feature at g = 3.4 and the broad band at g = 4.9. The simulated spectra in the inset of
Figure X depict the respective contributions of the ms = ± 1/2 and ± 3/2 doublets to the
low-field features in the spectrum of 7. The diminished intensity of the ms = ± 1/2 in the
spectrum of 6 reflects the more negative D-value (-14 cm-1) of this complex compared to
7 (-9 cm-1). Both species exhibit moderate rhombicity with E/D-values near 0.16 (E is
the rhombic zfs term), suggesting that the distorted N4S coordination environment
observed in the solid-state is maintained in solution. For reasons that are not clear to us,
there are modest differences between the g-tensors of 6 and 7 (Table 4.2); regardless,
both sets of g-values are comparable to those previously-reported for related Co(II)
complexes.134,143
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4.B.vi. Electrochemical Studies
The redox properties of 6 and 7 were measured in CH2Cl2 solutions with 0.1 M
[NBu4]PF6 as the supporting electrolyte. The resulting cyclic voltammograms (CV),
shown in Figure 4.8, were referenced to the ferrocenium/ferrocene couple (Fc+/Fc). Both
complexes exhibit a single redox event that corresponds to one-electron oxidation of the
Co(II) center. The redox couple observed for 6 is quasi-reversible (ΔE = +0.01 and -0.23
for 6 and 7, respectively) indicates that the Co(III/II) potential is sensitive to the identity
of the pyrazole substituents, as replacement of the TpMe2 with TpPh2 causes a shift of +240
mV. These results are consistent with the trend in S à Co(II) CT energies noted above.
The ability of the TpMe2 ligand to depress the Co(II/III) potential likely enhances the
reactivity of 7 towards O2.

6
7

Figure 4.8. Cyclic voltammograms of 6 and 7. Data was collected in CH2Cl2 with 0.1 M
[NBu4]PF6 as the supporting electrolyte and a scan rate of 200 mV s-1.
concentrations were 2.7 and 2.4 mM for 6 and 7, respectively.

Sample
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4.B.vii. Formation of a Cobalt-Dioxygen Adduct (7-O2) – Spectroscopic and
Computational Studies
The absorption features of 6 in CH2Cl2 remain unchanged after several days of
exposure to O2 at room temperature. The stability of 6 in air is not due to steric factors,
as its iron congener (1) reacts with O2 to yield the sulfinic acid derivative of CysOEt.31
Moreover, our previous spectroscopic studies demonstrated that both 1 and 2 are able to
bind nitric oxide (NO), proving that TpPh,Me and 2-TIPPh2 supporting ligands cannot
prevent O2 from accessing the M(II) center.1 Although complex 6 features a TpPh2 ligand
instead of TpPh,Me, the identity of the 5-substituent is not expected to impact small
molecule binding due to its distance from the metal ion.

Thus, the side-by-side

comparison of complexes 1 and 6 suggests that Co(II) is intrinsically less capable than
Fe(II) of activating O2 for S-dioxygenation in this particular ligand environment.
Whereas 6 is unreactive towards O2 under all conditions tested, treatment of
complex 7 with O2 at low temperatures generates an orange intermediate (7-O2) with
absorption bands at 385 and 483 nm (Figure 4.9). Formation of 7-O2 is apparent at
temperatures as high as -20˚C, but complete conversion requires temperatures below 70˚C. Bubbling argon through cooled solutions of 7-O2, or warming the sample to room
temperatures, causes the original Co(II) spectrum to fully reappear, indicative of
reversible O2 binding. The inset of Figure 4.9 highlights the reversibility of this process
by depicting the formation and disappearance of the 7-O2 chromophore during three
successive cycles of O2 and Ar purges.
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Figure 4.9. UV-visible spectral changes during the reaction of complex 7 with O2 at 70˚C in CH2 Cl2. Treatment of the starting complex (black solid line) with O2 yields 7O2 (red solid line). Purging with Ar regenerates 7 (black dashed line) and the subsequent
exposure to O2 returns the spectrum of 7-O2 (red dashed line). Inset: time traces of
absorption intensity at 480 nm during successive purges of CH2Cl2 solutions of 7 with O2
and Ar at -70˚C.
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7-O2

Figure 4.10.

X-band EPR spectrum of 7-O2 in frozen CH2Cl2 at 60K.

harmonic spectrum (red line) highlights the

59

Co hyperfine splitting.

frequency = 9.48 GHz; power = 1.0 mW; modulation amplitude = 10 G.

The second
Parameters:
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The geometric and electronic structures of 7-O2 were probed with spectroscopic
methods. The X-band EPR spectrum of 7-O2, measured in frozen CH2Cl2 at 60 K,
exhibits a quasi-axial S = 1/2 signal with g-values 2.10, 2.02, and 1.98 (Figure 4.10). The
hyperfine splitting from the 59Co nucleus is clearly evident in the gz-region of the secondharmonic spectrum, whereas hyperfine splitting within the gy-component is less clearly
resolved. The small magnitude of the 59Co hyperfine splitting (Az = 22 G; compared to
106 G for 7) indicates that the unpaired electron is not localized on the cobalt center.
Instead, the EPR features resemble those previously-reported for mononuclear, low-spin
cobalt(III)-superoxide species.123,132,144-147

This conclusion is confirmed by rRaman

measurements that provide definitive proof of Co/O2 adduct formation. Spectra of 7-O2
collected with 501.7 nm laser excitation (Figure 4.11) revealed a ν(O-O) mode at 1152
cm-1 upon

18

O2 substitution (Δ18O = 61 cm-1). Such frequencies are characteristic of

superoxo ligands bound to transition-metals in an end-on (η1) manner.132,147-151
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Figure 4.11. Resonance Raman spectra (λex = 501.7 nm, 10 mW, 77K) of 7-O2 in frozen
CD2Cl2 prepared with 16O2 (top, black line) and 18O2 (middle, blue line). The 16O2 – 18O2
difference spectrum (bottom, red line) reveals the presence of isotopically-active peaks.
Peaks arising from CD2Cl2 are indicated with an asterisk.
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The DFT-derived structure of 7-O2, shown in Figure 4.12a, consists of a sixcoordinate cobalt center coordinated to an O2 ligand in a bent conformation (Co-O-O
angle of 121˚). The computed O-O distance of 1.296 Å and ν(O-O) frequency of 1204
cm-1 are consistent with the superoxo nature of the O2 ligand. The negative charge of the
O2- moiety facilitates formation of a hydrogen bond between the distal atom (O2) and the
–NH2 donor of CysOEt. As illustrated in Figure 4.12b, the Co(III) center of 7-O2 is lowspin with a [dxz2, dyz2, dxy2, dx2-y20, dz20] configuration, which is also apparent in the
shortening of the Co-NTp bonds relative to the high-spin Co(II) precursor. The unpaired
electron is almost entirely localized in the O2 πop*-based MO, where “op” indicates that
the orbital lies out of the Co-O-O plane. The corresponding in-plane πip* MO is doublyoccupied and participates in a σ-bonding interaction with the Co(dz2) orbital.
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Figure 4.12. a) DFT geometry-optimized model of 7-O2 with select bond distances
indicated in angstroms (Å). b) energy-level diagram obtained from a spin-restricted DFT
calculation of 7-O2. Isosurface plots of the superoxide-based π* MOs are shown in the
inset.
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The bonding description provided by DFT is consistent with the spectroscopic
data. The computed g-values of 2.041, 2.006, and 1.989 replicate the quasi-axial nature
of the experimental g-tensor, although the gz-value is underestimated by DFT. The
calculations predict a
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Co Az-value of 13 G, in line with the dramatic decrease in
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Co

hyperfine splitting upon O2 binding. Similarly, TD-DFT calculations yielded a computed
absorption spectrum that nicely reproduces the energies and relative intensities of the
major features of the experimental 7-O2 spectrum (Figure 4.13). Based on alaysis of the
TD-DFT results, the band near 480 nm is assigned to overlapping O2-(πop*) à Co(3d)
CT transitions, while the feature around 385 nm arises primarily from Sπ à Co(3d) CT
transitions.

Figure 4.13. Comparison of TD-DFT computed (black line) and experimental (red line)
absorption spectra obtained for 7-O2. The dominant transition for each computed
absorption feature is indicated by the * and  symbols.
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4.B.viii. DFT-computed Mechanisms of Sulfur Dioxygenation
Reaction mechanisms were examined with DFT methods to better understand the
relative abilities of the Co- and Fe-CDO models to activate O2 for S-dioxygenation. To
this end, we have calculated the potential energies of intermediates and transition-states
for the reaction of complex 7 with O2 on both the S = 1/2 and 3/2 surfaces. The potential
energy surfaces (PES’s) are shown in Figure 4.14 alongside the analogous PED
previously reported for the Fe-containing 1 along the lowest-energy S = 2 surface.1 Each
set of calculations employed the PBE0 hybrid functional with 10% HF exchange, which
provides reliable geometries and energies for species derived from the reaction of O2 with
transition-metal complexes.48,75

Figure 4.14. Calculated potential energy profile for the S-dioxygenation reactions of Feand Co-CDO models 1 and 7. Free energies in (kcal mol-1) are relative to the starting
five-coordinate M(II) complexes and free triplet O2.
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The initial step involves coordination of O2 to yield a six-coordinate M/O2 species
(AM,S; where M is the metal ion and S is the spin state). Due to exchange interactions
between the unpaired electrons of O2 and the Co(II) center, three spin-states are possible
for the ACo species: S = 1/2, 3/2, and 5/2. Attempts to optimize the ACo, S=5/2 structure
failed, however, due to dissociation of the O2 ligand; thus, the S = 5/2 surface was not
considered further. In agreement with experiment, DFT predicts a low-spin (S = 1/2)
ground state for 7-O2. The entropic contribution to O2 binding is unfavorable for both the
S = 3/2 and 1/2 states (-TΔS = 14 ± 2 kcal mol-1 at 298 K, Table 4.3), as expected for a
bimolecular reaction. Yet the entalpic terms for the formation of ACo, S=3/2 and ACo, S=1/2
are quite different with computed values of +2.9 and -10.4 kcal mol-1, respectively. Thus,
as temperature decreases, the O2 binding equilibrium shifts towards formation of the lowspin Co/O2 adduct, consistent with our observation of 7-O2 at T < -20˚C.
The role of ligand sterics in modulating the O2 affinity of our Co-CDO models
was also probed computationally. Analysis of the geometry-optimized model of 6-O2
indicates that the phenyl rings of the TpPh2 ligand prevent the superoxo ligand from
forming a strong hydrogen bond with the –NH2 moiety of CysOEt. The loss of this
stabilizing interaction diminishes the enthalpic driving force for O2 binding to 6, thus
accounting for the fact that O2 binding to 6 is not observed even at low temperatures (80˚C).
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Table 4.3. Thermodynamic parameters computed by DFT for the reaction of Fe- and CoCDO models with O2 to yield the S-dioxygenation product (reported in kcal/mol, relative
to M(II) precursors and O2).

The next step in the reaction mechanism requires formation of a cyclic M-O-O-S
intermediate (BM,S) via attack of the distal O-atom on the thiolate ligand. Previous DFT
studies of CDO and related Fe-based models have identified this transformation as the
rate-limiting step, and our results indicate that the same is true for the analogous Co-CDO
complexes (Figure 4.14). The barrier for O-S bond formation (TS1) on the S = 1/2
surface is significantly higher in energy (by 7.4 kcal mol-1) than the same barrier on the S
= 3/2 surface, which is kinetically unfavorable. The DFT results therefore account for the
stability of 7-O2 at low temperature. It is also noteworthy that, regardless of spin state,
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substitution of Co for Fe raises the activation barrier for the rate-determining step by
nearly 4 kcal mol-1, in accordance with our experimental finding that Fe-CDO models are
much more reactive towards O2 than their Co counterparts.
The roles of spin-state and metal identity in promoting O-S bond formation
become apparent when the electronic features of the various [M/O2] adducts and TS1
structures are compared. Mülliken populations indicate that the amount of spin-density
localized on the S-atom in the [M/O2] species varies greatly across the series, ranging
from 0.27 (AFe, S=2) to 0.19 (ACo, S=1/2) to 0.02 (ACo, S=1/2) spins. This parameter is critical
because analysis of the TS1 electronic structures reveals that formation of thy cyclic
intermediate requires overlap between partially-occupied S(3p) and O2(πip*) orbitals
carrying opposite spins. Thus, t is not surprising that the height of the TS1 barrier is
inversely correlated with the degree of S-radical character. The presence of paramagnetic
Fe and Co centers in AFe, S=2 and ACo, S=3/2, respectively, allows unpaired spin density to
delocalize onto the thiolate ligand via metal-sulfur covalency. In contrast, the lack of
unpaired-spin density on the S-atom of ACo,

S=1/2

, which accounts for the large TS1

activation barrier on the S = 1/2 surface, is due to the low-spin (S = 0) nature of its
Co(III) center (vide supra).
Each step in the reaction mechanism after formation of the cyclic M-O-O-S
intermediate B is exergonic (Figure 4.14). Heterolytic cleavage of the O-O bond yields
either an iron(IV)-oxo (CFe,

S=2

) or cobalt(III)-oxyl (CCo,

S=1/2

and CCo,

S=3/2

) species

featuring a sulfenate ligand. This step is followed by insertion of the oxo/oxyl group into
the metal-sulfur bond to generate the sulfinate product bound to the M(II) center (D).
The relative energies of intermediates B through D, as well as TS2 and TS3, follow the
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same Fe (S = 2) < Co (S = 3/2) < Co (S = 1/2) pattern. Thus, the S-dioxygenation
mechanism is most facile for the Fe-CDO model, consistent with our experimental
observations.

4.C. Conclusions
In this chapter, I have reported the synthesis of two mononuclear Co(II)
complexes (6 and 7) that serve as active-site mimics of cobalt-substituted CDO.
Characterization with X-ray crystallography and/or 1H NMR spectroscopy confirmed that
6 and 7 possess the intended 5C [Co(TpR2)(CysOEt)] structure in which the CysOEt
“substrate” coordinates in a S,N-bidentate manner.

The facially-coordinating TpR2

supporting ligands reproduce the 3His triad found in CDO active sites. Both complexes
are brightly colored due to the presence of LF bands in the visible region and multiple S
à Co(II) peas in the near-UV region. The X-band EPR spectra of 6 and 7 display an
abundance of features across a wide field range. These resonances arise from intraKramers transitions within both doubples (mS = ± 3/2 and ±1/2) of the S = 3/2 ground
state. Simulation of the experimental data provided spin-Hamiltonian parameters for 6
and 7 that are consistent with distorted 5C geometries.
Complex 6 represents the cobalt analog of the previously reported Fe-based CDO
model 1, which was shown to react with O2 to yield the sulfinic acid of CysOEt.1 In
contrast, 6 is unreactive towards O2 over the span of multiple days, thereby replicating
the inactivity of Co-substituted CDO, the O2 affinity of the Co(II) center, however, is
somewhat dependent on the steric profile and donor strength of the TpR2 supporting
ligand. Complex 7, which features the less bulky and more electron-donating TpMe2
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ligand, reversibly binds O2 at reduced temperatures to yield a low-spin (S = 1/2) Co/O2
adduct (7-O2), as verified by EPR and rRaman spectroscopies.

Similar Co/O2

intermediates have been implicated in the mechanisms of biological and synthetic
oxidation catalysts. The relative stability of 7-O2 is due to two factors: (i) the nearly
complete electron transfer from Co(II) to O2, which generates a kinetically-inert low-spin
Co(III) center bound to a superoxide anion, and (ii) the hydrogen bond between
superoxide and the –NH2 group of CysOEt.
The putative O2 activation mechanisms of the Co- and Fe- CDO models were
further probed with DFT computations. These calculations revealed that the low-spin
Co/O2 species (i.e. 7-O2) represents a mechanistic “dead-end”, as the barrier leading to
formation of the S-O bond in the next step is very high (> 30 kcal mol-1). In contrast, the
less stable high-spin Co/O2 (S = 3/2) and Fe/O2 (S = 2) adducts delocalize spin density
onto CysOEt ligand via metal-thiolate covalency, resulting in a significant degree of Sradical character that lowers the transition-state barrier to S-O bond formation. In many
respects, the 7-O2 intermediate resembles the Co/O2 species observed in the studies of
cobalt-substituted homoprotochatechuate dioxygenase (Co-HPCD) that employed the
electron-poor substrate, 4-nitrochatechol (4-NC). Exposure of Co-HPCD/4-NC to O2
generates a S = 1/2 cobalt(III)-supoeroxo adduct with EPR features similar to those
reported for 7-O2.123 While the Co-HPCD/4-NC/O2 species decays to give the ringcleaved product, the rate is seven orders of magnitude slower than the analogous reaction
with Fe-HPCD/4-NC. The lower activity of Co-HPCD relative to Fe-HPCD has been
attrivuted to a lack of semiquinone (SQ) radical character in the Co-HPCD/4-NC/O2
species9,10 – a hypothesis that parallels our explanation for the contrasting reactivities of
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the Co- and Fe-CDO models towards O2.

Interestingly, under conditions of O2

saturation, the activity of Co-HPCD with the native homoprotocatechuate substrate is
actually greater than the activity of Fe-HPCD. Although intermediates have not been
observed in this case, DFT calculations suggested that use of the more electron-rich
substrate yields a high-spin O2-/Co(II)/SQ intermediate with S = 3/2, which encourages
formation of the C-O-O-C intermediate.39
In summary, the results presented here suggest that HPCD and CDO operate via
similar mechanisms that require full (or partial) oxidation of the bound substrate upon O2
binding, thereby permitting facile reaction with the superoxo ligand. The inactivity of
Co-CDO is attributed to the lack of unpaired spin-density present on the thiolate donor of
the low-spin Co/O2 adduct. Moreover, our findings support the conclusion that Cosubstituted forms of MNIDs only exhibit activity comparable to the native Fe enzymes in
cases when high-spin Co/O2 intermediates are energetically accessible.

4.D. Experimental

4.D.i. Materials
All reagents and solvents were purchased from commercial sources and used as
received, unless otherwise noted. Dichloromethane (CH2Cl2) and acetonitrile (MeCN)
were purified and dried using a Vacuum Atmospheres solvent purification system and
stored under N2. The synthesis and handlings of air-sensitive materials were performed
under inert atmosphere using a Vacuum Atmospheres Omni-Lab glovebox. The ligand
K(TpPh2) was prepared according to a literature procedure.152
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4.D.ii. Physical Methods
UV-vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer attached to a cryostat manufactured by Unisoku Scientific Instruments
(Osaka, Japan) for measurements at reduced temperatures. Infrared (IR) spectra were
collected with a Nicolet Magna-IR 560 spectrometer.

X-band EPR spectra were

measured using a Bruker EMXplus instrument equipped with an ER4416DM cavity, an
Oxford Instruments ESR900 helium flow cryostat, and Oxford Instruments ITC503
temperature controller. Simulations of the experimental EPR spectra were performed
using the program EasySpin (version 5).47 1H NMR samples were prepared in deuterated
solvents and spectra were recorded on a Varian 400 MHz spectrometer.

Cyclic

voltammograms were measured in the glovebox with an epsilon EC potentiostat (iBAS)
at a scan rate of 200 mV s-1 with 0.1 M [NBu4]PF6 electrolyte. The three-electrode cell
consisted of a Ag/AgCl reference electrode, a platinum auxiliary electrode, and a glassy
carbon working electrode. Under there conditions, the ferrocene/ferrocenium (Fc+/0)
couple has an E1/2 value of +0.51 V in CH2Cl2. Elemental analyses were performed at
Midwest Microlab, LLC in Indianapolis, IN.

4.D.iii. Synthetic Procedures
[Co(TpMe2)(OAc)] (8). Using a modified literature procedure,131 Co(OAc)24H2O (0.747
g, 3.0 mmol) was dissolved in MeOH (20 mL) and a solution of K(Me2Tp) (0.673 g, 2.0
mmol) in THF (20 mL) was added dropwise. After the addition was complete, the
solution was filtered and the solvent removed under vacuum. The product was then
extracted with CH2Cl2 and dried under vacuum, followed by another extraction with
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MeCN. Removal of solvent en vacuo provided a purple solid that was taken up in
CH2Cl2, filtered, and layered with pentane. Crystalline purple solid formed after one day.
Yield = 400 mg (48%). X-ray quality crystals were formed by layering a more dilute
CH2Cl2 solution of 7 with pentane. UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 305 (700),
573 (90). FTIR (cm-1, solution): 1543 (CO2, antisym). 1H NMR (400 MHz, CDCl3): δ =
61.5 (3H, 4-pz), 54.8 (1H, BH), 35.1 (9H, 5Me-pz), -40.8 (9H, 3Me-pz) ppm.
Synthesis of [Co(TpPh2)(CysOEt)] (6).

L-cysteine

ethyl ester hydrochloride (56 mg,

0.30 mmol) and triethylamine (92 µL, 0.67 mmol) were dissolved in CH2Cl2 (10 mL) and
stirred until all of the solid dissolved. Dropwise addition of [Co(TpPh2)(HpzPh2)]16 (202
mg, 0.20 mmol) in CH2Cl2 generated a brown solution that was stirred for 3 hours. The
volume of the solvent was reduced under vacuum, filtered, and then layered with MeCN.
Dark-brown crystals suitable for X-ray analysis formed after one day. Yield = 138 mg
(79%). Anal. calcd for C50H44BCoN7O2S (MW = 876.74 g mol-1): C, 68.50; H, 5.06; N,
11.18. Found: C, 69.33; H, 5.15; N, 11.23. UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]:
349 (2460), 378 (sh), 438 (380), 546 (120). FTIR (cm-1, solution): 3357 (N-H), 1729
(C=O). 1H NMR (400 MHz, CDCl3): δ = 77.0 (1H, BH), 46.7 (3H, 4-pz), 27.7 (6H), 17.7
(6H), 14.7 (3H), 4.4 (9H), -5.2 (3H, OCH2CH3), -5.4 (1H), -6.8 (1H), -39.9 (6H), -48.6
(1H) ppm.
[Co(TpMe2)(CysOEt)] (7). A solution of L-cysteine ethyl ester hydrochloride (56 mg,
0.30 mmol) and triethylamine (92 µL, 0.66 mmol) in CH2Cl2 (10 mL) was stirred until
the former compound had fully dissolved. Dropwise addition of 8 (84 mg, 0.20 mmol) in
CH2Cl2 provided a dark purple solution that was stirred for 3 hours. Afterwards, the
solution was filtered and the solvent removed under vacuum. The resulting solid was
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extracted with toluene and dried under vacuum to yield the crude product. Subsequent
extraction with MeCN, followed by removal of solvent en vacuo, yielded the pure
complex as a purple powder. Yield = 72 mg (71%). Anal. calcd for C20H32BCoN7O2S
(MW = 504.32 g mol-1): C, 47.63; H, 6.40; N, 19.44. Found: C, 47.39; H, 6.16; N, 18.68.
UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 328 (2310), 395 (460), 543 (125). FTIR (cm1

, solution): 3345 (N-H), 1720 (C=O). 1H NMR (400 HMz, CDCl3): δ = 62.5 (1H, BH),

51.7 (3H, 4pz), 32.0 (9H, 5Me-pz), 1.3 (2H, OCH2CH3), -4.1 (3H, OCH2CH3), -5.3 (1H),
-6.6 (1H), -48.1 (1H), -51.7 (9H, 3Me-pz) ppm.

4.D.iv. X-ray Crystallography
X-ray crystal structures were obtained at 100K with an Oxford Diffraction
SuperNova kappa-diffractometer (Rigaku Corp.) equipped with dual Cu/Mo X0ray
sources, X-ray mirror optics, an Atlas CCD detector, and a low-temperature Cryojet
device. The data were processed with the CrysAlis Pro program package, followed by
numerical absorption correction based on Gaussian integration over a multifaceted crystal
model.

The empirical absorption correction, using spherical harmonics, was

implemented in the SCALE3 ABSPACK scaling algorithm. Structures were solved using
the SHELXS program and refined with the SHELXL program91 as part of the Olex2
crystallographic package.92 X-ray diffraction parameters are summarized below; CCDC
1545173 and 1545174 contain the supplementary crystallographic data (CIF files) for
complexes 6 and 8.
Crystallographic data for complex 6: C50H44BCoN7O2S, Mr = 876.72 g mol-1,
monoclinic, space group P21, a = 15.77282(13), b = 16.76061(12), c = 16.80269(14) Å, α
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= 90, β = 91.5914(7), ϒ = 90˚, V = 4440.28(6) Å3, Z = 4, ρ = 1.311 g cm-3, reflections
collected 40 090, independent reflections 16 708 (Rint = 0.0435), 1124 parameters, R1 =
0.0489 and wR2 0.1354 for I ≥ 2σ(I).
Crystallographic data for complex 8: C17H25BCoN6O2, Mr = 415.17 g mol-1,
monoclinic, space group P21/c, a = 13.7807(3), b = 7.71018(14), c = 18.8008(3) Å, α =
90, β = 103.778(2), ϒ = 90˚, V = 1940.14(6) Å3, Z = 4, ρ = 1.311 g cm-3, reflections
collected 22 252, independent reflections 4939 (Rint = 0.0503), 521 parameters, R1 =
0.0461 and wR2 0.1177 for I ≥ 2σ(I).

4.D.v. Resonance Raman (rRaman) Experiments
To prepare rRaman samples of 7-O2, solutions of 7 in CD2Cl2 (conc. = 6.9 mM) were
added to NMR tubes and attached to a Schlenk line. The tubes were cooled to -78˚C and
several vacuum/argon cycles were performed, followed by exposure to gaseous dioxygen
(16O2 or 18O2). After mixing with a Vortex stirrer, the 7-O2 samples were frozen in liquid
N2 and detached from Schlenk line. The rRaman data were measured using 501.7 nm
excitation from a Coherent I-305 Ar+ laser (~10 mW of power at the sample). The light
scattered from the frozen samples (77K) was collected using a 135˚ backscattering
arrangement and disperse by an Acton Research triple monochromator featuring a 1200
groves per mm grating. The scattered light was detected with a Princeton Instruments
Spec X 100BR deep depletion, back-thinned CCD camera.

4.D.vi. Density Functional Theory (DFT) computations
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DFT calculations were performed with the ORCA 3.0 software package
developed by Dr F. Neese (MPI for Chemical Energy Conversion).154 All calculations
employed the spin-unrestricted formalism, unless otherwise noted. Geometries were
optimized with the Perdew-Burke-Ernzerhof (BPE0) hybrid functional51 with 10%
Hartree-Fock exchange. Calcuations utilized Alrichs’ valence triple-ζ basis set (TZV)
and polarization functions on main-group and transitional-metal elements (default-basis 3
in ORCA).95-97 The computational costs were reduced through the resolution of identity
and chain of sphere (RIJCOSX) approximation155 in tandem with the TZV/J auxiliary
basis set.156 The unrestrained optimizations used modified versions of the X-ray crystal
structures of 1 and 6 as starting points. In most cases, the TpR2 supporting ligand was
truncated to hydrotris(3-methylpyrazolyl)borate (i.e. TpMe,H); however, studies of O2
binding to complex 6 employed a TpPh,H ligand instead. The models omit the ethyl ester
moieties of the CysOEt ligand, as previous calculations indicated that this group has little
impact on molecular geometries, electronic structures, or relative energies. All optimized
structures correspond to local energy minima with only real vibrational frequencies. The
transition sates were located by performing a relaxed surface scan along the bond being
formed (or broken); the existence of the transition state was confirmed by the presence of
one imaginary frequency corresponding to the bond forming (or breaking) mode.
Frequency calculations provided zero-point energies, thermal corrections, and entropy
terms (vibrational, rotational, and translational).
Time-dependent DFT (TD-DFT) calculations employed the cam-B3LYP rangeseparated hybrid functional,72 which has been shown to provide good agreement between
experimental and TD-DFT computed absorption spectra for CDO.110

Absorption
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energies and intensities were computed for 40 excited states with the Tamm-Dancoff
approximation.111,112 EPR g-values were calculated by solving the coupled-perturbed
self-consistent field (CP-SCF) equations.106-109 Isosurface plots of molecular orbitals
were prepared using the ChemCraft program.

Table 4.4. Summary of X-ray Crystallographic Data Collection and Structure
Refinement

a

R1 = S ||Fo| - |Fc|| / S|Fo|; wR2 = [Sw(Fo2 - Fc2)2 / Sw(Fo2)2]1/2
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CHAPTER 5
Active Site Models of Cysteine Dioxygenase and Aminophenol
Dioxygenase that Employ the Sterically Accessible
TpMe2 Ligand for Enhanced O2 Reactivity

O

2

-80˚C

Abstract
The studies of cobalt-containing modes of cysteine dioxygenase (CDO) – discussed in
chapter 4 – indicated that dioxygenase models with the less sterically hindered TpMe2
ligand exhibit enhanced O2 reactivity compared to those with the TpPh2 ligand. This
finding prompted the reevaluation of prior efforts in the Fiedler laboratory to prepare
functional aminophenol dioxygenase (APDO) models. In these earlier studies, it was
shown that reaction of TpPh2-based APDO models with O2 results in oxidation of the
ligand to the corresponding iminosemiquinone without ring cleavage. This chapter
reports the synthesis, structural characterization, and O2 reactivity of CDO and APDO
models with the TpMe2 ligand. Significantly, the APDO model generated with this
accessible ligand exhibits oxidative ring cleavage. Moreover, exposure of the TpMe2based models to O2 at low temperatures enables the detection and spectroscopic
characterization of reactive intermediates in the catalytic cycle.
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5.A. Introduction
As discussed in Chapter 2, we have synthesized and characterized a series of
biomimetic complexes that mimic the structure and function of cysteine dioxygenase
(CDO).

These five-coordinate ferrous complexes, which employed the bulky

tris(imidazole-2-yl)phosphine (TIPPh2) ligand, react with O2 to form the corresponding
sulfinic acid, thereby replicating the reactivity of the enzyme. However, we were never
able to detect any reactive intermediates, even at low temperatures.
In constrast, aminophenol dioxygenase (APDO) models previously prepared by
Dr. Bittner in the Fiedler laboratory, as reviewed in the introduction chapter (Chapter 1,
section D.ii), did not show any ring-cleavage activity.

These complexes used the

tris(pyrazol-2-yl)borate ligand, along with 1-amino-4,6-di-tert-butylphenol to mimic the
active site. However, upon the addition of O2, only the two-electron oxidized species
was formed (Figure 5.1).48 Extensive spectroscopic, crystallographic, and computational
analysis confirmed that the resulting complex consists of a high-spin Fe(III) center
antiferromagnetically couple to an iminosemiquinone radical.
Our studies with the cobalt analogues of the cysteine dioxygenase models gave
very interesting results that carry implications for iron dioxygenase models.
different analogues of the Tp ligand were used – TpPh2 and TpMe2.

Two

The complex

employing the TpPh2 ligand, [Co(TpPh2)(CysOEt)], was unreactive toward oxygen at all
temperatures. Computations indicated that this is because of the bulky phenyl groups,
which prevented stabilization of Co/O2 adduct through hydrogen bonding to the amino
donor of CysOEt.

Alternatively, the analogous complex with the TpMe2 ligand,

[Co(TpMe2)(CysOEt)], exhibited much greater reactivity towards O2.

At room
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temperature, the complex reacted slowly with O2 to form the sulfinic acid product,
similar to the reactivity observed for the iron congeners. At low temperature, the UV-vis
absorption data indicated that O2 binds reversibly to the cobalt center. This Co/O2
species was also studied by EPR and rRaman spectroscopies, which confirmed formation
of a Co(III)-superoxo species. Computational studies of this adduct revealed a stabilizing
hydrogen bond between the distal oxygen of the superoxo ligand and the amine group of
the substrate ligand (Figure 5.2).157

Figure 5.1. Reaction of our aminophenol dioxygenase model, [Fe(TpPh2)(tBu2APH)], with
O2. Figure obtained from Reference 48.
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Figure 5.2. DFT-optimized structure of the Co/O2 adduct with select bond distances in
Å.157

These studies suggest that using a less bulky ligand could lead to the detection
and characterization of intermediates derived from reaction of the dioxygenase models
with O2. In this chapter, I will discuss the synthesis, characterization, and O2 reactivity of
two dioxygenase models that employ the TpMe2 scaffold: [Fe(TpMe2)(tBu2AP)] (9), where
tBu2

AP = 2-amino-4,6-di-tert-butylphenolate, and [Fe(TpMe2)(2-ATP)] (10), where 2-ATP

= 2-aminothiophenol. Complexes 9 and 10 serve as structural models of the APDO and
CDO active sites, respectively.
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5.B. Biomimetic models of aminophenol dioxygenase (APDO)

5.B.i. Synthesis and characterization
Complex 9, [Fe(TpMe2)(tBu2APH)], was synthesized by first deprotonating the
substrate ligand, 2-amino-4,6-di-tert-butylphenol with sodium methoxide (NaOMe) in
tetrahydrofuran (THF).

After removal of the solvent in vaccuo, the residue was

suspended in acetonitrile (MeCN), and K(TpMe2) and iron(II) triflate were added. This
mixture was stirred for 12 hours, followed by filtration through celite. Removal of the
solvent yielded a purple powder. This powder was purified by extracting with hexanes,
resulting in a very pale purple powder (23% yield) (Figure 5.3).

Figure 5.3. Synthesis of complex 9, [Fe(TpMe2)(tBu2APH)].
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X-ray quality crystals of this complex were grown by dissolving the complex in a
minimal amount of acetonitrile and allowing the solvent to slowly evaporate. Complex 9
crystallized as colorless needles.

This crystal structure is shown in Figure 5.4. The

structure consists of two symmetrically independent units having a very similar
configuration. The Fe(II) ion has a trigonal-bipyramidal coordination (with atoms N6
and N7 in axial positions) with an average τ-value of 0.58. Selected bond distances and
angles are provided in Table 5.1. The average Fe-NTp bond distance is 2.13 Å, similar to
values previously published for high-spin pentacoordinate FeTpR2 complexes.63,74 The
short Fe-O distance of 1.948 Å is consistent with coordination of an aminophenolate
anion.

Figure 5.4. Thermal ellipsoid plot (50% probability) of complex 9. Most hydrogen
atoms have been omitted for clarity.
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Table 5.1. Select bond distances and angles obtained of complex 9. Bond distances are
given in Å, angles are given in degrees (˚).

The iron-ligand bond lengths in complex 9 were compared to those reported for
its TpPh2 counterpart (Figure 5.5, Table 5.2). The average Fe-NTp bond length of 2.15 Å
in 9 is slightly shorter than the TpPh2 complex (by 0.02 Å). However, the bond distances
between the Fe(II) center and aminophenolate ligand are longer in 9 relative to those in
the TpPh2 complex. These differences arise from the the stronger donating ability of
TpMe2 compared to TpPh2, as discussed in Chapter 4 with respect to the Co-CDO models.

Figure 5.5. Bonds compared from complex 9 and its TpPh2 counterpart.

261

Table 5.2. Comparison of select bond lengths (in Å) of [Fe(TpPh2)(tBu2APH)] (taken from
reference 5) and complex 9.

The structure of complex 9 in solution was examined using 1H NMR
spectroscopy. The spectrum, shown in Figure 5.6, was taken in CDCl3 at room
temperature. Peaks appear from 55 to -30 ppm, typical of the paramagnetic shifts
observed for high-spin (S=2) Fe(II) complexes. The three pyrazole donors of the Tp
ligand are spectroscopically equivalent on the NMR time scale. Assignments were made
by comparison with previously published TpMe2 complexes.63 The 4-pyrazole hydrogens
appear at 53 ppm with an integration of three protons. There are four peaks that
integrate to nine hydrogen atoms, at 25, 18, 3.7, and -26 ppm. These peaks correspond to
the 3-Me and 5-Me substitutents of the Tp ligand, and the two tert-butyl groups from the
substrate ligand. Based on previously published data,50,63 the more downfield peaks at 25
and 18 ppm arise from the Tp ligand, while the more upfield peaks come from the tertbutyl groups of the aminophenolate. Three smaller peaks at 50, 48, and 38 ppm, each
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integrating to one hydrogen, are attributed to the B-H moiety and the aromatic hydrogens
of tBu2AP.

*

*

Figure 5.6. 1H NMR spectrum of complex 9 taken in CDCl3 at room temperature. The
peaks marked with an asterisk arise from solvent (CDCl3 and MeCN).

5.B.ii. Dioxygen reactivity
The reaction of complex 9 with O2 was studied under various conditions.
Treatment of 9 with O2 at room temperature results in immediate formation of a new
chromophore, with intense absorption features at 493 and 889 nm (Figure 5.7). This
unstable species decays quickly, fully disappearing within 20 minutes.
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The product of this reaction was isolated using a slight variation of a previously
published procedure.6 About 50 mg of complex 9 was dissolved in dichloromethane, and
O2 was bubbled through the solution for about 5 minutes. The mixture was then stirred
overnight. The reaction was treated with 6 mL of 3 M HCl and stirred vigorously for
three hours. The solvent was then removed in vacuo. The resulting residue was taken up
in methanol, followed by addition of chelex. After stirring this suspension overnight, the
chelex was separated by filtration and the solvent was removed. The remaining residue
was washed with toluene and dried. The resulting 1H NMR of the product is shown in
Figure 5.8. This spectrum was compared to the spectrum of the starting ligand, 2-amino4,6-di-tert-butylphenol. In the product, the aromatic peaks of tBu2APH have shifted from
6.7 ppm to 7.8 and 7.4 ppm. These shifts indicate that the starting ligand has been
consumed during the O2 reaction. This spectrum was compared to the spectrum reported
by Paine et al for the product of their APDO model after the reaction with O2 (Figure
5.9).50 The picolinic acid exhibited peaks at 8.07 and 7.59 ppm. Additionally, another
feature was observed, which they attribute to the formation of the formation of 4,6-ditert-butyl-2H-pyran-2-imine byproduct.

Although their spectrum was collected in

deuterated chloroform, the peaks of the product of complex 9 with O2 clearly coincide
with the picolinic acid peaks. The LC-MS spectrum of this product exhibits a peak at
235 m/z, again suggesting that the picolinic acid product is formed. As in the enzyme,
the ring of the susbtrate aminophenol is cleaved, after which water is lost to form the
picolinic acid product (Figure 5.10). Therefore, we can say that complex 9 is also a
functional model of APDO.
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Figure 5.7. Absorption spectrum of the reaction of complex 9 with O2. Initially upon
the addition of O2, a new species formed (red dashed line), which decayed over time (red
solid line). This spectrum was taken in THF at room temperature, [Fe] = 0.68 mM.

*
*
*
*

Figure 5.8. 1H NMR spectrum obtained from the product of the reaction of 9 + O2. The
spectrum was taken in MeOD at room temperature. Peaks marked with an asterisk arise
from solvent.
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Figure 5.9. Spectrum obtained by Paine et al of the product of their APDO model with
O2.50

Figure 5.10. Reaction of complex 9 with O2 at room temperature to form the picolinic
acid.
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This reaction with O2 was also studied at low temperature (-80˚C). Upon addition
of O2, a new intermediate was formed immediately with absorption features at 463, 509,
and 713 nm (henceforth referred to as species A) (Figure 5.11a). Over the course of
several minutes at -80˚C, species A convert to a new species with features at 493 and 889
nm, referred to as species B (Figure 5.11b). The spectral features of B are the same as
those observed for the initial intermediate formed at 20˚C (see Figure 5.7). Although
species B exhibits long term stability at -80 oC, it decays upon warming to 20˚C with the
disappearance of all absorpton features (Figure 5.11c). The formation of the intermediate
B was not reversible: bubbling Ar through the solution at -80 oC causes no change in
absorption features. Similarly, after warming the solution, the starting spectrum could
not be regenerated by cooling the solution back to -80˚C.
The detection of intermediates A and B is unprecedented observed for this type of
complex. For example, the previous reported APDO model [Fe(TpPh2)(tBu2AP)] does not
show any reactivity with O2 at low temperature, and no intermediates were
spectroscopically characterized. These results provide further evidence that TpMe2
complexes are much more reactive towards O2 than their TpPh2 counterparts, resulting in
functional dioxygenase models capable of forming metastable intermediates at low
temperatures.
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a

species A

b
species B

c

Figure 5.11. Absorbance spectra of the reaction with 9 with O2, taken in THF at -80˚C
at a) immediately after the addition of O2 (species A) b) after stirring at -80˚C for 20
minutes (species B) c) after warming the solution to 20˚C (species C). [Fe] = 0.68 mM.
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5.B.iii. Resonance Raman Studies of Intermediates A and B
Raman (rRaman) spectroscopy was employed to further characterize the
intermediates arising from reaction of 9 with O2 at -80 oC. To aid in the detection and
assignment of peaks arising from putative Fe/O2 intermediates, samples were prepared
with both 16O2 and 18O2. Spectra of species A in THF and THF-d8 were obtained using
laser excitation at several wavelengths, including 647.1, 501.7, and 413.1 nm.
Unfortunately, no isotopically active peaks were detected (Figure 5.12).

Samples

prepared in different solvents, including Me-THF and DCM, also failed to exhibit peak
shifts due to 16O2 / 18O2 substitution.
In contrast, resonance Raman spectra of intermediate B obtained with 501.7 nm
laser excitation displayed an abundance of isotopically-active features.

The low-

frequency region between 500 and 750 cm-1 features three peaks at 566, 603, and 720 cm1

that shift to lower energy upon

18

O2 substitution (Figure 5.13, top). In addition, two

isotopically-active peaks were found in the high-frequency region at 1092 and 1124 cm-1
(Figure 5.13, middle). For both sets of peaks, the isotope shifts are much smaller that
expected for O-O stretching modes, which generally display shifts of 40 to 80 cm-1. This
result suggests that intermediate B is generated after cleavage of the O-O bond.
To futher probe the structure of B, complex 9 was prepared using 15N-substituted
2-amino-4,6-di-tert-butylphenol. Resonance Raman samples of 15N-labeled B were then
generated using 16O2. As shown in Figure 5.13 (bottom), the peaks at 566 and 1124 cm-1
shift by 4 and 7 cm-1, respectively, upon 15N labeling. It is notable that these features are
also sensitive to

18

O2, which means that an oxygen-atom derived from O2 has been

incorporated into the aminophenolate ligand. This results confirms our initial hypothesis
that B forms after O-O bond cleavage.
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Using the resonance Raman data as a guide, the identity of B was explored using
DFT calculations. In the proposed APDO mechanism, cleavage of the O-O bond is
followed by incorportation of one oxygen atom into the aromatic ring to yield a lactone
unit (see Figure 1.57), while the second oxygen atom becomes a hydroxide ligand. A
computational model of the analogous species in our model system, depicted in Figure
5.13, was generated via DFT geometry optimization. Vibrational modes computed for
this species possess frequencies and isotope shifts consistent with the experimental peaks.
Based on these DFT results, it is possible to assign the peak at 566 cm-1 to a ν(Fe-OH)
mode that mixes with the Fe-N stretching motion. The character of the 603 cm-1 mode is
primarily derived from the breathing mode of the five-membered chelate ring, whereas
the higher-frequency modes around 1100 cm-1 arise from motions of the seven-membered
lactone ring.

Thus, the combined rRaman and DFT results strongly suggest that

intermediate B corresponds to the structure shown in Figure 5.14.
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Figure 5.12. rRaman spectra of species A in frozen THF collected with 413.1 nm laser
excitation. The black lines were obtained using natural abundance O2, while the red
spectrum was obtained by using 18O2.
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Figure 5.13. rRaman spectra of species B collected in frozen THF using 507.1 nm laser
excitation. The top spectrum (black) was obtained using naturally abundant (NA) O2 and
N. The middle spectrum (red) was obtained using 18O2 and NA N. The bottom spectrum
(blue) was obtained using NA O2 and 15N.

Figure 5.14. Structure of species B, which was identified the lactone intermediate of the
catalytic cycle.
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5.B.iv. Additional reactivity studies with complex 9
In previous studies performed in the Fiedler laboratory, it was shown that
treatment of [Fe(TpPh2)(tBu2AP)] with the 2,4,6-tri-tert-butylphenoxy radical (TTBP)
yields a novel iron(II)-iminosemiquine complex via H-atom abstraction.

To determine

whether similar chemistry occurs with the TpMe2 complex, the reaction of TTBP with
complex 9 in THF at -80˚C was monitored by UV-vis spectroscopy. Addition of the
radical causes formation of new chromophore (C) with intense absorption features at 545
and ~900 nm (Figure 5.15, top). The absorption and EPR features of C are very similar
to those reported by Paine et al. for six-coordinate iron(III)-amidophenolate complexes.
Thus, reaction with TTBP● triggers one-electron oxidation of the iron center and removal
of a proton from the tBu2AP ligand (net H-atom abstraction).
Interestingly, exposure to O2 at -80 oC causes intermediate C to convert to B over
the course of several minutes (Figure 5.15, bottom). This result suggests that species B
can be made via two different pathways: (i) direct reaction of the Fe(II) complex with O2
in a mechanism that proceeds via species A, or (ii) initial reaction of with an H-atom
abstractor followed by O2 (Figure 5.16). The former pathway mimics the catalytic cycle
of extradiol dioxygenases, where the latter more closely resembles the mechanism of
intradiol catechol dioxygenase.
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species C

species B

Figure 5.15. Absorption spectra of the reaction of complex 9 with TTBP in THF at 80˚C (top) and after the addition of O2. [Fe] = 1.1 mM.
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THF
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species B

THF

Figure 5.16. Complex 9 can form species B by two different pathways.

Complex 9 was also treated with a one-electron oxidant, acetylferrocenium
tetrafluoroborate ([AcFc]BF4). Addition of [AcFc]BF4 to 9 in THF at low temperature (80˚C) gives rise to a new species with features at 451, 652, and 875 nm (Figure 5.17).
Raising the temperature to 20˚C causes further spectral changes with new bands at 553,
796, and a broad, intense feature around 1000 nm (Figure 5.17). These species observed
in the AcFc+ reaction differ from the intermediates seen upon addition of O2 or tri-tertbutylphenoxy radical, and future studies are required to elucidate their identities.
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Figure 5.17.

Absorption spectra of the reaction of complex 9 (black line) with

[AcFc]BF4 at -80˚C in THF after stirring at -80˚C for 30 minutes (red dotted line) and
after warming to 20˚C (gray line). [Fe] = 0.79 mM.

5.C. Biomimetic model of thiol dioxygenase

5.C.i. Synthesis and characterization
Following a similar procedure for the synthesis of complex 9, 2-aminothiophenol
(2-ATP) was deprotonated using sodium methoxide (NaOMe) in THF. After removal of
the solvent, acetonitrile was added along with K(TpMe2) and iron(II) triflate. This mixture
was stirred for 12 hours at room temperature. After filtration through celite, the MeCN
was removed in vacuo. The product was extracted with DCM and MeCN, yielding
[Fe(TpMe2)(2-ATP)] (10) as a pale yellow powder in 48% yield.
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Colorless prisms suitable for X-ray crystallographic analysis were obtained by
slow evaporation of a concentrated solution in acetonitrile (Figure 5.16). The resulting
structure revealed that 10 contains a monoiron(II) center in a distorted trigonal
bipyramidal geometry (τ-value = 0.52). The amino group of 2-ATP and a pyrazole donor
of TpMe2 occupy the apical positions. Select bond distances and angles are listed in Table
5.3. The average bond distance of Fe-NTp is 2.11 Å is similar to the value found for
complex 9, again indicative of a high-spin (S = 2) ferrous complex. The Fe-S/N bonds to
the 2-ATP “substrate” are similar to those observed for the related complexes
[Fe(TpPh,Me)(CysOEt)] (3) and [Fe(TpPh,Me)(CS)] (4) (Chapter 2). Complex 10 has Fe1N7 and Fe1-S1 bonds of 2.278 and 2.311 Å, respectively, while the analogous bonds in
complexes 3 and 4 are 2.28 and 2.31 Å, respectively.

Complex 10 is therefore a

structural model of cysteine dioxygenase.

.

Figure 5.18. Thermal ellipsoid plot (50% probability) of complex 10. Most hydrogen
atoms have been emitted for clarity.
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Table 5.3. Select bond distances (Å) and angles (˚) of complex 10.

Complex 10 was also characterized by 1H NMR in CDCl3 at 20˚C (Figure 5.17).
The peaks arising from the TpMe2 ligand are consistent with previous complexes studied
in our laboratory. The 4-pyrazolyl hydrogens appear at 56 ppm, and the 3- and 5-Me
groups display resonances at 24 and 18 ppm. The last peak from the Tp ligand, the B-H
moiety, appears at 42 ppm. Based on peak integrations, the features at 18, -4, -8, and -26
ppm are assigned to the aromatic peaks of the 2-ATP ligand. Again, the 1H NMR data is
consistent with a high-spin (S = 2) ferrous complex.
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*
*
*

Figure 5.19. 1H NMR spectrum of complex 10 obtained at 20˚C in CDCl3. Peaks
marked with an asterisk arise from solvent.

5.C.ii. Dioxygen reactivity
Spectroscopic methods were employed to monitor the reactivity of complex 10
with O2 under a variety of conditions.

Upon addition of O2 at 20˚C, a new chromophore

is observed with absorption features at 567 and 866 nm. This intermediate slowly
decays, giving rise to a species with weak absorption features in the 500-1000 nm region
(Figure 5.18).
The product of this reaction was isolated following a similar procedure as
described above. A solution of complex 10 in DCM was saturated with oxygen, and
allowed to stir overnight. 3M HCl was then added, and the mixture was stirred for 3
hours. The aqueous layer was separated from the organic layer, and the solvent was
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removed. The remaining residue was taken up in methanol and chelex was added. After
this suspension stirred overnight, the chelex was separated by filtration, and the solvent
was removed.

The remaining residue was washed with toluene to remove excess

pyrazole. The 1H NMR spectrum obtained from this residue is displayed in Figure 5.19.
The spectrum exhibits four peaks due to aromatic hydrogens: a triplet at 7.1 ppm, a
doublet at 7.0 ppm, a doublet at 6.7 ppm, and a triplet at 6.5 ppm. The NH2 resonance
appears at 5.8 ppm. Comparison of this spectrum to the one obtained for the free 2-ATP
ligand (Figure 5.20) revealed clear differences.

However, it is noteworthy that the

spectrum of 2-ATP exhibits a set of weak peaks corresponding to the product derived
from the O2 reaction. This result suggests that the isolated product in not the sulfinic
acid, but the disulfide arising from oxidative coupling of two 2-ATP molecules
(compound a in Figure 5.24). This suspicion was confirmed by comparing our data to
the 1H NMR spectrum of compound a reported in the literature. We then performed a
control experiment in which 2-ATP was exposed to O2 in the absence of iron, followed
by the acid work-up described above. This procedure yielded the same NMR spectrum
as the one obtained from the reaction of 10 with O2.
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Figure 5.20. Absorption spectra obtained from the reaction of complex 10 (black line)
immediately after the addition of O2 (red dashed line) and after stirring (red solid line) in
THF at 20˚C. [Fe] = 0.84 mM.

Figure 5.21. Product isolated from the reaction of complex 10 with O2 after workup.
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a)

b)

Figure 5.22.

Comparison of the 1H NMR spectra in MeOD at 20˚C of a) 2-

aminothiophenol and b) product of the reaction of 10 with O2.

The reaction of complex 10 with O2 was then performed in THF at -78˚C in a dry
ice/acetone bath, followed by the same acidic workup. The resulting 1H NMR spectrum
exhibited peaks due to the disulfide product (compound a) as before, but the presence
additional peaks in the aromatic region indicated that other product(s) were generated
(see Figure 5.21, peaks arising from the disulfide product are marked with an asterisk).
Two other possible products are the sulfinic acid (doubly oxygenated; compound b) or
the sulfonic acid (triply oxygenated; compound c).

The 1H NMR spectrum of 2-

aminobenzenesulfonic acid – obtained from a commerical source – was measured in the
same solvent. This species exhibits peaks at 7.8, 7.4, and 7.0 ppm, which correspond to
those peaks in the product spectrum marked with black squares.

This leaves the peaks
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at 8.6, 8.2, 8.0, and 6.7 ppm as unassigned. These peaks do not correspond to the TpMe2ligand, 3,5-dimethylpyrazole, or the free 2-ATP ligand. This set of peaks may arise from
the sulfinic acid product (compound b), but further work is requried to confirm this
hypothesis.

* *

n

n

*

*

n

Figure 5.23. 1H NMR spectrum obtained in MeOD at 20˚C of the product of the reaction
of complex 10 with O2 in THF at -78˚C. Peaks marked with an asterisk arise from the
disulfide product. Peaks marked with a black square arise from the sulfonic acid product.

Figure 5.24. Summary of the possible products formed in the reaction of complex 10
with O2 in THF at -78˚C.
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The reaction of 10 with O2 at low temperatures was monitored using UV-Vis
spectroscopy. The spectra shown in Figure 5.25 were collected at -80˚C in THF. Upon
the addition of O2, a new species (intermediate D) is formed immediately with absorption
bands at 498, 660, and 860 nm (Figure 5.25a). Similar to the situation seen with complex
9, this intermediate is not stable and converts after 20 minutes at -80˚C to a new
chromophore (intermediate E) with a peak at 574 nm and a broad feature at 856 nm
(Figure 5.25b). The spectral features of E are similar to those observed at 20˚C upon
exposure of 10 to O2. Warming the sample to 20˚C causes the absorption features of E to
decay, resulting in a rather featureless spectrum (Figure 5.25c).
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b

a

species D

species E

c

Figure 5.25. Absorption spectra obtained from the reaction of complex 10 with O2 in
THF at -80˚C a) immediately (species D) b) after stirring at -80˚C for 20 minutes (species
E) c) after warming to 20˚C. [Fe] = 0.84 mM
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5.C.iv. Additional reactivity studies with complex 10
The

one-electron

oxidation

of

complex

10

with

acetylferrocenium

tetraflurorborate ([AcFc]BF4) was monitored with UV-vis spectroscopy.

At low

temperature (-80˚C in THF), addition of [AcFc]BF4 generates a new chromophore (F)
with absorption features at 585 and 945 nm (Figure 5.26a). Reaction of F with O2 gives
rise to a spectrum with features identical to those observed for species E (Figure 5.26b).
Thus, as was the case for complex 9, the most stable low-temperature intermediate (B in
the case of complex 9, E in the case of 10) can be generated via two different routes:
through direct reaction of the Fe(II) complex with O2, or stepwise one-electron oxidation
followed by exposure to O2.
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a

species F

b

species D

Figure 5.26. Absorption spectra obtained from the reaction of complex 10 a) with 1
equivalent [AcFc]BF4 and b) after the addition of O2 to the oxidized species. These
spectra were taken in THF at -80˚C. [Fe] = 0.62 mM.
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5.D. Conclusions
Complexes 9 and 10 are structural models of the mononuclear nonheme iron
active sites of aminophenol dioxygenase and cysteine dioxygenase.

These five-

coordinate complexes consist of a high-spin (S = 2) ferrous center bound to the TpMe2
ligand scaffold along with a bidentate “substrate” ligand: 2-amino-4,6-di-tertbutylphenolate (tBu2AP) for complex 9 and 2-aminothiophenolate (2-ATP) for complex
10. Reaction of complex 9 with O2 results in oxidative cleavage of the Bu2AP ligand; the
ring-cleaved product cyclizes to yield the corresponding picolinic acid, which was
detected by NMR spectroscopy and mass spectrometry. Thus, complex 9 is a functional
model of APDO. However, reaction of complex 10 with O2 generates the disulfide of 2ATP as the predominant product instead of the expected sulfinic acid.
In both complexes, intermediates of the reaction with O2 were observed at low
temperature. In complex 9, two intermediates were detected. The identity of the first
intermediate (A) could not be definitively assigned due to the lack of isotope-senstivite
rRaman features, although we suspect that it is an Fe/O2 adduct. However, on the basis
of rRaman and DFT data, it was demonstrated that the second interediate (B) is the
lactone intermediate derived from insertion of an O-atom into the aromatic ring, which
occurs after cleavage of the O-O bond. Intermediate B can be generated via two distinct
pathways: (i) either by reaction of the Fe(II) complex with O2 in a process that goes
through species A, or (ii) by stepwise reaction with an H-atom abstracting agent (like
TTBP•), followed by the addition of O2.
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Similarly, two intermediates (D and E) are observed in the reaction of complex 10
with O2 at -80 oC. In both cases, additional rRaman spectroscopic and MS studies with
18

O2-labeled samples are necessary for confirmation.

5.E. Experimental

5.E.i. Materials
Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Dichloromethane (CH2Cl2) was purified and
dried using a Vacuum Atmospheres solvent purification system and stored under N2. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox equipped with a freezer set to −30 °C.

5.E.ii. Physical Methods
UV−vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for experiments at reduced temperatures. Infrared (IR) spectra were measured
with a Nicolet Magna-IR 560 spectrometer. X-band EPR experiments were performed
using a Bruker EleXsys E650 instrument equipped with an ER4415DM cavity, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat. The
program EasySpin (version 5) was used to simulate the experimental spectra.38 1H NMR
spectra were recorded in deuterated solvents using a Varian 400 MHz spectrometer.
Mass spectrometric data were measured using either an Agilent 6850 gas
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chromatography−mass spectrometer (GC−MS) with a HP-5 column or a Bruker matrixassisted laser desorption/ionization (MALDI) time-of-flight (TOF) microflex instrument.
X-ray diffraction (XRD) data were collected at 100 K with an Oxford Diffraction
SuperNova kappa-diffractometer (Rigaku Corp.) equipped with dual microfocus Cu/Mo
X-ray sources, X-ray mirror optics, an Atlas CCD detector, and a low-temperature
Cryojet device. The data were processed with the CrysAlis Pro program package91,
followed by numerical absorption correction based on Gaussian integration over a
multifaceted crystal model and then empirical absorption correction using spherical
harmonics, as implemented in SCALE3 ABSPACK scaling algorithm. Structures were
solved using the SHELXS program and refined with the SHELXL program within the
Olex2 crystallographic package.92 X-ray crystallographic parameters are provided in
Table 5.4.

5.E.iii. Synthetic Procedures
2-amino-4,6-di-tert-butylphenol (tBu2APH). Following a published procedure158, 3,5-ditert-butyl-o-benzoqinone (4.41 g, 20.0 mmol) was dissolved in MeOH.

60 mL of

ammonium hydroxide (NH4OH) was added, and the mixture was stirred at room
temperature for 20 minutes. Sodium borohydride (NaBH4) (1.0 g, 27 mmol) was added.
After stirring for 30 minutes, the mixture was filtered, resulting in a yellow powder. This
powder was washed with a mixture of 3:1 MeOH:NH4OH to give pure product in 50%
yield. 1H NMR (400 MHz, CDCl3): ∂ = 6.9 (d, 1H), 6.8 (d, 1H), 5.8 (s, 1H), 1.4 (s, 9H),
1.3 (s, 9H).
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[Fe(TpMe2)(tBu2APH)] (9).

2-amino-4,6-di-tert-butylphenol (0.22 g, 1.0 mmol) and

sodium methoxide (NaOMe) (0.060 g, 1.1 mmol) were combinded in ~3 mL THF. This
mixture was stirred for 1 hour, and the solvent was removed under vacuum. Acetonitrile
(8 mL), K(TpMe2), and Fe(OTf)2 were added and this mixture was stirred for 12 hours.
The solution was filtered with celite, and the solvent was removed en vacuo. The
remaining residue was washed with hexanes to yield the product as a pale purple powder
(0.132 g, 23% yield). X-ray quality crystals were grown by dissolving the complex in a
minimal amount of acetonitrile and allowing the solvent to slowly evaportate. 1H NMR
(400 MHz, CDCl3): ∂ = 53.5 (s, 3H, 4-H-pz), 49.9 (s, 1H), 47.9 (s, 1H), 31.0 (s, 1H), 24.7
(s, 9H, Tp-Me), 18.5 (s, 9H, Tp-Me), 3.7 (s, 9H, t-Bu), -26.0 (s, 9H, t-Bu).
[Fe(TpMe2)(2-ATP)] (10). 2-aminothiophenol (0.15 g, 1.0 mmol) and NaOMe (0.060 g,
1.1 mmol) were combined in ~3 mL THF. This mixture was stirred for 1 hour, and the
solvent was removed under vacuum. Acetonitrile (8 mL), K(TpMe2), and Fe(OTf)2 were
added and this mixture was stirred for 12 hours. The solution was filtered with celite, and
the solvent was removed en vacuo. The product was extracted with DCM and tried,
resulting in a pale yellow powder . X-ray quality crystals were grown by dissolving the
complex in a minimal amount of acetonitrile and allowing the solvent to slowly
evaporate. 1H NMR (400 MHz, CDCl3): ∂ = 56.7 (s, 3H, 4-H-pz), 42.5 (s, 1H, BH), 24.1
(s, 9H, Tp-Me), 18.3 (s, 9H, Tp-Me), 12.7 (s, 1H), -4.2 (s, 1H), -7.5 (s, 1H), -26.0 (s, 1H)
ppm.
2,4,6-tri-tert-butylphenoxy radical. Following a published procedure159, 2,4,6-tri-tertbutylphenol (0.53 g, 2.0 mmol) was dissolved in 35 mL benzene and 6.3 mL of 1M
NaOH was added. This mixture was degassed using two freeze-pump-thaw cycles. The
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solution was frozen again, and potassium ferricyanide (1.65 g, 5.0 mmol) was added, and
put through one more freeze-pump-thaw cycle.

This was then warmed to room

temperature and stirred for ~1 hour under argon. Solution was removed by vacuum.
This blue residue was then taken into the glovebox and the product was extracted with
diethyl ether. The solvent was removed, the residue was taken up in acetonitrile and put
in the freezer. Dark blue crystals formed over a few days.

5.D.iv. Dioxygen reactivity studies
Following established procedures,31,33 the products of the oxygenation reactions
were isolated by addition of 3M HCl to the reaction mixture and stirred for 3 h. For
complex 9, the solvent was removed, and the resiude was taken up in methanol. Chelex
was added, and this mixture was stirred 12 hours. After filtration, the solvent was
removed and the residue was washed with toluene. For complex 10, after addition of the
hydrochloric acid, the aqueous layer was collected and dried. The residue was taken up
in methanol and chelex was added. After filtration, the solvent was removed and the
residue was washed with toluene. 1H NMR data of the reaction products were interpreted
with the aid of published spectra and/or by comparison to spectra measured with
commercially available material. Product of 9 + O2 reaction: yield = 57%. 1H NMR (400
MHz, CD3OD): δ = 7.8 (s, 1H, Ar-H), 7.4 (s, 1H, Ar-H), 1.4 (s, 9H, tBu), 1.3 (s, 9H, tBu).
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Table 5.4.

Summary of X-ray Crystallographic Data Collection and Structure

Refinement

a

R1 = S ||Fo| - |Fc|| / S|Fo|; wR2 = [Sw(Fo2 - Fc2)2 / Sw(Fo2)2]1/2
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CHAPTER 6
Synthesis, Characterization, and Preliminary O2/NO Reactivity
Studies of First-Generation Biomimetic Models of
Non-Heme Iron Sulfoxide Synthases

Abstract
Sulfoxide synthases (SOSs) are a recently-discovered class of nonheme iron enzymes that
utilize O2 to catalyze an oxidative C-S bond forming reaction between thiol- and
imidazole-containing substrates. The enzymatic reaction also involves monoxygenation
of the sulfur atom of the thiol substrate. A recent crystal structure revealed that the Fe(II)
center of EgtB – the best characterized SOS – is coordinated by a three-histidine facial
triad, similar to the active site of cysteine dioxygenase. This chapter presents the
synthesis and structural characterization of a series of SOS models based on two different
ligand scaffolds: (1H-imidazol-4-yl)-N,N-bis((pyridin-2-yl)methyl)-methanamine (Lk),
and bis((1-methyl-imidazol-2-y1)methyl-((2-pyridyl)methyl)amine (BIPA). Both ligands
possess an imidazole donor intended to occupy a cis position relative to a potential
thiolate “substrate”. Methyl thiosalicayte and various monodentate arlythiolate ligands
were used to mimic the presence of the thiol-containing substrate. The reactivity of the
SOS models with O2 and its surrogate, NO, were explored.

294

6.A. Introduction
Two sulfoxide synthases (SOSs) with mononuclear nonheme iron active sites
have been reported to date, EgtB and OvoA. These enzymes catalyze the key C-S bond
formation step in the biosyntheses of ergothioneine (Egt) (Figure 6.1) and ovothiol A
(Figure 6.2), respectively, from Cys and His building blocks. The EgtB and OvoA
reactions, like those of the dioxygenases, utilize all four oxidizing equivalents of O2. Egt
is a micronutrient that humans obtain from dietary sources and enrich to millimolar
concentration in certain tissues.

The precise functions of Egt and ovothiol A are not

fully understood, but several studies have emphasized their antioxidant properties.
While the active site of EgtB was first thought to contain a 2-histidine-1carboxylate triad based on sequence analysis, a 2015 crystal structure revealed a 3His
triad similar to CDO. The data also indicated that the EgtB substrates - γ-glutamyl
cysteine (γGC) and N-α-trimethyl histidine (TMH) – do not occupy outer-sphere binding
sites as originally supposed, but instead coordinate directly to Fe. Seebeck et al. have
revealed the importance of the conserved second-sphere Tyr377 residue in the catalytic
function of EgtB. Substitution of Tyr377 by Phe converts EgtB from a SO synthase into a
TDO that catalyzes the dioxygenation of γGC.53 The TDO activity of the mutant EgtB
still requires TMH, indicating that the same Fe:γGC:TMH:O2 complex is formed in both
pathways. Based on kinetic data, Seebeck suggested that the Tyr377 residue stabilizes a
putative Fe(III)-hydroperoxo intermediate with a S-based radical, thereby preventing
formation of the Fe-O-O-S ring that leads to S-dioxygenation. However, no oxygenated
intermediates have been observed spectroscopically. Recently, De Visser and coworkers
used computational (DFT) methods to explore various aspects of the SOS mechanism.61
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Future studies utilizing biochemical and synthetic approaches are required to provide
experimental support for these computational insights.
mechanism is shown in Figure 6.3.

Figure 6.1. Reaction catalyzed by the SOS EgtB.52

Figure 6.2. Reaction catalyzed by the SOS OvoA.53

The proposed catalytic
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Figure 6.3. Proposed mechanisms for WT and Y377F EgtB. 61

To the best of our knowledge, no biomimetic models of the SOS active site have
been reported to date. With the goal of addressing this lack, this chapter will discuss the
synthesis and characterization of the first generation of SOS models. These models
employ neutral, tentradentate ligand scaffolds featuring an imidazole donor:

(1H-

imidazol-4-yl)-N,N-bis((pyridin-2-yl)methyl)-methanamine (Lk), and bis((1-methylimidazol-2-y1)methyl-((2-pyridyl)methyl)amine (BIPA) (Figure 6.4).

These ligands

were selected because they are capable of placing an imidazole donor in a cis position
relative to a potential thiolate substrate, thereby mimicking the arrangement of substrates
in EgtB. The thiol-containing substrate was modeled with methyl thiosalicayte and
various monodentate arlythiolate ligands (Figure 6.5). The compositions of the resulting
complexes are provide in Figure 6.6, which also includes the numbering scheme that will
be employed throughout this chapter.
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Figure 6.4. The neutral, tetradentate ligand scaffolds used to model the active sites of
SOS.

Figure 6.5. Substrate ligands used to model the active sites of SOS.
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Figure 6.6. List of complexes synthesized in this study.

6.B. Results and Discussion

6.B.i. Synthesis and Solid State Structure
The ligand Lk was synthesized following a previously published procedure
(Figure 6.7).160 1H-imidazole-4-carbaldehyde was dissolved in degassed methanol, and
the flask was purged with argon. Bis(2-pyridylmethyl)amine, glacial acetic acid, and
sodium cyanoborohydride were added, and the reaction was stirred for 24 hours. This
solution was then treated with hydrochloric acid until the pH was acidic. The solvent was
removed using a rotovap, resulting in a sticky yellow residue. This residue was dissolved
in 250 mL CH2Cl2 and washed with saturated sodium bicarbonate solution. The organic
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layer was collected, dried with MgSO4, and the solvent was removed. The pure product
was

obtained

as

a

yellow

sticky

solid.

An

iron

precursor

complex,

[Fe(Lk)(MeCN)2](OTf)2 (11), was then synthesized by combining Lk and Fe(OTf)2 in
acetonitrile and stirring for ~3 hr. The dark brown solution was then filtered, the volume
was reduced, and layered with diethyl ether. A brown oil formed after a few days. The
liquid was decanted, and the dark brown oil was washed with diethyl ether. This oil
solidified under vacuum to form a dark brown powder.

Figure 6.7. Synthesis of Lk following a previously published procedure.160
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Figure 6.8. Thermal ellipsoid plot (50% probability) obtained from the crystal structure
of complex 11. Most hydrogen atoms and counteranions have been removed for clarity.

Red-brown X-ray quality crystals of this precursor complex 11 were formed by
letting the mother liquor of the first recrystallization attempt sit at -10˚C for a week
(Figure 6.8). The resulting X-ray structure revealed an Fe(II) complex possessing an
octahedral coordination geometry consisting of Lk and two MeCN ligands. The pyridyl
groups are arranged cis to one another, while the imidazole donor forms a hydrogen bond
with one of the triflate counteranions. Analysis of the residual electron density indicates
presence of 10-15% of a trans-conformer superimposed in the crystal with the cis-isomer.
This results in a global disorder including the H-bonded triflate ion. However, because of
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the low contribution of the alternative structure, the disorder was neglected. Select bond
lengths and angles are shown in Table 6.1. N1 respresents the amine nitrogen, N2 and
N5 represent the pyridyl nitrogens, and N5 denotes the imidazole nitrogen bound to the
iron center. The average Fe-NLk bond distance is 1.97 Å, with Fe-N1 being the longest
bond at 2.010 Å. These bond distances are typical of low-spin Fe(II) complexes. The
bond angles indicate that the octahedral geometry is slightly distorted.

Table 6.1. Select bond lengths (Å) and angles (˚) obtained from the crystal structure of
complex 11.
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BIPA was also synthesized in three steps following published procedures. First,
2-hydroxymethyl-1-methylimidazole (HMMI) was synthesized.161

Paraformaldehyde

and 1-methylimidazole were combined in a round bottom flask. The mixture was heated
to 160˚C using a heating mantle, and the flask was wrapped in glass wool. After 1.5
hours, the heating mantle was removed, and MeOH was added. This was allowed to cool
to room temperature. This mixture was filtered through celite, and the dark brown filtrate
was placed in the freezer. After one day, crystals were formed. HMMI was then used to
synthesize

2-(chloromethyl)-1-methylimidazole

hydrochloride

(CMMIHCl).162

Thionyl chloride and HMMI were combined in CHCl3 at 0˚C. This mixture was then
refluxed at 65˚C for 1 hour, during which a precipitate formed. Next, CMMIHCl and
CH2Cl2 were combined and 2-aminomethyl-pyridine was dissolved in CH2Cl2 and added
followed by triethylamine. This mixture was refluxed at 40˚C for 48 hours, during which
the solution turned from yellow to brown. BIPA was isolated as a dark brown oil.162
This synthesis is summarized in Figure 6.9.
The precursor complex, [Fe(BIPA)(MeCN)2](OTf)2 (16), was synthesized
following the same procedure used in the synthesis of complex 11. BIPA and Fe(OTf)2
were combined in MeCN and stirred for 3 hours. The solution was filtered, the volume
was reduced, and the solution was layered with diethyl ether. After a day, a dark
greenish brown oil formed. The liquid was decanted, the oil was washed with diethyl
ether, and the residue was dried. This resulted in a brown powder.
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Figure 6.9. Synthesis of BIPA following previously published procedures.162,163

Yellow elongated prisms of 16 suitable for X-ray crystallography were grown
when the mother liquor sat undisturbed at -10˚C for several days. The resulting structure
revealed that the Fe(II) center is coordinated by the tetradentate BIPA ligand, an
acetonitrile molecule, and a triflate anion (Figure 6.10). There is an isomorphous overlap
with the mirror isomer (pyridine and the opposite imidazole rings are statistically
interchanged by ~8%). The non-coordinated triflate counter ion is ~25% rotationally
disordered. Selected bond lengths and angles are listed in Table 6.2. It is notable that the
average Fe-NBIPA bond length of 2.18 Å is much larger than the corresponding value of
1.97 Å measured for complex 11, indicaating that the two precursor complexes possess
different spin states (11 is low-spin, 16 is high-spin). The change in spin state is likely
due to presence of the weak-field triflate donor in the coordination sphere of 16.
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Table 6.2. Select bond lengths (Å) and angles (˚) obtained from the crystal structure of
complex 16.

Figure 6.10. Thermal ellipsoid plot (50% probability) obtained from the crystal structure
of complex 16. Most hydrogen atoms and the triflate counteranion were omitted for
clarity.
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With the precursor complexes (11 and 16) in hand, we then sought to attach a
thiolate “substrate” ligand to one of the labile coordination sites of the Fe(II) center.
Preparation of the desired complexes followed the same general procedure (Figure 6.11,
Figure 6.12). The thiol pro-ligand was reacted with 1.1 equivalents of sodium methoxide
to generate the thiolate anion, followed by reaction with 11 or 16. As the triflate salts of
the resulting product gave oils instead of solids, a counteranion methathesis was
performed with NaBPh4. The triflate complexes were dissolved in methanol, followed by
addition of sodium tetraphenylborate. The solvent was removed, resulting in yellowishbrown solids. Unfortunately, numerous attempts to grow crystals of these SOS models
were unsuccessful, with the notable exception of [Fe(Lk)(MTS)]BPh4 (complex 12). Xray quality crystals of 12 were grown by layering a concentrated solution in
dichloromethane with pentane.

Figure 6.11. Synthesis of complexes 12-15.
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Figure 6.12. Synthesis of complexes 17-20.

The X-ray crystal structure of complex 12 revealed that the Fe(II) center has an
octahedral coordination, with the pyridyl donors occupying positions trans to each other
(Figure 6.13). The imidazole group of the ligand shows signs of overlap with one of the
pyridyl rings (not resolved), meaning that minor impurity of the cis-isomer is also present
in the crystal. The MTS “substrate” ligand coordinates in a bidentate manner with the
thiolate donor trans to the amino group of LK. The MTS ligand is not planar, as the
carbomethoxy group is twisted by ~30º relative to the adjacent aryl ring. Importantly, the
X-ray structure of 12 revealed that the thiolate and imidazole donors occupy cis positions,
which is critical for promoting SO synthase reactivity. The imidazole C2 and S atoms are
separated by 3.78 Å in 12, whereas the corresponding value in the EgtB structure is 3.5
Å.
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Select bond lengths and angles obtained for complex 12 are provided in Table 6.3.
The average Fe-NLk bond length is 2.20 Å, indicating that this complex features a highspin Fe(II) center. This average length is longer than the Fe-NLk distances observed in
complex 11, indicating that coordination of the anionic MTS ligand triggers a change
from low-spin to high-spin. Because this is the only thiolate-containing complex 12 was
able to crystallize, the remainder of the characterization techniques will focus on this
complex.
This data suggest that these complexes containing either the Lk or BIPA ligand
scaffolds act as structural models of sulfoxide synthases. The pyridyl and amino donors
of the LK scaffold replicate the 3His facial triad of EgtB, while the pendant imidazole
accounts for the histidine-derived substrate. The thiolate ligand of MTS mimics the
presence of a cysteine substrate in a position cis to the bound imidazole.
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Figure 6.13. Thermal ellipsoid plot (50% probability) obtained from the crystal structure
of complex 12. Hydrogen atoms and the counteranion have been omitted for clarity.
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Table 6.3. Select bond lengths (Å) and angles (˚) obtained from the crystal structure of
complex 12.

6.B.ii. Solution state properties
Complexes 11 and 16 were both examined by 1H NMR spectroscopy in CDCl3 at
room temperature. These spectra exhibit paramagnetic peaks ranging from 120 to -15
ppm, typical of high-spin Fe(II). The spectrum of complex 11 (Figure 6.14) displays
three peaks at 52, 51, and -6 ppm that correspond to the methylene spacers of the Lk
ligand based on integrations. The aromatic peaks appear at 120, 95, 82, 80, 75, 31, and
17 ppm. The NMR data indicate that, in non-coordinating solvents like CDCl3, complex
11 adopts a high-spin configuration, in constrast to the solid-state (vide supra). The
spectrum of complex 16 (Figure 6.15) exhibits three peaks corresponding to the
methylene spacers of the BIPA ligand at 57, 47, and 13 ppm. The aromatic peaks appear
at 96, 88, 79, 52, 51, 46, and -12 ppm. Additionally, the peak from the methyl groups
appears at 17 ppm.
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Figure 6.14. 1H NMR spectrum of complex 11 taken in CHCl3 at room temperature.

Figure 6.15.
temperature.

1

H NMR spectrum obtained from complex 16 in CHCl3 at room
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The peaks of the spectrum of 12 (Figure 6.16) were assigned using the spectrum
of complex 11 as reference. The peaks corresponding to the methylene protons of the LK
ligand shift slightly to 59, 54, -3 ppm. The methyl group from the methylthiosalycilate
substrate appears at 11 ppm. The aromatic peaks from the Lk ligand and the substrate
ligand appear from 82 to -15 ppm. Resonances of interest of the remaining complexes
can be seen in Table 6.4.

*
*

Figure 6.16. 1H NMR spectrum obtained for complex 12 in CDCl3 at room temperature.
The peaks marked with an asterisk arise from the tetraphenylborate anion.
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Table 6.4. Select resonances (ppm) of the remaining Lk-containing complexes (13-15)
and BIPA-containing complexes (17-20).

The UV-Vis spectra of complexes 11 and 16 are very similar (Figure 6.17).
Complex 11 exhibits peaks at 318 and 381 nm along with a weak feature at 579 nm
(Figure 6.17, black line). Complex 16 exhibits comparable peaks at 307, 377, and 588
nm (Figure 6.17, red line). The spectrum of complex 12 exhibits an intense peak at 382
nm, a shoulder at 466 nm, and a less intense, broad feature at 599 nm (Figure 6.18).
Based on our previous studies of complexes 1-5, the features at 382 and 466 nm are
assigned to S → Fe(II) ligand-to-metal charge transfer transitions.
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Figure 6.17. Absorbance spectra of complex 11 (black line) and complex 16 (red line)
obtained in THF at room temperature.

Figure 6.18. UV-Vis spectrum of complex 12 obtained in DCM at room temperature.
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6.B.iii. O2 and NO reactivity
Preliminary studies were performed regarding the O2 and NO reactivity of
complex 12, [Fe(Lk)(MeSal)]BPh4. Exposure of a solution of 12 in CH2Cl2 to O2 at room
temperature causes slight changes in the absorbance spectrum (Figure 6.19). The newlyformed species exhibits a small peak at 304 nm along with a broad feature around 620
nm. This species was not stable. Slow decay of these features was observed after 5
hours (Figure 6.20). The feature at 304 nm was still present in the end spectrum.

Figure 6.19. Absorbance spectrum of the reaction of complex 12 (black line) with O2 at
room temperature in CH2Cl2. immediately (red dashed line) and after stirring several
hours (gray line). [Fe] = 1.82 mM.
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Similar to complexes 1-5, the reaction of complex 12 with nitric oxide (NO) is
dependent on temperature. The reaction at room temperature produced a new species
with an intense absorbance bands at 445 and 730 nm (Figure 6.20). These features are
characteristic of six-coordinate {FeNO}7 adducts with S = 3/2. The {FeNO}7 speces
decays to yield a new species with weak features at 440, 560, and 798 nm (Figure 6.20).
This reaction was also studied by IR spectroscopy. Initially, a new feature at 1770 cm-1
was observed along with an increase of intensity of the features at 1721 and 1706 cm-1
(Figure 6.21, top). Multiple spectra were taken, and as time progressed the feature at
1721 cm-1 decreased, while the feature at 1706 cm-1 increased in intensity (Figure 6.21,
bottom). There is not a true isosbestic point in this conversion. This reaction was also
performed with isotopically labeled

15

NO. Again, the features at 1721 and 1706 cm-1

increased in intensity. However, the relative intensities of these features did not change
over time.

Additionally, a new feature at 1743 cm-1 was observed (Figure 6.22).

According to Hooke’s Law, if the feature at 1770 cm-1 observed in the spectrum with
naturally abundant arises from the N-O stretch, it should shift to 1738 cm-1 when 15NO is
used. This is very close to the frequency observed in that reaction at 1743 cm-1. IR
studies revealed that NO binding is accompanied by a large increase in the ν(CO)
frequency from 1654 to 1710 cm-1, indicating that the carbonyl donor of MTS is
displaced by NO. Thus, the IR data is consistent with formation of a {FeNO}7 species
(Figure 6.23).
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Figure 6.20. Absorbance spectrum of the reaction of complex 12 with NO at room
temperature in CH2Cl2 immediately (red dashed line) and after stirring several minutes
(gray line) [Fe] = 1.19 mM.
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Figure 6.21. Top: Initial species formed upon the reaction of complex 12 with NO at
room temperature. Bottom: Changes in the spectrum as time progressed. Spectra were
collected in CH2Cl2.
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*
*

Figure 6.22. Comparison of the IR spectra obtained from the reaction of complex 12
with naturally abundant NO (black line) and isotopically labeled

15

NO (red line line).

Spectra were obtained in CH2Cl2. The peaks arising from the N-O and

15

N-O stretches

are marked with an asterisk. The difference spectrum is shown by the gray line, offset for
clarity.
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Figure 6.23. The reaction of complex 12 with NO at room temperature displaces the
carboxylate groupe of the MTS ligand.
The reaction of complex 12 with NO at -70˚C produces a slightly different
species. The absorbance spectrum exhibits a broad shoulder at around 430 nm, two weak
features at 515 and 554 nm, and a broad feature at 683 nm (Figure 6.24). The EPR
spectrum exhibits g-values of 4.33, 3.98, and 2.0. This rhombic spectrum is indicative of
a S = 3/2 species and closely resembles spectra reported for related high-spin {FeNO}7
adducts (Figure 6.24, inset).

320

EPR

Figure 6.24. Absorbance spectrum of the reaction of complex 12 with NO at -70˚C in
CH2Cl2. Inset: EPR spectrum obtained from this species at low temperature, obtained in
frozen CH2Cl2. [Fe] = 1.19 mM

6.B.iv. Additional reactivity studies of complex 12
Complex 12 was also reacted with acetylferrocenium tetrafluoroborate,
[AcFc]BF4, which is a one-electron oxidant. At low temperature (-70˚C), the addition of
1 equivalent of [AcFc]BF4 resulted in the formation of the species 12ox with features at
415, 450, and 495 nm along with a very intense feature at 737 nm (Figure 6.25, top). The
complex 12ox was then treated with cyanide to mimic the binding of superoxide to the
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ferric center.

This resulted in a new species (12-CN) with intense features at 453 and

536 nm (Figure 6.25, bottom). Attempts to grow X-ray quality crystals of this species
were unsuccessful.

Figure 6.25. Top: Absorbance spectrum of the reaction of complex 12 with 1 equivalent
of [AcFc]BF4 (red dashed line) at -70˚C in CH2Cl2. Bottom: Absorbance spectrum of 12ox
(red dashed line) reacted with an excess of CN- (black solid line) at -70˚C in CH2Cl2.
[Fe] = 1.45 mM.
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6.C. Conclusion
In this chapter, I have described the synthesis and characterization of the first
synthetic models of sulfoxide synthase. These complexes employ two different ligand
scaffolds:

either

(1H-imidazol-4-yl)-N,N-bis((pyridin-2-yl)methyl)-methanamine,

referred to as Lk, or bis((1-methylimidazol-2-y1)methyl-((2-pyridyl)methyl)amine,
referred to as BIPA. These are neutral, tetradentate ligand that mimic the 3-histidine
facial triad found in the active site of SOSs. Methyl thiosalicylate and a series of
monodentate thiol ligands were used to mimic the cysteine-derived substrate. These
complexes are structural models of the SOS active sites, as confirmed by the crystal
structure of complex 12.
The reactivity of complex 12 towards O2 and its surrogate, nitric oxide (NO), was
explored through a set of preliminary experiments. Treatment of 12 with NO generated a
six-coordinate {FeNO}7 species, as confirmed through IR, EPR, and UV-vis absorption
spectroscopies. The nitrosyl ligand appears to displace the weakly-coordinate carbonyl
donor of the MTS ligand. These results provide an encouraging foundation for future O2
reactivity studies and the synthesis of SOS models featuring alkylthiolate ligands.

6.D. Experimental

6.D.i. Materials
Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Dichloromethane (CH2Cl2) was purified and
dried using a Vacuum Atmospheres solvent purification system and stored under N2. The
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synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox equipped with a freezer set to −30 °C.

6.D.ii. Physical Methods
UV−vis absorption spectra were collected with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisoku Scientific Instruments (Osaka,
Japan) for experiments at reduced temperatures. Infrared (IR) spectra were measured
with a Nicolet Magna-IR 560 spectrometer. X-band EPR experiments were performed
using a Bruker EleXsys E650 instrument equipped with an ER4415DM cavity, an Oxford
Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat. The
program EasySpin (version 5) was used to simulate the experimental spectra.38 1H NMR
spectra were recorded in deuterated solvents using a Varian 400 MHz spectrometer.
Mass spectrometric data were measured using either an Agilent 6850 gas
chromatography−mass spectrometer (GC−MS) with a HP-5 column or a Bruker matrixassisted laser desorption/ionization (MALDI) time-of-flight (TOF) microflex instrument.
X-ray diffraction (XRD) data were collected at 100 K with an Oxford Diffraction
SuperNova kappa-diffractometer (Rigaku Corp.) equipped with dual microfocus Cu/Mo
X-ray sources, X-ray mirror optics, an Atlas CCD detector, and a low-temperature
Cryojet device. The data were processed with the CrysAlis Pro program package91,
followed by numerical absorption correction based on Gaussian integration over a
multifaceted crystal model and then empirical absorption correction using spherical
harmonics, as implemented in SCALE3 ABSPACK scaling algorithm. Structures were
solved using the SHELXS program and refined with the SHELXL program within the
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Olex2 crystallographic package.92 X-ray crystallographic parameters are provided in
Table 6.5.

6.D.iii. Synthetic proceudures
(1H -imidazol-4-yl)-N,N-bis((pyridin-2-yl)methyl)-methanamine (Lk).

Following a

published procedure160, 1H-imidazole-4-carbaldehyde (0.96 g, 10.0 mmol) was dissolved
in degassed methanol and purged with argon. Bis(2-pyridylmethyl)amine (1.80 mL, 10.0
mmol), acetic acid (1 mL), and sodium cyanoborohydride (1.0 g, 16.0 mmol) were added,
and the mixture was stirred for 24 hours under argon. The mixture was treated with acid
until it became acidic. The solvent was removed, resulting in a sticky yellow residue.
This residue was dissolved in dichloromethane and washed with saturated sodium
bicarbonate solution. The organic layer was collected, dried with MgSO4, and the solvent
was removed, resulting in the pure product as a yellow sticky oil (1.29 g, 46 % yield). 1H
NMR (400 MHz, CDCl3): ∂ = 8.5 (d, 2H), 7.7 (m, 4H), 7.5 (d, 2H), 7.2 (m, 2H), 6.9 (s,
1H), 3.8 (s, 4H), 3.6 (s, 2H).

13

C NMR (400 MHz, CDCl3): ∂ = 158.4, 148.8, 136.9,

135.0, 129.9, 123.8, 122.3, 59.2, 56.9, 53.5, 48.1.
2-Hydroxymethyl-1-methylimidazole (HMMI). Following a published procedure161,
Paraformaldehyde (9.95 g, 330 mmol) and 1-methylimidazole (9.6 mL, 120 mmol) were
combined in a large round-bottom flask. This mixture was heated (using a heating
mantle and the flask was wrapped in glass wool) to 160˚C for 1.5 hours, which resulted in
a color change to dark brown. The heating mantle was removed, and methanol was
added (12 mL). After cooled to room temperature, the mixture was filtered with celite,
and the dark brown filtrate was put in the freezer. After one day, crystals formed. These
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crystals were collected and dried (3.11 g, 23.1 % yield). 1H NMR (400 MHz, CDCl3): ∂
= 6.8 (s, 1H, ArCH), 6.7 (s, 1H, ArCH), 4.6 (s, 2H, CH2O), 3.7 (s, 3H, NCH3).
2-chloromethyl-methylimidazole hydrochloride (CMMI HCl). Following a published
procedure162, thionyl chloride (11.73 mL, 161.7 mmol) and chloroform were combined in
a flask and cooled to 0˚C in an ice bath. HMMI (3.11 g, 27.7 mmol) was dissolved in
chloroform and added to the cooled solution dropwise. This mixture was refluxed at
65˚C for 1 hour, during which a solid formed.

After the mixture cooled to room

temperature, the solvent was removed, resulting in an off-white powder. Diethyl ether
was added and the suspension was stirred overnight. The mixture was filtered, and the
solid was collected and dried (4.18 g, 90% yield). 1H NMR (400 MHz, MeOD): ∂ = 7.6
(s, 1H, im), 7.5 (s, 1H, im), 5.1 (s, 2H, CH2-im), 4.0 (s, 3H, im-CH3).
bis((1-methylimidazol-2-y1)methyl-((2-pyridyl)methyl)amine (BIPA).

Following a

published procedure162, CMMI HCl (3.76 g, 22.5 mmol) and dichloromethane were
added to a round-bottom flask and cooled to 0˚C in an ice bath. 2-aminomethyl-pyridine
(1.17 mL, 11.3 mmol) was dissolved in dichloromethane and added to the cooled solution
dropwise. Triethylamine (6.28 mL, 45.1 mmol) was diluted in dichloromethane and
added to the cooled solution dropwise. This mixture was refluxed at 40˚C for 48 hours,
during which the reaction because dark brown.

After the solution cooled to room

temperature, it was washed with 50 mL deionized water five times. The organic layer
was collected, dried with MgSO4, and the solvent was removed, resulting in a brown oil
(0.923 g, 27.8 % yield). 1H NMR (400 MHz, CD3CN): ∂ = 8.5 (d, 1H, pyr), 7.7 (m, 1H,
pyr), 7.3 (d, 1H, pyr), 7.2 (t, 1H, pyr), 6.9 (s, 1H, im), 6.8 (s, 1H, im), 3.7 (s, 2H, CH2pyr), 3.7 (s, 4H, CH2-im), 3.3 (s, 6H, im-CH3).
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[Fe(Lk)(MeCN)2](OTf)2 (11). Lk (0.838 g, 3.0 mmol) and Fe(OTf)2 (1.06 g, 3.0 mmol)
were combined in acetonitrile (~8 mL) and stirred for 3 hours. The solution was filtered,
the volume was reduced, and layered with diethyl ether. After a day, a dark brown oil
formed. The liquid was decanted and the oil was washed with diethyl ether. Drying of
this oil resulted in a brown powder. X-ray quality crystals were grown from allowing the
decanted mother liquor to sit at -10˚C for several days. 1H NMR (400 MHz, CDCl3): ∂ =
119.8 (s, 1H), 95.1 (s, 1H), 81.5 (s, 1H), 79.2 (s, 1H), 74.6 (s, 1H), 51.5 (s, 2H), 50.9 (s,
1H), 33.1 (s, 1H), 16.9 (s, 1H), -5.5 (s, 2H).
[Fe(Lk)(MTS)]BPh4 (12).

Complexes 12-15 were prepared following the same

procedure. Methyl thiosalycilate (0.036 g, 0.2 mmol) and triethylamine (30.7 µL, 0.22
mmol)

were

combined

in

dichloromethane

and

stirred

for

30

minutes.

[Fe(Lk)(MeCN)2](OTf)2 (0.146 g, 0.2 mmol) was dissolved in dichloromethane and
added slowly. This mixture was stirred for one hour, and the solvent was removed. The
remaining residue was taken up in methanol and filtered. Sodium tetraphenylborate (0.07
g, 0.2 mmol) was also dissolved in MeOH, and added to the product solution.

A

precipitate formed immediately. The solvent was removed, and the residue was washed
with methanol to give the pure product complex. X-ray quality crystals were grown by
layering a solution of 12 in DCM with pentane. 1H NMR (400 MHz, CDCl3): ∂ = 81.7 (s,
1H), 59.5 (s, 2H), 53.9 (s, 2H), 42.9 (s, 1H), 27.9 (s, 1H), 18.3 (s, 1H), 11.3 (s, 3H,
COOCH3), 7.2 (s, 8H, B-Ar), 6.8 (s, 8H, B-Ar), 6.7 (s, 4H, B-Ar), -3.9 (s, 2H), -6.5 (s,
1H), -14.8 (s, 1H).
[Fe(Lk)(PhS)]BPh4 (13). Product isolated as an yellow powder.

1

H NMR (400 MHz,

CDCl3): ∂ = 78.8 (s, 1H), 73.6 (s, 1H), 70.1 (s, 1H), 67.9 (s, 1H), 59.1 (s, 2H), 56.7 (s,
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2H), 38.0 (s, 1H), 20.2 (s, 1H), 7.46 (s, 8H, B-Ar), 6.9 (s, 8H, B-Ar), 6.8 (s, 5H, B-Ar), 12.7 (s, 2H), -21.2 (s, 1H).
[Fe(Lk)(MePhS)]BPh4(14). Product isolated as an orange solid.

1

H NMR (400 MHz,

CDCl3): ∂ = 78.6 (s, 1H), 68.7 (s, 1H), 59.4 (s, 2H), 57.2 (s, 2H), 38.5 (s, 1H), 35.2 (s,
3H, S-Ar-CH3), 20.6 (s, 1H), 7.5 (s, 8H, B-Ar), 6.9 (s, 8H, B-Ar), 6.8 (s, 5H, B-Ar), -12.7
(s, 2H), -18.5 (s, 1H).
[Fe(Lk)(Me3PhS)]BPh4 (15). Product isolated as a yellowish brown solid.

1

H NMR

(400 MHz, CDCl3): ∂ = 61.8 (s, 1H), 54.1 (s, 2H), 52.9 (s, 1H), 49.4 (s, 2H), 33.7 (s, 1H),
29.1 (s, 1H), 23.3 (s, 1H), 9.4 (s, 3H, S-Ar-o-CH3), 8.7 (s, 6H, S-Ar-m-CH3), 7.6 (s, 8H,
B-Ar), 7.0 (s, 8H, B-Ar), 6.8 (s, 4H, B-Ar), -4.9 (s, 2H), -7.6 (s, 1H).
[Fe(BIPA)(MeCN)2](OTf)2 (16). BIPA (0.97 g, 3.1 mmol) and Fe(OTf)2 (1.11 g, 3.1
mmol) were combined in ~8 mL acetonitrile. After stirring for three hours, the solution
was filtered. The volume was reduced and layered with diethyl ether. After a few days, a
dark brown solid formed. The liquid was decanted, and the solid was washed with
diethyl ether and dried. 1H NMR (400 MHz, CDCl3): ∂ = 96.2 (s, 1H), 87.9 (s, 1H), 78.9
(s, 1H), 57.1 (s, 2H), 52.3 (s, 1H), 51.0 (s, 1H), 46.7 (s, 1H), 45.8 (s, 1H), 16.7 (s, 6H, imCH3), -12.5 (s, 1H).
[Fe(BIPA)(MTS)]BPh4 (17).

Complexes 17-20 were prepared following the same

procedure. Methyl thiosalycilate (0.036 g, 0.2 mmol) and triethylamine (30 µL, 0.22
mmol)

were

combined

in

dichloromethane

and

stirred

for

30

minutes.

[Fe(BIPA)(MeCN)2](OTf)2 (0.148 g, 0.2 mmol) was dissolved in dichloromethane and
added to the substrate solution. After stirring for 1 hour, the solvent was removed. The
remaining residue was taken up in methanol and filtered. Sodium tetraphenylborate
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(0.068 g, 0.2 mmol) was dissolved in methanol and added. The solvent was removed,
and the residue was washed with methanol resulting in the product. 1H NMR (400 MHz,
CDCl3): ∂ = 59.8 (s, 1H), 57.8 (s, 1H), 52.8 (s, 2H), 51.2 (s, 2H), 49.2 (s, 2H), 40.5 (s,
1H), 23.5 (s, 1H), 22.9 (s, 1H), 17.9 (s, 3H, COOCH3), 15.4 (s, 6H, im-CH3), 7.5 (s, 8H,
B-Ar), 7.0 (s, 8H, B-Ar) , 6.7 (s, 4H, B-Ar), -1.9 (s, 1H), -5.2 (s, 1H), -16.9 (s, 1H).
[Fe(BIPA)(PhS)]BPh4 (18). Product was isolated as a brown yellow solid.

1

H NMR

(400 MHz, CDCl3): ∂ = 77.2 (s, 1H), 76.2 (s, 1H), 69.7 (s, 1H), 61.1 (s, 1H), 57.0 (s, 2H),
56.0 (s, 1H), 55.3 (s, 1H), 53.9 (s, 1H) 52.6 (s, 1H), 49.9 (s, 1H), 41.9 (s, 1H), 19.5 (s,
1H), 15.3 (s, 6H, im-CH3), 78.4 (s, 8H, B-Ar), 6.9 (s, 8H, B-Ar), 6.7 (s, 4H, B-Ar), -11.2
(s, 1H), -18.3 (s, 1H), -24.0 (s, 1H).
[Fe(BIPA)(MePhS)]BPh4 (19). Product was isolated as a yellow brown solid. 1H NMR
(400 MHz, CDCl3): ∂ = 69.7 (s, 1H), 61.3 (s, 1H), 57.0 (s, 2H), 56.0 (s, 1H), 55.2 (s, 1H),
52.7 (s, 1H), 49.7 (s, 1H), 19.5 (s, 2H), 15.3 (s, 6H, im-CH3), 3.1 (s, 3H, S-Ar-CH3), 11.1 (s, 1H), -18.3 (s, 1H), -23.1 (s, 1H).
[Fe(BIPA)(Me3PhS)]BPh4 (20). Product was isolated as a yellow green solid. 1H NMR
(400 MHz, CDCl3): ∂ = 66.4 (s, 1H), 63.0 (s, 1H), 58.4 (s, 1H), 57.3 (s, 1H), 54.7 (s, 2H),
51.7 (s, 1H), 49.9 (s, 2H), 30.5 (s, 3H, S-Ar-o-CH3), 26.2 (s, 6H, S-Ar-m-CH3), 21.4 (s,
2H), 15.1 (s, 6H, im-CH3), 7.7 (s, 8H, B-Ar), 6.8 (s, 8H, B-Ar), 6.6 (s, 4H, B-Ar), -5.9 (s,
1H).
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Table 6.5. Summary of X-ray crystallographic data collection and structure refinement.

a

R1 = S ||Fo| - |Fc|| / S|Fo|; wR2 = [Sw(Fo2 - Fc2)2 / Sw(Fo2)2]1/2
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CHAPTER 7
Conclusion

O2
20˚C

O2
-80˚C

ABSTRACT
Mononuclear nonheme iron dioxygenases (MNIDs) play a central role in the catabolism
of amino acids, bioremediation, and biosynthetic pathways. In this thesis, we have
focused on two classes of MNIDs – aminophenol dioxygenases (APDO) and thiol
dioxygenases (TDO). The former participates in tryptophan degredation, while the latter
catalyzes the initial step in the catabolism of cysteine and related compounds. The
catalytic mechanisms of these enzymes are still debated, but it has been proposed that the
redox-active nature of the substrates is critical for activity. We have developed a series of
synthetic active-site models to answer this central question. These complexes were
characterized via crystallographic, spectroscopic, kinetic, and computational methods.
The high-spin iron(II) complexes feature a facially coordinating scorpionate ligand to
replicate the enzyme active site – either a hydrotris(pyrazolyl)borate (Tp) or
tris(imidazolyl)phosphine (TIP) scaffold. The reactions of these complexes with
dioxygen were studied extensively, and the resulting intermediates were interrogated with
multiple spectroscopic and computational methods. At room temperature, the same
products were collected as seen in the enzyme, but reactions at low temperature yielded
insights into the different intermediates formed. Collectively, our studies have elucidated
aspects of the poorly understood catalytic mechanisms of nonheme iron dioxygenases.
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My doctoral research centered around the synthesis and characterization of
several iron complexes related to mononuclear nonheme iron dioxygenases (MNIDs) and
their reactive intermediates. Initial studies focused on cysteine dioxygenase (CDO) - a
MNID that utilizes a unique 3-histidine facial coordination environment around the iron
containing active site. This enzyme regulates the levels of cysteine in mammals by
converting this amino acid into the corresponding sulfinic acid using molecular oxygen.
In

order

to

model

this

active

site,

a

neutral

tridentate

ligand

scaffold,

tris(imidazolyl)phosphate (TIP), was used along with a bidentate substrate ligand, such as
cysteine ethyl ester (as in complex 1) or cysteamine (as in complex 2). These complexes
contain a high-spin, five-coordinate ferrous center that can bind and activate O2. It was
found that complexes 1 and 2 react with O2 at room temperature to form the
corresponding sulfinic acid, as seen in the enzyme. However, no intermediates of this
reaction were detected, even at low temperatures.
Computational studies were then performed in order to further understand this
reaction. The potential energies were computed along the S = 1, 2, and 3 surfaces using
density functional theory (DFT). It was found that the S = 2 surface was the lowest in
energy, and the formation of the Fe-O-O-S cyclic intermediate was the rate-determining
step. The Fe/O2 adduct and the transition state of the rate-determining step were studied
further. Both of these species carry a large amount of unpaired spin density on the sulfur
atom of the substrate ligand. In the transition state, this spin density localized on the Sdonor orients itself to align with the spin density on the distal oxygen atom, allowing for
the formation of the O-S bond. Therefore, sulfur radical character appears to facilitate
the formation of the O-S bond in the rate-determining step.
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A common strategy used to gain more insight into the binding of O2 and the
ferrous-superoxo intermediate is to use small molecule analogues that are more
spectroscopically active. Nitric oxide (NO) is frequently used to mimic O2 because it is a
diatomic molecule with an unpaired electron in a π* molecular orbital. NO reacts with
ferrous centers to form a {FeNO}7 species, which can either be high-spin (S = 3/2) or
low-spin (S = 1/2). It is important to note that the NO adduct of CDO is low-spin, which
is more commonly seen in heme systems. Similarly, cyanide and azide anions are often
added to ferric complexes to mimic the structure of ferric-superoxo intermediates.
Cyanide forms a linear, low-spin S = 1/2 adduct, whereas azide forms a bent, high-spin S
= 5/2 species. Both of these species can be studied by UV-Vis, electron paramagnetic
resonance (EPR), and resonance Raman (rRaman) spectroscopies.
The species formed upon addition of NO to complexes 1 and 2 is dependent on
temperature. At low temperature (-70˚C), an S = 3/2 species is formed, with absorption
features at 440 and 660 nm, typical of a high-spin, six coordinate {FeNO}7 species.
Along with the dominant S = 3/2 feature, a variable amount of an S = 1/2 species is also
observed. This signal displays superhyperfine splitting from the N atom of one NO
ligand based on studies with

15

NO. At room temperature, a new S = 1/2 species is

formed, with UV-Vis and EPR features similar to a dinitrosyl iron complex (DNIC).
Therefore, NO reacts with the ferrous center at low temperature to form a high-spin, sixcoordinate species. This converts to a five-coordinate low-spin species, formed by the
dissociation of one of the imidazole groups of the TIP ligand, which was confirmed by
calculations.

At room temperature, a DNIC forms along with the disulfide bond

formation of the substrate ligand.
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The ferric forms of complexes 1 and 2 were formed by treating the complexes
with one equivalent of acetylferrocenium tetrafluoroborate (AcFcBF4), a one-electron
oxidant. The ferric species was then reacted with a large excess of cyanide. The
resulting cyanide adduct exhibited an intense absorption feature at 645 nm, which is
attributed to the S à Fe(III) charge transfer transition. The EPR spectrum indicated that
this species is S = 1/2, with g-values of 2.20, 2.16, and 1.99. Calculations specified that
this species is six-coordinate. These g-values are slightly different than those observed
for the cyanide adduct of CDO, which appear at 2.38, 2.23, and 1.94. These values are
indicative of the energy splittings between t2g set of d-orbitals. Calculations showed that
this energy splitting is smaller in the enzyme (2780 cm-1) than the model complex (4830
cm-1). Additionally, the Fe-S bond is longer in Fe(III)-CDO at 2.28 Å, whereas this bond
in 1-CN is 2.20 Å. In the rRaman spectrum of the azide adduct, the feature attributed to
the Fe-S bond appears at 377 cm-1. This corresponding feature in the spectrum of Fe(III)CDO occurs at 340 cm-1. This data indicate that the Fe(III)-S bond is significantly
shorter and stronger in the model complex.
Another strategy commonly used to gain further insight into these difficult to
study reactions involves replacing the iron atom with a more spectroscopically active
metal ion. Some mononuclear non-heme iron dioxygenases exhibit equal or greater
activity with cobalt or manganese. In our case, cobalt was used because the starting
complex and O2 adduct contain half-interger spins and large absorption features, which is
ideal for studies with UV-Vis, EPR, and rRaman spectroscopies.
substitution with cobalt does not change the structure of the complex.

Additionally,
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In

these

complexes,

a

monoanionic,

tridentate

ligand

scaffold,

tris(pyrazolyl)borate (Tp-), was used along with the same substrate ligands as the iron
complexes. The Tp- ligands contained either methyl groups (TpMe2, complex 6) or phenyl
groups (TpPh2, complex 7) in the 3- and 5-positions of the pyrazole rings. The metric
parameters of these complexes were similar to those of the iron analogues. Complex 7
does not react with O2 over the temperature range examined here. However, complex 6
exhibited interesting reactivity. At room temperature, this complex reacts with O2 to
form the sulfinic acid product, as seen in the iron analogues and in CDO itself. At low
temperatures, however, a new species formed. The addition of O2 at -70˚C resulted in a
new species with absorption features at 385 and 483 nm. This species could then be
converted back to the starting complex by bubbling argon through the solution or by
warming the solution to room temperature. Reintroducing O2 to the solution or cooling
back down to -70˚C regenerated the O2 adduct. This process could be repeated multiple
times. This indicates that O2 binds reversibly to the cobalt center. This Co/O2 adduct
was also studied by EPR spectroscopy, exhibiting g-values at 2.10, 2.02, and 1.98. This
signal displayed hyperfine splitting from the cobalt center. This data indicate that this
Co/O2 adduct contains a mononuclear, low-spin Co(III) S = 1/2 center.

rRaman

spectroscopy was also used to further characterize this adduct. Upon the addition of O2, a
new feature appears at 1152 cm-1, which shifted to 1091 cm-1 when isotopically labeled
18

O2 was incorporated, the expected shift for an O-O bond. This is characteristic of a

superoxo ligand bound to a transition-metal in an end on (η1) fashion.
Calculations were used in order to understand why the Co/O2 adduct does not
react further at low temperatures to produce the sulfinic acid product. The Mulliken

335

spins were calculated for the rate limiting steps for the iron S = 2, cobalt S = 3/2, and
cobalt S = 1/2 species.

It was found that the transition state barrier is inversely

proportional to the amount of unpaired spin density on the sulfur atom. The Mulliken
spin of the sulfur atom for the cobalt S = 1/2 species is very small at 0.02, and the
transition state barrier is 31.2 kcal/mol. This transition state is too high in energy for the
reaction to progress further. Alternatively, the iron S = 2 species exhibits a larger
Mulliken spin of 0.27 on the sulfur atom, and the transition state is 11.8 kcal/mol,
allowing the reaction to proceed. The geometry optimized structure of the Co/O2 adduct
for complex 6 showed a stabilizing hydrogen bond between the NH2 group of the
substrate ligand and the distal oxygen. This interaction is not present in complex 7 due to
the bulky phenyl groups, which could explain why this complex is stable in the presence
of O2.
Our studies with the cobalt analogues suggest that using a less bulky supporting
ligand increases the chances of observing reactive intermediates. This strategy was
applied to synthetic models of aminophenol dioxygenase (APDO) – an area of research in
our laboratory. APDO is an mononuclear nonheme iron dioxygenase that contains the
common 2-histidine-1-carboxylate (2H1C) facial triad. This enzyme plays a role in the
biodegradation of nitroaramatics, converting aminophenols to picolinic acid. Using the
less sterically-hindered TpMe2 ligand, complex 9 was prepared using 2,4-di-tert-butyl-6aminophenol (tBu2APH) as the substrate ligand. The crystal structure of this complex
revealed a five-coordinate, high-spin ferrous center that faithfully models the structure of
the APDO active site. Complex 9 is also a functional APDO model, as the reaction with
O2 yielded a picolinic acid product derived from oxidative ring cleavage.
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When this complex is reacted with O2 at low temperature (-80˚C), new species
were detected.

Immediately upon the addition of O2, an intermediate formed with

absorption features at 463, 509, and 713 nm (referred to as species A). This species is not
stable, converting over the course of 30 minutes to a new species (B) with features at 503
and 866 nm. These features decay upon warming the solution to room temperature, and
this process is not reversible.
rRaman spectroscopy was used to characterize these different species. Species A
did not exhibit any isotopically active peaks, and thus its identity remains unclear.
However, species B exhibited a number of isotopically active peaks. Upon the addition
of naturally abundant O2, new features appeared at 566, 603, 720, 1092, and 1124 cm-1.
When isotopically labeled 18O2 was used, these features shifted slightly to 558, 598, 717,
1088, and 1122 cm-1. The 15N isotope was then incorporated into the tBu2APH ligand and
the resulting complex was reacted with naturally abundant O2. The peaks at 566 and
1124 cm-1 shifted to 562 and 1117 cm-1, respectively. The fact that some peaks are
isotopically active for both

18

O2 and

15

N indicates that this intermediate forms after the

breaking of the O-O bond. We therefore proposed that species B is an iron-lactone
intermediate, and this hypothesis was confirmed with calculations.
In summary, a series of ferrous complexes that are both structural and functional
models of cysteine dioxygenase and aminophenol dioxygenase have been synthesized
and characterized. Our data suggest that radical character on the substrate ligand in the
Fe/O2 intermediate is required for the reaction to progress. In order to gain a better
understanding of the reactive intermediates, the ferrous center was replaced with
cobalt(II), which is a more spectroscopically active divalent metal ion. When a less
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sterically hindering supporting ligand was incorporated, intermediates of the reaction
with O2 were observed at low temperatures.

This strategy was also used with our

aminophenol dioxygenase models, allowing for the observation and characterization of
intermediates in the reaction with O2.
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